Gene list
Applied filters:
Organism: Buchnera aphidicola str. Bp (Baizongia pistaciae), Bp (Baizongia pistaciae)
Gene type: CDS
Number of genes found: 504
 | ||||||
| Show UniProt / TrEMBL protein name | |
View in Fasta format (DNA) | |
View as list | |
|
| ||||||
# Buchnera aphidicola str. Bp (Baizongia pistaciae), Bp (Baizongia pistaciae) >bbp189 aceE, pyruvate dehydrogenase E1 component MAEFSSNDIDPIETEDWIQAIKSVIREDGLERANFIINTVKKYVPYKNKV VFKKCAISNYVNTIPVEEEPNYPGDLFIEQKIRSVIRWNAIMMVLRASKK NLDLGGHLSSFQSAATIYEVCFNHFFHATNENNGGDLVYFQGHISPGIYS RAFIEDRLTQKQLDNFRQEIDGIGLSSYPHPKLMPNFWQFPTVSMGLGPI CAIYQAKFLKYLEHRNLKCTNNQKVYAFLGDGEMDEPESKGAISIAAREK LDNLIFIVNCNLQRLDGPVIGNGKVIDELESVFKGCGWKVIKVIWGSKWD SLLKKDVSGKLIKLMNETLDGDYQTFKSKNGAYIRKYFFGKYLETQELVK DMSDDQIWNLDRGGHDPKKIYAALSKANSIVGKPVIILMHTVKGYGMGDI AEGKNIAHQIKKIDIKGITYIKNRFKVPVEENELKYLPYVSFDANSIEYK YLHARRKKLGGYLPIRLSNFTNFFTLPKLDEFSTLLTEQKKEISTTIVFI RILNILLRNSFIKDRIVPIIADEARTFGMEGLFRKIGIYNFIGQKYTPQD KELLAYYKEDKKGQILQEGINELGAAASWLAAATSYSTNNFPMIPFYIFY SMFGFQRIGDLFWAAGDQQARGFLIGGTSGKTTLNGEGLQHGDGHSHIQA LTIPNCISYNPAYAYELAVIVHDGLQRMYGPSQENIYYYITTMNENYVMP GISKNMYEGICKGIYKLKHVGKKNVKVQIMGSGSILQCVCRAAEILLEEY DIGSDVYSVTSFTELARNGQDCDRWNLLHPTQEKKVPFVTKIMNKLPAIA VTDYMKLFSEQVRAYIPAVTYRVLGTDGFGRSDSRKNLRRYFEIDEYHIV IAVLGELEKIGDVDKNTIVNAISKFKIDINKVNPRLA >bbp190 aceF, dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex MDKQVVMPDIGTDLVEVIEILVKIGDQVKKDDSLITVEGQKASIEIPASH TGTIKNIIVHIGEKITTGSLIAILNGIDDNVKSKNDSSSYSFKNSKNTST NSNLGNVNNNINNRTILVHATPTVRRLARKFDIKLENITGTGRKGRILKE DVISYKNISLFNDIKKSLKKTNVNYYKDNVTCDDFKSIELTRTQIRSSKN LLKSWLTIPHVTQFDESDITELENFRQKYNSDLKDKSKKLTILIFVIKAV SKALEMFPKFNGRLINKDNRIAIVLNEHINIGIVVDTDDGLLVPVINRVN KKNISSISNDLRIISERARSRKLNFSDIKEYGSFTISNLGGIGGTNFTPI IKYPELAILGISRALIKPYWNSHAFIPKLMLPLSLSYDHRAIDGVAAVRF ITFVKKMLTDIRFLMI >bbp164 ackA, acetate kinase MFNKLVLILNCGSSSLKFSVVSSDNYTTKLSGIVEFLNLSQIRFFWKIKK KEYVRVINKSKSYDYALNYILTKILKEESKIFNNIACVGHRVVHGGVNLN KSVLITQEIIKLITDACSFAPLHNPINLLGIKASHAVLPHLKEKNVAVFD TSFHSSIPKFAYLYAIPYKFYKKFGIRKYGAHGISCQYSVCRSSELLQIE LTSLNIIICHLGGGASVSVVKNGVCVDTSMGLTPLEGLIMGTRSGDIDPS VIFFMNKQLNLSISTINNILINKSGLLGLSGVSSDFRNLESEYNSNIRIK LAIDMFCYRLSKYISGYMSVVKGKLHGIVFTGGIGENSSLVRSIVISKLA FLNFKLNSDINMLMKSGKEGFINIKNTFPILVIPANEELIIAKESFSEIN >bbp322 acpP, acyl carrier protein MQNIEKKIKKIIAQQLGLIEQKITNESLLVEDLNADSLDIVELIMAFEEE FNIEITDEEAENLTSVQSIFDIIKKYVF >bbp237 acpS, holo-[acyl-carrier protein] synthase MSILGVGIDILSILRIKRIIKNKLGTKFSQKILSNYELNILPNCKQNYTK FLANRFSVKEAASKALGTGIRNGLKFSDLELHHDKNGKPYLKFLKQAKKM LQAMNTKSTHVSLSDEKLYVCAIVIFED >bbp428 adk, adenylate kinase MHIVLIGGPGTGKGTQAELLSKKYMLPVISTGHILRKISTKKTLFGEKIK NIINSGKLVPDTIIIKIITNEILHKNYTNGFILDGFPRTIKQAKNLKNTN IQIDYVFEFILPTKLIFKRIQTRTINPITGTIYNNVIQKNSELKNLKINT LKSRLDDQYPIILKRLKEHKKNIVYLKDFYINEQKHKSLKYHEINSQNTI KNVNIEIKKILENKL >bbp171 ahpC, peroxiredoxin 2 MVLVTYPAPDFTASAISCNGDIINNFNFKEFTNNQTSILFFWPMDFTFVC PSEIIAFNQELSKFKKRNVKLIGVSIDSVYVHHAWRNTLSHNGQIDKINF TMVSDLKREIQRSYGIEHPQLGVALRATFLIDKNRIIRHQTINDLPFGRN ISETLRMIDALHFYEKYGEVCPANWKKGDTGIKTTQEGIHKYLEKISKK >bbp364 alaS, alanyl-tRNA synthetase MIYTSNEICQMFLNFFYKKGHTILPGSTLIPNNDPSLLFTNSGMNQFKDI FIQKNYNFKYNRVTTLQNCLRTGGKHNDFENVGYTPQHHTFFQMLGNFSF RDYFKLDAILYAWKFLTSKEQLNLSKEKLWITVYQDDLESYNIWKNIIKI DKHKIIKIGNKYNSSDSDNFWQMGEIGPCGPCTEIFYDYGNTLPGTIPGN NGCNVPRFVEIWNIVFIQFNKLSNGKLIKLTESYVDTGMGLERISAVINN VTSNYEIDLFKPLIKHILELSTVNTPKNKSIYVIADHIRACSFIISENII PSNEKHGYVLRRIIRRAIRHGHNLGIKSLFLHKLIPTLINTMGKFNPVLK KQQNKIENVLKLEEQKFIETLEKGLKLLHKELKQIQPKHVLSGKLAFNLY DTFGFPIDLTIDICKEHNISINIMEFKRYLNQHKQNSINKNFLNTRNAYY IEDNNINIKTHFVGYQFNKTQSIINNIIIKNNKKTLQINDYQNSILFLNE TPFYGESGGQIGDSGIIHNKTGKFIVNCTKMFGNIIGHVGTLASGYLNIH DTVCAEINLPKRKSIQINHTATHLLHASLRKILGKHVFQKGSFISDQSLK FDFSHNAPMNLREIQEVENIINKKIQKNISVSTTLTTLQEIQNKKVMALF QDKYKDKVRMISINDFSVELCGGTHTKYTGDIGLFKITSEISISSGIRRI EAVTGKHAISIIHHQEKTINNIANMLNSKTNNIEQTITKLLNNNIHLKKQ IYTLYNQNIYNIVNSLSKHNILIKDVNIIIKNLKNENLLSLRNIVDKLKN RFKCSVIIISSIINNKSIIIVGVTRNVTDRISALDILNKLTKKLGGRGGG KNNIAEGGIKNLISLPIELKKIKTWISSRL >bbp521 amiB, putative N-acetylmuramoyl-L-alanine amidase MIIAIDAGHGGQDPGAIGKNKFQEKNITLSIAKKLTKLLNHTNFFKAVMI RRGNYFLSVFKRTQIAEKYHANLLISIHANSSKNRKISGVSIWVLPKNVH NTRIQKHKLNKKTKNIHKKINTKTSKFKNFYEIEYDLAKIIIQELRKVST LNQKKPKYAKFGILKFSQFPSILVETGFISNPIEEQHLNKKFYQNLISKS ISIALKKYFLKRIKQYN >bbp132 apaH, bis 5'-nucleosyl-tetraphosphatase MSTYFIGDIHGCFNELMHLLEKVSFDANSDVLWLTGDLINRGPKSLEVLR FVSSLGDNVKMVLGNHDVNLIALYASIKNSKKSSLMNNLLKSHDIDYLIY WLRKQPLFRVDHKKKIIMSHAGMYPYWDIQTASCYAKKIESMLCNHNYDT FLDFLYNNSDIKSKLYECTVFKNRELECLKLALNVFTRMRYCLPNGELDM TCKQSPSKNISSLLPWFFIKNSCLEDYCVFFGHWASLEKNITPKNIISLD TGCCWGGILSMFRLEDKKWFVQESEIKK >bbp209 apbE, putative thiamine biosynthesis protein ApbE precursor MAYVINICILYFLIISIQINKVQKKYETVFLCGYTMGTTWKVKIINNRHL TYYNLKKKIEKQLCYDNNQISSWNKNSDISNFNKNFTTKPQKINKNLAKL ISIGLLVGKKTNNLLDITSGTLINIWGFGPTSRKHSIPSKKTIKLAQMLT GLNHIKLLINKQQYYLQKDIPKLQINLSTLGEGFAADNLKRILDDEGIND YYISIGGTVVTHTSPKNSQNKIIAIQKPTETDNEIHCLISLKNNAVSTSG TYRNYYTLHKKIIHIINPITGNPANTDLVSVTVISKSALKSDAWDTGLIL LGFRQAKKISIQEKLAVCLIKKNKSTLFTWTSPQFKKFLIK >bbp333 argF, ornithine carbamoyltransferase anabolic MNALYKKNFLKLSDFTSLDIRNIINIACILKYQKKNKNEFPYLKNKNIVL IFEKQSTRTRCAFEIASFDQGAQVTYLGPGSTHLGYKESIQDTARVLSSI YDGIQYRGHNHETIKNLAKYSNVPVWNGLTEKFHPTQILADLLTIYETLP EKSFCNIKCAYVGDARNNISNTLLEASSLLGLNLCLVAPKCFWPNYDFFL KCQLKAKKNHGNIICTEDIQKGVRGADFIYTDVWVSMGEPKKTWHNRIKL LKKYQVNLKMLLLTQNKKIKVLHCLPSFHDKNTIVGEEIINKHNLDNGIE ITNQVFNSQSDVIFRQSENRLHTIKALLLSTLLKEFPYI >bbp048 argG, argininosuccinate synthase MRNKNIKKVVLAYSGGLDTSAIIPWIKENYSSEVIAFVANVGQNQADLKD IEYKALKSGASQCIIKDLREEFIRDYVYPVLKSGALYEENYLLGTALARP IIAKSQVDLALKLKADGVCHGATGKGNDQVRFETAYVGLAPELKIIAPWR EWSFKSRGELLSYLKEKNVKTTASIEKIYSKDENAWHVSTEGGVLEDLWN KPNQDCWTWTNDPKDAPNVPEIISIKIKNGSVIAVNNEFLSPFKCLEKLN LVGIKHGIGRIDVVENRLVGMKSRACYETPGGTILVNALRSLEQLVLDRD SYKWRQQIALEMSYVIYNGNWFSPFRKSLQAAATELATEIDGEVILELYK GTVTAIRKFSPNSLYSKEFATFDQDEVYRQSDADGFIKLYSLPSKIRAIN KCMNKALMK >bbp049 argH, argininosuccinate lyase MKLWGGRFVHESNSFFKKFNSSIQTDYKLVEQDIFSSMSWADALLKSGVL IKSECNEIKNALQKLLCIVKKTPNIVLDSNLEDVHSWVETQLILLVGDLG KKLHTGRSRNDQIATDLKLWCKHKIKDLFNRIIEFKIELIKISDNTQSVI MPGYTHLQRAQPITFSFWCLAYLEMIKRDEDRLKDALKRLNSSPLGCGAI SGTTWNIDRENLAKSMGFKSATNNSLDSVSDRDYVVELASVASISMMHLS RFAEDLIFFNSSESKFVELSDTITSGSSLMPQKKNPDSLELIRAKSGRVF GFLVSILVVLKGLPLSYNKDMQEDKKGLFDALNTWSKCLFMSSLVLKNLH INSINCLKASKKSYSNATELADYLVNKGITFRDAHHITGQIVLEALKLNV PLEKLDLSIFKKYSSSIELDVYNFLDVISLLEKRNSKGGVAPKIVSKAII CEKKQLKI >bbp224 argS, arginyl-tRNA synthetase MTIKSIISKHIKKVLNIIKIFITHEDLAIVRTSDKKVWDYQVNGIIKLAN NLNKNPYVLSKYIISNMRYYEYKMYKKITASKLGFINIFINKTWLEKELT KKIKSFRLGIKKVTPKNIIIDYSSPNVAKKMHVGHLRSTILGDATARILE FLGHNVMRINHIGDWGTHFGMIIAYLKQNFISYNEINQLDLNELYQKAKV NFDLDSEFSKKTRNYVVKLQKKDKECIRIWKKIVKKTITENQKIYKKLNV TLTNKHIVGESFYNDMLPDIIQDLKTKKIAKQCNGAYIVFLNKFKNRDGA PMGVIIQKQDGAFLYSTIDLACLKYRCEVLRADQILYFIDSRQKEYLKQI LEIAKKAGYISNNIIIRHNEFGMICSKNKRPFSTRSGNNIILSDLINEAI KRAKKIAKNKNKNLSNKELEYLSEKIGIGAIKYFDLSKNRLTDYIFKWDE ILTFDGNTAPYMQYAYIRILSIFKKLNISMLKLSGNIILTELLENKLAIK LFQFEEIILESLQHSAPHIICKYLYELSKIFSKFYEKCSIYKSKNTKIRK NRLLLSLLTARTLKKGLFIIGISTIKYM >bbp288 aroA, 3-phosphoshikimate 1-carboxyvinyltransferase MHECLTLNPISLVNGTINLPGSKSITNRALLLSAMSNSTTHLKNILYSQD TQYMLNTLKICGIKFNCSYTNLSCTIEGCNKPLNISHKTSLFLGNAGTAF RSLAAIFSLNNNNILLTGNKRMKQRPIKHLVQALQQGGAQITYSEQDQYP PIKIKGGFIGGNIFVSGKISSQFLSALLIATPLAQLDSTITVTEKLVSKP YIDITLNLISKFGIKIIHKDYTKFNVQGRQKYISPKEYSIEGDASSASYF LAAAAIKGGSVKVTGIGLNSIQGDVKFANVLKKMGAYITFGKDFIVCKKK DLIGIDLDMNDIPDAAMTIAIVALFSKGKTVIRNIYNWRVKETDRLSAMT NELKKIGAQVIEGNDYIEILPPINFVYAKINTYDDHRIAMCFALIALSGI KVTLLNYKCVNKTFPDYFQKLKSICSY >bbp480 aroB, 3-dehydroquinate synthase MVNLGKDTYPVYIGSNLLEISNIFFPIESNTQVAIITNDVVFKIWNKKIT YYLHKLGAQVKNVIISDGEIYKNIDTVEIILSTLLKYSYCRDAVLIALGG GVIGDITGFVASIYQRGIKFVQIPTTLLAQVDASIGGKTSVNHVLGKNMI GSFWQPSSVIINFDFLNTLPRRQLISGIAEIVKYAVSFDVNFFNWLEENL ERVLKLDYSALSYCINRCCEIKISIVEKDEKEIHDRMLLNLGHTYGHAIE TFLGYGTWLHGEAVSVGIVMASKTSELLGFMKDNDITRIISLLQRVGLPI SGPKNMSFESYISNFKRDKKVISGKLRMVLPVFIGNVKIFSNVHENILMS VIKNC >bbp091 aroC, chorismate synthase MAGNSIGKLFRVTTFGESHGPKLGCIIDGTPPGLEISENDFQKELDRRRP GTSKYTTQRRELDKITILSGIFQGKTTGTSIGLTVKNTDQRSQDYNNIQK LFRPGHADFTYYKKYGIRDPRGGGRSSARETVMRVAAGAIAKKYLYTKYG ILIRGYLKQIGNITCKLKSWNEVEKNPFFCPDVKQINNLNLLIKKLKKEG DSIGAKIKIIAEKVPIGLGEPVFDRLDADLAHSLMSINAVKGVEIGDGFA VVNQKGSEHRDEMNKHGFTNNHAGGILGGISNGENIIATIALKPTSSIKK IGKTIDLHGREQKISILGRHDPCVGLRAVPIAEAMMSITIMDHILRHRGQ CSKTY >bbp437 aroE, shikimate 5-dehydrogenase MVKHCIDQFCVFGNPINHTQSPYIHSLFSKQTGIVYEYSARLVPFKEFNS YVLNFFLNKGKGANITVPFKENAYVISNNLTIRAKMSRAVNTFKKLHNNK ILGDNTDGIGVLHDLKRIKFIKSKFNRVLLIGAGGAARGIIFSLLSYGCS IVVLNRTITRALQLVEDFKNVGSISIFKEKFASNYSFNLIINATTINICQ NSNLSTIKSLIHKDVYCYDINYSIKHKYTEFLLWCIKNGAICVSNGIGML VSQAAHSFYLWYGILPETNSIICKLNRQFYML >bbp118 aroH, phospho-2-dehydro-3-deoxyheptonate aldolase MKKTDELRTIRIDPLVTPAELAQRHVITPSIMDTVISTRKNIANIMTGLD PRLLVIIGPCSVHDPVAAVEYAGRLQVLRKKYESRLEIVMRTYFEKPRTV IGWKGLISDPDLNGSFHVNNGLSIARKLLLDINKLGVPAATEFLDMVIGQ FIADLISWGAIGARTTESQIHREMASALSCPVGFKNGTDGNIRIAVDAIR AASVEHLFLAPNKYGQMTINYTSGNPFGHVIMRGGKSPNYHAKDIAIAIK YLHEFTLSEYLMIDFSHGNCLKQHRRQLDVGESIAKQIRDGSTAIFGVMI ESFLEEGSQKVIDNKSLVYGKSITDPCLGWNDSAFLLEKLANAVDSRF >bbp481 aroK, shikimate kinase MTEKRNIFLIGPMGAGKSTIGRHLAQQLSMEFYDSDQEIEKRTGVDVSWI FDIEGELGFRKREQKIISEIIDKRGIVLSTGGGSILSREIRNKLSSRGVV IYLETSVEKQLVRTKKNKQRPLLQVDNTSIQTVLEELAFHRNPLYQSIAD ITIRMNDRSIKAIVFYIIRLLNNF >bbp362 aroQ, 3-dehydroquinate dehydratase MKELFNILLINGPNLNLLGHREPKIYGNTTLSQLTHALTKEATTFNIHLH HIQSNSESTLINKIHNSKNNINYIIINAGAFSHTSIALRDALIGINIPFI EVHISNIYTRENFRSHSWLSDISSGVICGLGLDGYFWALRTAIKRIKKIS TLQV >bbp398 asd, aspartate-semialdehyde dehydrogenase MKKNIGLIGWRGMVGSVLVERMICENDFFHFNPIFFSTSQKNSKGPTING EYFGVLKDAYDLDILKELDILISCQGSDYTNKVYFKLRDIGWNGYWIDAA SVLRMNQDTVIILDPVNSNTIRESIDSGFKTFVGGNCTVSLMLMSLGGLF SEKLIEWITVSTYQAASGSGAKYIEELLMQMGSMYTEASGYLGNPAHSIL NIEKKVRNLSCSDKFPKKNFKVPLAGSLIPWIDKKMRNGQSREEWKIQAE TNKILSSNKDILIDGLCVRIGALRCHSQSFVIKLKKDISIPEIEQILLNH NSWTKVIPNRKHDTMTELTPAAVTGTLNTPVGRLRKLNIGQKYLSAFTVG DQLLWGASEPLRRMLKFLI >bbp329 asnS, asparaginyl-tRNA synthetase MKTVSIFDIYLNKIKLNSKINIQGWVRNRRRSKLGLLFIDLYDGSCLYTM QVVVKDILSNYDSEISKLSVGCSINVFGVLISSIGTKQKYEIQAKVVKVI GIINNPGSYPISSKYHTMKHLRNVPHLRSRTNFFGAVSRVRNYLFNALHE FLFKNGYYWIPSPIITGLNSEGAGDMFKVSILDLNNIPKNKNGKINFKKD FFGKEAFLTVSGQLTLETYACSLSKVYSFGPIFRAENSNTRRHLSEFWML EVETAFSNLCDIIKFSENMLKYAIGIILDKCVIDINFFRENVDEKIFCRL KDFSSKQFFQIEYKEAINILIKSNRFDHKVMFIGMELSSDHERFLVEEYF KFPLVITNYPKSLKAFYMRVNDDNKTVSAMDVLVPGVGEIIGGSEREERL NVLDRRFFELNLNKEDYWWYRDLRKYGTIPHSGFGLGFERLLSYILGIKN IRDVCPFPRTAYKADF >bbp293 aspS, aspartyl-tRNA synthetase MRTNFCGTLNVSHVGKTIKLCGWVNKFRNLKEILFIDIRDQTGIIQVLFS KKSELLFKKAADLRNEFCIQVLGIVQERITKNKNYTMSTGEIEIFALELK IFNKSQPLPIDLKSCNIEETRLKFRYLDLRHPNMIRNIIIRNDITIIIRN FMKKNKFLDIETPILTKSTPEGARDYIVPSRIHKNKYYALPQSPQLFKQL LMISGIDRYYQIAKCFRDEDLRSDRQPEFTQIDIEVSFLNAKKVRKIIER MITSVWNKIINVHLKKFQKLSFYDAIKMYGTDKPDLRNPIQLIDVTNIIH VKNNINAITLPNKKTQQNIVIAMCIPRGMSLNINYINSYHHLVQKYTKNK LFNVEVLNHCPIKEQKKTSFHKKPSSDLTFQLISKTSAKHGDMIFYLSEK SPLVYEIMGKLRIELGKDLNLIDYNSWKPLWITNFPLFKKNELNQYISTH HPFTAPKYMKIDTSITNYEEIVADSYDLVINGYEIGSGSVRIHDLELQKT VFNILGINTVLQKNNFNFFLNALKYGTPPHAGIALGLDRITMLLTNSHNL RDVIAFPKTTTGSCLTTGAPSKIIHF >bbp006 atpA, ATP synthase subunit alpha MQISSSEICELISKKIAKFDIISSMHNEGRVISVSDGIIQIYGLSDVMQG EMLSLPGDKYAIALNLEKNVVGAIVMGEYTHITEGTKIISTGRIFEIPVG SKFLGRVINALGVPIDGKGRIQEEKFLPVEINAPGVIDRQKISEPLQTGY KSIDAMVPIGKGQRELIIGDRQTGKTSLAIDTIINQRNTKIKCIYVAIGQ KFSTIVNLVRQLEDNQALNHTIVIVASASESAALQYLVPYSGCSLGEFFR DQGKDALIVYDDLSKHAIAYRQISLLLRRPPGREAFPGDIFYLHARLLER ACRVNSNYLKNILGTVNKFSTGSLTALPIIETQDGDVSSFIPTNVISITD GQIFLESNLFNSGIRPAINPGISVSRVGGAAQCQIIRKLSSGIRTSLAQY QELIAFSQFSSELDEITRNQLIHGKKLIEILKQKQYHPMSIAEQAIILFA AENNFLNDVSVEQIIKFEKMLLLFFNTNNSELVLSINNYKRINDVVENQL SDVINAFKLTKCWS >bbp002 atpB, ATP synthase A chain MNLEHNFNLPNYINHHLHHLQLNLSNLKFLNFNDNYIRNFWVCNFDSIFL SIFLGLVILISFFKISKTFTIQTPNKIQICIELIIDFINNNVKEIYHGKN KLIAPLSLTIFVWIFLMNLMDLIPIDLVPFIFQNFFETQIPIKLVPTTDV NITISMSLVVFLLIIFYSIKIKGIKGFLKDLFLQPFHNPIFFVFNFILES ISLLSKPVSLGLRLFGNMYAGEMIFILISGLLPWWLQWILSVPWAIFHIL IISLQSFIFMVLTIVYLSMASTKH >bbp009 atpC, ATP synthase epsilon chain MNNNKVYSLNVVSFEKIIFNDFVKKIQVSGSEGELGIYPGHLQLLSLIKP GPLLILDDHDYQHVIYISGGIIEVQPTVVSILADTAIRGLDLDLNVVLDK KLKLENKISNVDCIDRNDVIQQLSCELAKLRVIEMFKNQYIKKNN >bbp008 atpD, ATP synthase beta chain MITGKIVQIIGAVVDVEFSQQSVPKIFNALKVDNQGSILILEVQQQLGSG IVRTIAMGSSNGLKRGLLVVDLEHGIKVPVGTATLGRIVNVLGQPIDMKG PLKNHDNSDIEYWEIHRKAPSYSEQLTSYEVLETGIKVIDLICPFSKGGK VGLFGGAGVGKTVNMMELIRNIATEHSGYSVFTGVGERTREGNDFYHEMS DSRVLDKVSLVYGQMNEPPGNRLRVAFTGLTIAEKFRNEGHDVLLFIDNI YRYTLAGTEVSALLGRIPSAVGYQPTLSEEMGVLQERITSTNKGSITSIQ AVYVPADDLTDPSPATTFSHLDSTITLSRQIVSLGIYPAIDPLNSTSRQL DPRIVGQLHYDVALGVRSILQRYQELKDIIAILGMDELSEDDKILVSRAR KIQKFLSQPFFVAEIFTGFSGKYVKLQDTINGFKDIIEGKVDHVPEQAFY MVGSINEVIEKSKKL >bbp003 atpE, ATP synthase C chain MDNVSMDMLYIAVAVMIGLAAIGAAVGIGILGSKFLEGVARQPDLTSLLR TQFFVVMGLVDAIPMIAVGLGLYMLFAVI >bbp004 atpF, ATP synthase B chain MDFNVTIVGQAISFVLFVFFCMKYVWPSVIFIIETRQKEIKDSLTFIENS KKELNIFKENSKNEIKIIKKNASKIIDSAIQQKTQILKQAYLAAEKEKQT ILKQAKLDVMIEYQKARYELRQKVSKIAVEIAKKIINRSICIEEQNSIIS SLIKKI >bbp007 atpG, ATP synthase gamma chain MIGIREIRSKMKSINNTKKITKAMEMVSISKLRKIKKRMCSSRPYFNIIN QVISHVITGNLEHYHTYFNQRNVKRIGVIIVSTDRGLCGNLNTLLFKKVL EVLTEHINEHILNNLFVIGTKALTFFKSFTNNIVFSLSNLKNDFKIIDLM EMIRISLEMYISGKIDKLFLAYNKFNSTIIQTPTLVQLLPILKPKLGKKE VKKTWDYIYESNSKVLLNVVLNRYIEFQIYQSILENLVCEQASRMLAMKQ ATDNSADLLKALQMNYNKVRQSSITQELTEIISGAAAVSLN >bbp005 atpH, ATP synthase delta chain MSSTKDELQLYAKAIYNCAISNHQSLDHWKTMLQLMANILNNEIIKNLIS KAYFSQHVISLFIDLCCNKVNQYGINLIKILAENKRLMLLEKLYKEFINL CELYQGVVNITVISAHKLNEEYISKINIMLKKRFFKKINVTYVIDESIIG GLIIKFCDTVINASIHSRLEKLLNILQY >bbp058 bacA, bacitracin resistance protein MTMTTNIFNAIILGIVEGITEFFPISSSGHLLIFTNILEMKNNEIKILNT IIQTGAALSILLHFKEKFVIFLEQIFICKQITKKNDLIYHHIILGNIPII FIGLCIYQYIKYLSNFYSIIYALIFGTILLILTEISKTKISSNKNIETPQ ILIIGIFQCLALWPGFSRSCATISAGILSGLKQSKSVEFSFILSVPIFFG ASVLDVINNFYDISINNIPMLFSGFLSAFITSNIVIKRCLNTMKNCSLIP FIIYRSILSIIIYLFFMH >bbp273 bioA, adenosylmethionine-8-amino-7-oxononanoateaminotr ansferase MQKNNLNFDKQHIWHPYASMIQPTPCILVKSAKGIILKLHNGKKLIDGMS SWWSTIHGYNHPRLNNALKNQINKMSHVMFGGITHYPAISLCKKLIEITP NSLTRIFLSDSGSVSIEIAIKMILQYWQSLGKNKVIFLTIKKSYHGDTFA AMSVCDPKNSFHQFYHNFLPINIFADNPKCSFDGLWNKKDIISFKKLIQK HKDVVAAVILEPIVQSVGGMKFYHPNYLKQVRFLCDLYKIPLILDEIATG FGRTGKFFAFEHSNIVPDVLCIGKAITGGTITLSATLTTDKIANVISNSA SGCLMHGPTFMGNPLACAAAYENILILQENKWKIQVKNIETCLRTYLFPL KTHYEVYDVRVLGAIGVVECYHYINISMMQNYFVKNNVWIRPFRKLIYLV PAYIIDNASLKKLINVISNALNYENFFMK >bbp272 bioB, biotin synthase MKTQWNFEKVKELFDQPFFDILFLAQNIHRKNFNANQIQISTLLSIKTGA CPEDCKYCPQSARYKTNIKIEKLLTLKQILKSAQQAKKLGSTRFCMGAAW KNPKERDMHFLKTVIQEVKKLGLETCMTLGTLHNDQADRLAKAGLDFYNH NLDTSKSYYQKIVTTRTYQDRLNTLKKVRKSGMKICSGGILGLGEKLKDR IELLIELSNLEIAPESIPINMLVKVKGTPLENQTSIDTFDFIKTIAITRI MMPTSYIRLSAGRENMNEQTQAMCFLSGANSIFYGCKLLTTPNPKKERDK QLFSKLGLNIKHKNTNLNYSILSDNSLNYTSKIHSQQFYNAETA >bbp270 bioC, biotin synthesis protein BioC MIDKKKIAEAFGKAAANYDNFSVIQRIAGNILLSKIETFFNISILDAGCG TGWFSKKWRQLGNTVTALDFSKNMLLTAKNTNSADYYLHADMEQLPICDN IFDLSWSNLSLQWCNKFNKAISELCRVTKPGGMVVFSTIAHGSLYEFNKA YRTINSSYQENKFLSINDIKLSCCNKKTLIDNILITFSFSKILEAMYSFK KIGANYISSNHSKILTKKKIRQLQENWPYNPNGYLLSYRFVFGVIYL >bbp269 bioD, dethiobiotin synthetase MKNCWFITGTDTNIGKTVSSIILLELARRYGYNTSGYKPIAAGCRTNDFK QYNSDAVLLRKFSTVKLSYQEVNPYLFIDPVCPFFTNEKNHMNVCMNKLS SGLQRLKKKSNWILIEGIGGLHTPFSNEFVMSDWIKKENLKTILVIGIKL GCINHAILTQKAILSSGLEFFGWIANYLLPTDTYNLTHIDILKKNMKSPY LGCIAYTPNIYNQIHHIPITIKLPLQN >bbp271 bioF, 8-amino-7-oxononanoate synthase MNWNKRINHKLNMHIFNKKFRVKVAVQKNNNRIINVNGMQYINFSSNDYL GLRNNARIVQAWKTAATRYGIGSTGSSLITGYSTIHQSLEEKLAKWLDYP KAILFISGYTANTAIISTLIQKNDRIFMDKLSHSSILEPSYNSSGKCYRF IHNNPSSLMNKFYSSSGKNPLIITEGIFSMDGDIAPLSIISSFSKKIKGL LMVDDAHGIGVSGYNGKGSCEQHRVKPDILTITFGKAFGISGAAVLCSNN IAEYLWQFSKHLMFSTAMPIAQAYAIRQALYCIQHADKLRRKLQENINFF LKNSQCLSHLLKCSHTAIQPIIIGDNEETMILSDQLKSKGIWVNAIRPPT VPNKSSRLRITLNALHTKEDIEQLIESIYKLYDR >bbp487 bioH, putative biotin biosynthesis protein MNKKLHWKSLGTGTTNLILIHGWGVNSKIWSILVQSQLYQHFKLHFVDLP GFGHSNQLLPMTLNDTAELLSVYIPKNSILLGWSMGGLIASKIALNYPQK IKGIISVCSSPCFIVRPNWPGIPKKIFLKFYNKLNINFDRTISEFITLQS HNTNYLEIKNLKQQILSQPYPTIYTLKKNLETIFKTDLRTKIKKLKIPML RIYGSLDTFVPKKIREILDILWPKTKSITIAHASHIPFVSHQKEFYESII NFKNYLNTLKITCQK >bbp418 bolA, BolA MIKQKIINLLQKKINYEKLKIYNESKKHNITHNKNSHFKILIVSNYFINI DIIDRHRKIYSWLSIFFFKYKIKSLSIYAYTTLEWKNKKCKSFFNSPLCK NKPNS >bbp135 carA, carbamoyl-phosphate synthase small chain MKHVLRKEKTLEISATLVLKDGTIFYGKSVGIQGETYGEIVFNTSMTGYQ EILTDPSYSNQIITFTYPHIGNVGINKNDCESNVIHAKGLIVRDISSIYS NHRSQMSLLNYLLNQKIIVISNIDTRKLTRILRTTGSQYGYITTKKIHSI INVLKHINILDNPITNKDLVKQVSTKKFYIWKKNVNKQKNNNITNAKLKE KIWHVVVYDFGVKKNILNMLTHRNCYLTVIPADTSAEKVLQILPDGIFLS NGPGDPRSCTYALNAINAFLKINIPIFGICLGHQLLALASGAKIIKMKFG HHGSNHPVKELKSNTVMITSQNHNYTVDTNNLPKNINITHISLFDGSIQG LQRNDKHAFSFQGHPEASPGPHDSMILFDKFIKLMKKSYNSQQKTII >bbp134 carB, carbamoyl phosphate synthetase large chain MPKRNDIKSILILGAGPIIIGQACEFDYSGAQACKALKELGYKIILVNSN PATIMTDPDMADSTYIEPIHWSIIKKIIQQEHPDAILPTMGGQTALNCVL DLDNHGILKKHKIEIIGATINSIKKAENRKLFEKSMNKIGLKTAKCEIVH NINMAHNVIDKIGFPAIVRPSFTMGGSGGGIAHNYEEFKNICTEGLKLSP SKELLIDESLIGWKEYEMEVVRDKNNNCIIVCSIENIDPMGIHTGDSITV APAQTLTDKEYQNMRNASISILKEIGVETGGANVQFAINPDNGDMIVIEM NPRVSRSSALASKATGFPIAKIAAQLAVGLTLDELKNDIIGINSTASFEP SIDYVITKIPRFNFEKFLGCNDRLTTQMKSIGEVMAIGRTFQESLQKAMQ SLEIGVSGFNSKIKKYTSKSIKKIKNELKEAGSERLWYIADAFRMSIPMS EIFSLTLIDKWFLFQIKEIIDIEQEIQKIDINKIRYNHFKYFKKKGFSDL RIAQLSNNSEKKIRSIRYNLKLHPVYKRIDTCSAEFANDTAYMYSTWEDE CESSPNNNNKKIIILGGGPNRIGQGIEFDYCCVHAAQALREDGFETIMIN CNPETVSTDYDISNRLYFEPIILETILEIVRIEKPYGVIIQYGGQTPLKL AKELEQANVPIIGTSPDSIDKSENRKRFQKIVSMLNLKQPKNATVTNLQE AIIQAKSIKYPIMIRPSYVLGGQSMEIVYDEKNLTNFFNNVCINFKKFPI LLDHYLENAIEVDVDAICDGTHVFIGGIMEHIEQAGIHSGDSACSLPAYT LNKNIQNEIRSQVKKLALSLSVKGLMNVQFAIQNENIYIIEVNPRAARTI PFVSKATGVALAKIAARVMIGKTLLEQNCIHEIIPSHYSVKEVVLPFNKF FGVIPELGPEMKSTGEVMGIGKNFKDAFSKAMLAAQANMKKSGRVLISVK NSDKKNIVSLAKKLKNIGFKLDATTGTALSLINSGINARLVNKIQEGKPD IQDRLKNNEYVYIINTTDSNKTIKDSKIIYNSALQDKIHYDTTINGARAT IMAITSNPKKYITSLQKMHHQIKSTN >bbp057 cca, tRNA nucleotidyltransferase MKVYLVGGAIRNKFLNLPVQDRDWVVVGATPEILLSLKFKQVGKGFPVFL HPYSKEEYSLARVDRKIGVGHTGFSFDYSNKVTLKEDLMRRDLTINAIAQ DNNGNYIDPFKGIRDIKNRILRHVSPAFSEDPLRVLRIARFCALFHHLGF RIATETMKIMSIVVKNNELLNLTRDRVWKETEKAFNTDNPHVYFQVLKNC NALSVIFPEINLVYQRQYYCIDNMYHNFYDTFDIFMGLAELSKISRDIDI RFSYLFFCINRMLFIDTSSYILVINQKELVRYFKALCQRFCIPAYIKNVS ICFSRFYKFLSVIHYQSSKDIIMFFYIIDAWRKPYMIRKLSVLNNFCVSR NAYFKNITCQQYPRNFLKYAFNVANKISIKPILKMGFSGLQIKYELIRLR INAIENWRQNITVYKKCCF >bbp419 clpP, ATP-dependent Clp protease proteolytic subunit MTLYDKEINKNSLLIPMVIEKTSYGERSYDIYSRLLKERIIFLTGTIDDN TANLIVAQMLFLEAENAKQDIYIYINSPGGVITAGMSIYDTMKFIKPNVN TICIGQACSMAALILTAGKKGYRYCLPNSRIMIHQPIGGYNGQASDIEIH AKEIIKVKRKLNELMAFHTSQSINTIEKDTERDCFLSANQAIKYGLIDTI LSYRT >bbp420 clpX, putative ATP-dependent protease MVDNSKNNTETLLCCSFCEKNQKEVKKLIAGLSAYICDECIKLCNNILEE ENNNLSSYYDVKKKIPTPYEIFKHLDNYIIGQLHTKKVLSVAVYNHYKRL NHLNSKKNNNIELGKSNLLLIGPTGCGKTLLAETLAKFLDVPFSISDATT LTEAGYVGEDVENIIQRLLQKCNYNIKKAETGIIYIDEIDKISRKSENPS ITRDVSGEGVQQALLKLIEGTLASVPMQGGRKHPQQEFLKVDTSKILFIC GGAFLGLNKIIEKRTKLGTKIGFNAKVNKNLKICSKDALMQQVIPEDLIK FGLIPEFIGRLPILTILHELDKKMLVKILSEPKNALIKQYQTLFKLEDVE LKICTKVIEYIAQKAMNQNTGARGLRSIIEMLLLDTMYRLPSMTNIKTII IDESTIVNNNLTPILIYKKHDSKTTSGK >bbp253 cls, cardiolipin synthetase MINYLFTITTWLIIISYWFIIIIVTCRILSKRRAISSSAAWLLVIYIIPF IGICTWFLLEEPYLGTRKLKLIKSVWSKKNKHFNNLKSHNYIFENNNSEV ARSLFKLCKYRQGISGIKFNKLKLLKNTKDVIKNLVRDIYLAKNTIEIVF YIWKPGGLADNVAIALIQSAKRGIKCRLMLDSAGSLEFFRSKWVDMMQQS GIQIVEALKINLLHFFFRRMDLRQHRKFILIDNYITYIGSMNLVDPYLFK KSLGIGQWIDLMTRIEGPISTTMGAIYSCDWEVETGQQISPKRVKNNLII PTYPIKECTSIVQVIASGPGFTEDMIHQALLTAIYSAQQKLTMTTPYLVP SDDLLRAICTAAQRGVEVILIIPKSHDSLLVKWASRVFFSELLESGVKIY QFKKGLLHSKSVLVDKQLSLIGTVNLDMRSLWLNFEITLVIDDKNFGKSL AIIHNEYISHSSLLDPKLWKIRSYWKKIIEKLFYFLSPLL >bbp287 cmk, cytidylate kinase MSFKNLVPVITIDGPSGVGKSSVCKVISKKLQWNVLESGWIYRVLAFIIF KNNVCFSSRNLNILFKNINLHDFIQRINFKNYVISQSLFTNISQEYIGNL ASRLACIPYIRHFLLFQQRSFRKFPGLIANGRDMGTVVFPDAIIKFFLIS DFKTRVARRCLEYEKKGINSCNYKKIFYDMKTRDQRDHNRKISPLIPAKN AILIDSTYMSLKQVSNVLLSYILKMQKFKL >bbp394 corC, magnesium and cobalt efflux protein CorC MSDDNAQHSDKENKKGFFSILLSQIFHDEPKNKEELLTLIKYSEENELID RETGHMLEGVIHITKQKIRDIMIPRPQMITLKLTYSLEQCLDVITKSLHS RFPVMSENENYVEGFLITKDLLPFIKNNTEMFCIKKILRPAIVVPESKHV NHMLKEFRLTKNHMAIVIDEFGVVSGLVTIEDILELIVGNIEDEYDETKK NICQLNQSTFIIKSLTSIKEFNETFNTNFNDEEVDTIGGLVMKKIGHLPI RGEYININQYKFKIHIANNRRIILLQVTIPKK >bbp059 crr, PTS system glucose-specific IIA component MKFFSNFFKNKNNLSSHNVINIFAPISGDIVEIESVPDEVFSNKIVGDGI AISPNSNILLAPINGTIGRIFETLHAFSIKSDDDIELFVHFGIDTVKLKG RGFKKISEENIAVKIGDPIIFIDLPFLKKLVKSTLTPVIISNIDKFKKIT KNTGSVIAGKTVIFSVQK >bbp433 cspE, cold shock protein CspA MSKIKGNVKWFNESKGFGFITPEDGSKDVFVHFSAIQSNGFKTLSEGQSV EFEITEGAKGPSAANVISL >bbp365 csrA, carbon storage regulator-like protein MLILTRRVGETLIIGDNISITVLGVKGNQVRIGVNAPKEISVHREEIYQR IQTEKKTQTQ >bbp158 cvpA, colicin V production-like protein MNVIDCISIIVIIISAVISFFRGFLQELSSIFIWIVGVCVFFRYYSFFSI FSTYVRNIFLKNIISYIVFFVFFLFFKSIFDYCIIIFIEKCGISLINKIF GMFFGIIRGVLFLCIVLFFLELLTNFAYNKYFKNSFFVPYFNCFIKVVIK YLFKKYILFKS >bbp534 cyaY, CyaY MKKNNSNPLKINEYHTLVNKLFLLIEENIDKNQEKCDIDCELHHNMLIIN LNNTNQVIINKQESLKQIWLATKKNGYHFEYINKQWICNRTKKDFWNVLQ ESCVYQTNKCIQFLKNIY >bbp417 cyoA, ubiquinol oxidase polypeptide II precursor MFGAIKMQFIKYKSYILKFLLVSCIFCINGCDCTILCPNGLIAQEQRFVL FVSFFTMLLIIIPVIFMTIFFVLRYRESNFSKTYDPKWSHSNIIELLIWG IPIIIIVFLSIFSWKSVHDLDPKKPIVSNVQPIKINVISLDWKWLFIYPD QKIATINKLIIPINTPIIFNLTSGSVMNSFFIPSLGSQIYVMPGMKTNLN LIANKLGQFKGFSSNYSGKGFSNMKFDVLVTSDHIFFYEWVKKIQKSKYK LNSMYQFNQLAIPSDNNAIKYFSNLKENLFNVVIANVLKISL >bbp416 cyoB, ubiquinol oxidase polypeptide I MFGKLSLNSIPYHDPIIMITCCVVILVFLVISIIITIAQKWQYLWNEWCC TVDHKKIAKMYIFLAFIMLFRGFADAIMMRMQQFLVSSYHGNGTGFLPPH HYDQIFTAHGVIMIFFVAMPLVIGLMNFVVPLQIGSRDVAFPFLNNLSLW LTIFSALLMNVSLGIGEFAQTGWLAYPPLSELQYSPGVGVDYWIWSLQIS GIGTTLTAINFLVTIIKMRSSGMNWFKIPVFTWTSFCTNILIIASFPVLT VSLLLLTLDRYLGFHFFTNDFGGNMMMYVNLIWIWGHPEVYILILPVFGI FSEVVATFSSKELFGYTSLIWATIVITILSFIVWLHHFFTMGASANVNAF FGITTMIISIPTGVKIFNWLFTMYRGNVRINSIMLWTIGFLITFSIGGMA GVLLSLPVIDFSLHNSLFLVAHFHNVIIGGVVFGCFAGITYWFPKLFGFM LSEKWGKRAFWCWFFGFFCAFMPLYALGLMGMTRRLSQNINPQFHSMLTI AALGTILIFIGIVFQIIQIFVSIRDRNLNRDCSGDPWNGRTLEWSTTSPP PFYNFAVLPIVQFRDSFWESKKSFKSNKLPILYTSFHMPKNTKFGFLIGF FAFLLGFSAVWYIFWLFFISFFVIIYLLVIKSLDTNCDYIISIEEIKEIE KCINIKKMD >bbp415 cyoC, cytochrome O ubiquinol oxidase subunit III MKKKYKIDTNIFSKELLGFWLYLMSDCIIFCTLFSVYFILVDNVAQGPSG HNIFQNNLIIIETFLLLFSSFSCNLVLFEMKNKNLYMVFLWLGITFLLGL LFVFLELFEFFHLINLGFGPTRSGFLSSFFVLIATHGIHVISGLIWIIVM IKYVYTFNITNLIYYRMLCLNLFWHFLDIVWVFIFSFVYLFGMV >bbp414 cyoD, cytochrome O ubiquinol oxidase protein CyoD MLKNRYLKYLFILILLSILSIMPIFAIIYRIFSRNYLYAFIIVCLFFQIL AHIKFFLNLDFSLEQRWKLISVIFSLVVGLIILLGSIWVIKNLNNNLCIM >bbp413 cyoE, protoheme IX farnesyltransferase MYYVNVILYLLEVLKPKIILGNLLSLYGGYGVAARGHIYSKLLFLDSLSL FLIVGSACVLNNVIDCDIDKIMLRTQCRLLVKYNKFCKLAILIAMFMLFL GLILCVKFINVVCFCLFLLGWLTYIFLYSFFLKKTSAISTIVGSISGSLP PIVGYCSVTNNFDFCSLNLLIMFALWQIPHSYAICILHFRDYKIANIPVF PVIYGFKITRYHIILHIILFFISVIVLTFINSINYKFLIISFFLCLTWLY YSLLELTIKNSKLWAKNIFRWSIIVIFLLNIIMLFGFV >bbp051 cysE, serine acetyltransferase MIMSSKEVEIIWHQIISEVEILMDQEPELAGFYHAYILQHDSFDMALSYI LSNQLSNKVMSTVFVRDIINKVYIACRKIVAYAIQDIKALFNHGLVHCYS FSLLHSKGFHALQAYRISNFLWCEEKKSLALYFQNRISCLFSVDIHPASM IGSGIVLDNAIGITIGQTSAIKDSVSVLSQSLALLGSAFKISSVQCPKIN EGVIIGANVAILGNVVIGEKTKIQACTVVLQSVPPNSIVTSVLAKIVSFK NINE >bbp431 cysS, cysteinyl-tRNA synthetase MKFNTMLKIFNSYTRLQEQLEVDKKKTINMYVCGITAYDFCHIGHGRTFI FFDVVVRYLRSLGYALKYVRNITDIDDKIIAASLKNNESYISLSNRMISN MKDDFSALNILPPDSEPRVTENISDIIKFISILLNKKHAYVACNGDIMFS VSSYLNYGALSNQFSKILNKEINISHYSTKKNIADFALWKTSKSSIFVGW NSPWGNGRPGWHIECSSMCRSAFKNKIDIHGGGVDLLFPHHENELAQSVC IDSNFSIKHWMHTGLVIINNEKMSKSLNNTLLLRDLLTQYDSEIIRFFLL STHYRHPLYFCYKNLSNSSKLLKKLYLSLRGVDFDIKGLDIVDNFKTDFY KAMNSDFNTPLALSILLRLSKEINKFKLIDSNKASQLASKLRQLGSILGI LLKDPEYFLQNNFNCNNSIIGKINSLIYERDKARRVKDWVRADRIRKELL ELGIVLEDTSFNTFWRSLQ >bbp090 dapA, dihydrodipicolinate synthase MLRGSIVALITPMNEYGHVCETSLEKLINYHINNGTKAIVSVGTTGESST LSQEEHINVVMLTLEITNKRLPIIAGTGANATSEAILLTKKFENTGISAC LTVTPYYNRPTQKGLYQHFKAISENTKIPQILYNVPIRTGCDLIPETIIK LSKFKNIIGIKEATGDLSRVQKIKNSVHKNFFIISGDDTTFLDFIQLGGH GVISVTANIAAKIMSNICHLALNKNFKLARFMNNKLIPLHQGLFHEPNPI PIKWLAKKIGLIASDTLRLPMTPVSNKTRLILEKALYFSKITAK >bbp136 dapB, dihydrodipicolinate reductase MKKTTLNIAISGALGKMGINLIHEIYHTKNVFLTAAIVKNNSPYVQKNVG KITKIGEINIPITNSLEENINKFDILIDFTNPKTTLKNLEICAVAKKNII IGTTGFTQEEQKKIKLLSKKIGIVQSSNYSIGINLMISLLEKTTQIIGKN TDIEIIEAHHNKKIDAPSGTSLEIGKKICKTMNWDFSKQAIYERHSSMKS RANNEIGFSSIRAGNIVGEHKVLFANSGEHIEITHKAISRSIFSKGAIQA AIWLFSKNYKNGLFNMNHILNI >bbp211 dapD, 2,3,4,5-tetrahydropyridine-2-carboxylateN-succin yltransferase MHTLKNIINKTFDNKLNIHQHNVDQKTTDAINQVLHMLNIGKLRVSEKIN GFWITHQWLKKAILLSFLVNKNVLFSNKQTCFYDKIKLKYCNYTEEKFKN EKIRIVPPATVRHGAFIGKNTILMPCYVNTGAYIDEGTMIDTWATVGSCA QIGKNVHLSGGVGIGGVLEPLQNNPTIIEDNCFIGARSEIVEGVIIESNS VISMGVFIGQSTKIYDRNNKKILYGKVPSGSVVVPGSLPSKNNCNLYCVV IVKQVNAQTLSKTGINKLLREITE >bbp089 dapE, succinyl-diaminopimelate desuccinylase MSSCSVVNLAKQLISIPSISPMDLGCQKLISDRLINIGFSVENMNVNQTN NMWAYKGSGTTLAFSGHTDVVPIGNKILWNSPPFSPTVDKGVLFGRGSAD MKGALAAMVIAVERFVKKQPDHHGRIAFLITSDEESMAHDGTIKIVSNLI KRKENIDYCIIGEPSSEQKLGDVIKNGRRGSITAYLCIYGVQGHIAYPNF SDNPIHKSISFFCTLISNCWDNGNVFFSPTSVQIYDIESKSSSDNMVPSE LTVKFNFRFSNEITSSDIKKKVELLLKHFNLKYSIEWHVSGNPFLTKVGL LSDIVVRSVEELCHISPNLSTSGGTSDGRFIAELGSQIIELGLINKTIHK ANECVEIKDLRLLCHLYECIITKIFEK >bbp533 dapF, diaminopimelate epimerase MHIKVVHKSVKIKFSKMHGLGNDFIIINAMMQKTFPVTSNIIQNLSNRYT GIGFDQLLLVENSKNVNIDFHYRIFNANGTEVSQCGNGARCFALFVLLKK LTKKRTLYVSTNTTTLILNVLNNGNVCVDMGVPCFKLKNIFGENIIENSL HSIKFVNKIINYDLVSIGNPHCIIYVNNLKKYPVKKIGFYLSTHKIFPEG INVNFVEVLSKNEIALRVYERGVGETLACGSGACASVALGIQQGLLFNEV QVNLLNGILKINWKGGSEKLYMTGPAVHVYDGYFYL >bbp102 dcd, deoxycytidine triphosphate deaminase MRLSDRDIELWIKNKKLVIEPIPNKELIHGVTIDVRLGNEFYTFCNKFNK NIDLSKSRNEISKILKKVMNKKHIIPNDHVFLLKPGMFVLAITLEKIFLP NNLVGWLDGRSSLARLGLMIHATSHRIDPGWGGNIVLEFFNSSNMILSLC PGMLIAAVSFEILSSPSIRPYNIRKNAKYFNQSEVTFSRIDQD >bbp196 ddlB, D-alanine-D-alanine ligase MTIITEKIAVLLGGTSQERNISLISGYNILNSLLKSGIHAVAIDTKDFPI TQLPHQKFTKAFIALHGRDGEDGTIQSVLKYLNIPFTGSKTLPSAISINK FKTKLLWQSFNLPVVPYLHINKHEFNKKFLQKFKKNISLLGLPIIVKPNQ EGSSIGITIVYSYETLYKACKTAFIFDNSILIEKFIYGEEYTISILGKKI LPIIRICPENTFYNYNSKYLSNRTTYFCPSGLNKLKELELKKITLTAWNI IDGTGWGRVDVIMDYKNKFWLLEANTCPGMTDHSLFPMSAKKAGISYQIL VQKILELAN >bbp335 deaD, ATP-dependent RNA helicase MTHTNMTFSSFGLNSCIITALNDIGYVQPSPIQAACIPYLIKGKDVLGMA QTGSGKTAAFALPLLHNIKLDVRVPQILVLTPTRELAVQVAEAFSNFSKK LIGVHVLALYGGQRYDLQLKSLRKGPQIIVGTPGRLLDHLKRRTLSLSNL HSLVLDEADEMLRMGFIEDVETIMTEIPDRHQTALFSATMPEAIRRISRR FMKNPKEIRIQSNITTRPDIQQSYWMVYGKKTDALIRFLEAEDFSATIIF VRTKNATLEVSEVLERYGYNSAALNGDMNQSLREQTLEKLKDGRLDILIA TDVAARGLDVDRISFVINYDIPMDSESYVHRIGRTGRAGRKGKALLFVEN RERRLLRNIERAMNISISEVNLPKSDFLSKRRLEKFAQKVQIQLDSKDLH EYRGLLPKLQPNNNSLDIESLAAALLKMAQGERSLIVKPESIVRARHLKI KDTYRNNNYKSLNYVSRYNRDKNVDLYRIDVGRNDGVEVRHIVGAIANEG DISSRKIGNVRLFSNYSTIELPKGLSNTLPKTFIRTKILNKFINIKLLYN SNFKGNYNDIKDVKVYNSNKLRSKKMNNKKFVSSGVRKKIKTNISCNRRR SV >bbp439 def, polypeptide deformylase MSVLKILKYPDDRLRIIAKPISKIDTKIHNIIINMFDTMYYENGIGLAAT QVNIPLQIIVIDKIEELNHPLVLINPKITKRSGLTSIQEGCLSIPNYQAE ISRSKKITVTALNYFGKRIKLKTSSTLSICIQHEIDHLIGKLLIDYLSNL TNLKLLKKNK >bbp484 deoB, phosphopentomutase MKRAFLIVLDSFGIGATKDAHRFGDVGANTFGNIAKFCFLNKANNYGRKG LLYIPHLLSLGLAKVAIASSGQDLLGIQDTNNVIGSYAYSNEISSGKDTS SGHWEIAGAPVLFDWDYFSSSLNSVPKYLIQDIVDQCNLSGFLGNCHASG TDILDRFGEIHISTKKPILYTSIDSVCQIACHESIFGLKRLYNLCRSIRK IFDKRKINIARIIARPFTGFKKEHFRRTGNRRDFSMEPHKITVMEKLIGE KKGRVIAIGKISDIYAGKGISCSMYATGLVNLFNTTIQEIKNAKNNTIVF VNFVDFDSLWGHRRDVSGYAKDLEWFDYNLPKLLKLVHNEDLLIITADHG CDPTWIGTDHTRENVPILIYQRSMESKNFGYRETFSDIGQTLAKYFNLST MSYGTSIF >bbp483 deoD, purine nucleoside phosphorylase MVTPHINAKKGDFSDCVLMPGDPLRARYIAKNYLKNAIEVTNIRSMLGYT GRYKGHRISVMSHGIGIPSSLIYVKELVSEYNVKKIIRIGTCGTVIEHIN INDIIICLGASTDSKVNRLRFHDNDFSSVADFYLILDLFNSANNAGIKIN IGNFFTTDLFYVKNDKLLDTLQRYNILGIDMETAGIYSLASELGIQVASI CTVSDHILKKDQMSYIDRESNLNNMIYISLEALILKKV >bbp184 dksA, DnaK suppressor protein MQKEKNKKQSSLSILFMAGVQPYKNKKNEKYMNTKQIDHFKKILIAWKNQ LRNDISQTRLNIQDKATNYPDPIDRAVQEEEFSFELRHRDRERKLIEKIE KTLKKVENKDFGYCESCGIEIGIKRLEARPTANLCIDCKTLSEIREKQIL G >bbp012 dnaA, chromosomal replication initiator protein DnaA MSPSIWEKCLKYLQNKLSPIEFSMWIRPLKAEFKKNILILYAPNEFSFNW IKDNYIENLKKLLKNFCNINTTPTLMLKICKPKIIQKKFFNELTLKKNIL NSKLTYNVNTKLSNIIYSSEINTNYTFQNFTKGQSNQLAFKTIYKIAHNP GKNYFNPLFLYGKSGLGKTHLLHAVANTILKYKNTIKIIYINSENFIQNM ITSLKNNTIEEFKKYYRSVNTLLIDDIQFFAYKKHSQEELFHTINALLNR NQQIIITSDQFPQKIHGIETRLKSRFECGLTIRIDPPDLNTRTKILIKKS HIYDINLSYKVAFFIAKNLKSNIRELEGALNKILANSDSKKKIITINFAY KTLQELFSLPKKSITIKNIQKVVSNYYHITIINLLSQCRLKSIVKPRQIA MAISKKLTNKSLSEIGREFNGRNHATVLYACKKIKKLQEKNNNIKKDFLT LLKILSS >bbp489 dnaB, replicative DNA helicase MKNVKKKNLDNQVEKLIELPNSLEAEQSILGGLMLDNEQWDYISEKISEN DFFSLSHQLIFREMKYLLNKGYPIDLITLSESLEQKGKLEYIGRFAYLAE LSKNVPSTANITTYADIVRERSMVRKIIKIANKIIQAGYDPRGKTSQELL NLAESKILSISEQNFQKNSGPKNIEELLDITLANIEKLFNTPYKGITGIN TGYQDLNNKTSGLQPSDLIIIAARPSMGKTTFAMNICENIAMTYKKPVLI FSLEMSGEQIMMRMLSSLSRVNQEKLRTGQLNDEDWARISSTINILLKKK NMYIDDSSTLTPSEMRSRSRKIYRENNGLSLIMVDYLQLIKVPSLIGNRT LEIAEISRMLKSLAKELKIPIIALSQLNRSLEQRRDKRPINSDLRESGSL EQDADLIMFIYRDELYHEHTDLKGIAEIIIGKQRNGPIGTIKLTFNGHWS RFDNYSESKYSDE >bbp024 dnaC, putative DNA replication protein MKNHIKFLKRLKCIVPKHIKPKFHNDEELLAWNQEQGRLSSEAILRKNKA MKMQRILGRSGIRELYMNCSFENYHIEHEGHKKVVIASKEYAHNFNKNMA SFIFSGKPGTGKNHLASAIGNYLILNGKSVLIVTVADLMSNIKSTFNGNN NVTEERLLNNLSNVDLLMIDEIGMQIESRYEKVIINQIVDRRSSSKRSTG MLSNLDYRGLKILLGERVIDRMRLGNSLWLTFNWDSYRKKIHGNEF >bbp220 dnaE, DNA polymerase III alpha subunit MFNFKFVHLRVHSDFSMIDGLVKPNILAQHAKKLNMPAIAITDSSNLHGM IKFYRATFSQGIKPIIGVDFKVFPDDKYVSSNMFTKITLLAVNNSGYRNL LLLLSRAYKIGYNNKVGVFITKEWLVEHRKGIILLSGGCYGDIGVNLLNN NKSLVLNCLSFYNRFFENFYYLEIMRIGRSNEEQYISRIKDISAREGIPV VATNEVCFLNKQDFEVHKIRVFINLGCTIKSNSAHYNYTPQQFMRTSNEM EELFLDFPDAISNTIEISKRCNVILKFNKYFLPKFQTGNMNTTDFLVMKA KKGMQKRLIQLFPNKQDRINNVNRYYTRLLSELNVINKMGFPGYFLIVME FINWAKKNDIPVGPGRGSGAGSLVSYVLNITELDPLSFDLLFERFLNPER VFMPDLDVDFCMDKRDKVIEHVSKIYGEESVSQIISFGTLTAKSVIRDVG RVFGFPYGFLNRLSKLIPLDLGMTLEKAISQKVELLELYKFDKDVRELIN IAKRLEGITRNVSKHAGGVVISPKKITDFVPLYYDENGNNPVTQFDKNDI GYTGLVKFDFLGLKTLTVIHGTVKMINTKFSNNQKKLININTISLKDKNC FKFLQTAQTIAVFQLESNGMKDLIRRLKPDSFEDLVALVALFRPGPLQSG MVDNFINRKHGKEKILYPNKECQHALLKPILKSTYGIILYQEQVMKIVQV FANYTLGHADLLRRTMEKKDQVEMNKHREMFKNGAKENNINTKLSTKIFN LLEQFAGYAFNKSHSVSYALVSYQTLWLKLYYPEEFMASAMNADIDNIKK IVVLINECKVMKLKIIPPNVNQSDYYFKVDDDKNIIYGLGAIKGIGKSVI LDIVNARKNRKRFSELFDLCVSVNSKRITHKVIEKLIMSGGCDCFGLNRS ILMHSCEYIIKSANQYLKSIILKKRDLFGLLLDDFNVIKKKYYSIKKLYS MKQILDWEKDSLGLYLTGHPVDEHVHLQMRYNNVIRLKDLFNNKITTEQI SILGMISFLKFKVTKTKKNMVFMILEDSFVQIEVIIFDNILRRYRHLLEK EVIIIVTGRIQKSMFSKKYIVLAEKLI >bbp053 dnaG, DNA primase MPSLIPKEFINELIFKTNIIDIINTRLPLKKVGKNYNTHCPFHQEKTPSF TVNFEKQFYFCFGCNTHGNIIDFLMNYEQLTFVESIKELAKIHGLTIPCK NINKEKLFNYEKITNLYLLTKNIADLYHRNIFKTEYAYQYILNRGIDKSM IKYFNLGFSPKNWYDLEKKNKKQCYNQKELQEIGILKTTILGYTYDRFKN RIIFPIRNKNGNIVGFGGRTLNNHIPKYINSPETQIFHKGFQLYGLYEML KTNPKPKQILIVEGYVDVIALVQFKINYTISTLGTIISNEQIKLLFRTSN TIIFCYDGDVSGQKAAWRTLNISLSHIHDGKNVKFIFLPNNEDPDSIIRK EGHDNFKIRIKKSIDFSKFLLQTLFKKTDLNSISEKSHTSTIAISLIRKI PGKITQTYLFQTLSKKIGILDYHVLINNNINNINTKIYTKKPIKKTTIRI VIALLIQNPWLALTLPSLKHLQNYKIIGLSCFLDLVEKCISMPNSNTGQI LEKYRNKNIFKHLANLAKWDHMIHNEKIKDFFLDSLTKICDIILEDRQNK LISQERLNGLNKQEKYELWSINKELAKK >bbp141 dnaJ, chaperone protein DnaJ MSKQDYYKTLGVTQSSDEREIKRAYKKLAMKYHPDRNPGNKNSEEKFKTI KEAYEILIDPKKRTAYDQYGHSAFEQGNSTGNNNTFTHSFSSNSDFSDIF GDVFGDIFGGTRKQKSERQGSDLRYDMTLTLEEAVRGTIKEIKIPTLQKC PTCYGYGTKTGTKPQFCPTCRGNGQIQMRKGFFTVQQTCPQCHGEGNFIR DPCRRCHGNGRIEISKTLSVKVPPGVDTNDKIRLNNEGEAGENGAMAGNL YVQINVKKHPIFEREENNLYCEVPISFSMAALGGEIEVPTLDGKVKLKIP CETQSGKLLRIRGRGVKSIRNNNRQGDLLCRIIVETPVNLNDLQKDLLYK LGESFNGFKGEKNSPKSKRFFEGVKRFFDDLTR >bbp142 dnaK, chaperone protein DnaK MSKIIGIDLGTTNSCIAIMDGNKARVLENSEGDRTTPSIIAYTNDNEILI GKPAKRQSITNPKNTLFAIKRLIGRKFTDNEVQRDIKIMPYKIIQSENGD AWINIKNKKLAPPQISAEILKKMKKTAEDYLGESIQEAVITVPAYFNDAQ RQATKDAGRIAGLKVKRIINEPTAAALAYGLDKGKGNKTIAVYDLGGGTF DISIIEIDDVDKEKTFEVLATNGDTHLGGEDFDNRLINYLVEDFKKDQGT DLRNDSLAMQRLKESAEKAKIELSSTQQTDVNLPYITADSTGPKHLNIKV TRSKLESLVEDLITRSIEPLKIALKDAKLSISDIDDVILVGGQTRMPMVQ KKVAEFFKKEPRKDVNPDEAVAVGAAVQGGVLSGEVKDVLLLDVTPLSLG IETMGGVMTTLISKNTTIPTKHSQIFSTAEDNQTAVTIHVLQGERKRSID NKSLGQFNLDGIQPAPRGMAQIEVTFDIDSDGILHVSAKDKNTGKEQKIT IKASSGLNETEIKKMILDAEQNSESDQKFEELVKVRNQGDQISHSTKKQL KDLEKTINVNDQKEINEALNKLDTALKGENKTKIEEKIQEVLKISTKLIE KNKPKQTSESSNSNSPSSSKPEENVVDAEFEEVKDQKK >bbp011 dnaN, putative DNA polymerase III beta chain MKFEILNKFLIKSLKKVNNLITRNHIFPILENILLIAKDNTITLTSTNID MEIKIIILDVTLLEPGSITVSGKKILNICQNLPKDHNLKIQYINNKLKIV SHNNQYLLATLPIKNFPNLKISENQNNFVISQNDLKDVLCATYFSMAIQD LRNFLNGLFFEVRNQHLYAVATDGYRIAICKKPLHNLDKKKYNSIILPRK GVLELIKLLNYSNEVISINISNNYFQIEFKNLIFTSKIITEKFPDYTSLI LTHISKKMILNTTLFKEALSRVAILSNENFRGVNIKNDQNKLLITTSNQH DEEASEIIDIIYTNIKIKMSINASYMIDILNAIQDQEICLSKNDVTHSIQ IQAHHYKIAPKAIYIIMPLYA >bbp230 dnaQ, putative DNA polymerase III epsilon chain MKKYDRKIVLDIETTGMNPAGCFYKNHKIIEIGAVEMINNVFTGNNFHSY IQPNRLIDKQSFKIHGITDNFLLDKPKFHEISVKFLEYITNSDLIIHNAK FDVGFINYELNMINSDKRKISDYCNVVDTLPLARQLFPGKKNSLDALCNR YKINVSHRDFHSALIDAKLLAKVYTFMTSFQQSISIFDKNSNLNSIQKNA KLDSRVPFRSTLLLATKDELQQHMKYLKYVKQETGNCVWLEDKYN >bbp425 dnaX, DNA polymerase III subunit gamma MNYHILAKKWRPQTFNDVIGQQYIVSAISNSLLLGRIHHAWLFFGIRGTG KTTIARILAKSLNCKLGISPNPCRKCSNCVEVEQGNFIDLYEVDAASRTK VEDMKELLDNIRYLPSKGRFKIYLIDEVHMLSRYSFNFLLKNIEEPPQHI KFILATTNLEKIPDTILSRCLQFQLKPINLNEIVACISNILHKENITYEI KALSLISQKSEGSLRDAITLTEQMISMGKGNITEKIVRKTLGMLYEDQIL YILTTLLNKDLKNLVLCFKYISDTHINFENILVEILQLLHQISIIKIIPS IKLNDTKYSKNMQHAIQKIAELSNYNDIYLYYQTALLGKKELHIAPDQKI SIEMTLLRMFNLNTKPIYIK >bbp381 dsbA, thiol:disulfide interchange protein DsbA precursor MKNFWMLFLIILLGFDSSNKSFIEGKEYSKVYNKMSDRPPPIIEFFSFLC PYCYDLEKKYNINHYIHKKISKNLIITKYCVNLSNGEFEKQLQKIWAVSV IKKLEKKILIPIFEGIQKKHTITTIPNLINTFLKLTKMNKHDYDFISNSF VVKSFIYKQERIEKFIKLDRVPATIIKGKYIINDMIIQKKSITNFINKYI EIIQFLLNKKL >bbp507 dut, deoxyuridine 5'-triphosphate nucleotidohydrolase MKKIKIKILDDRIGTQFSLPSYATSGSSGLDLRACIKDSIILLPNETVLI PTGIAVYIDDPYITAIILPRSGLGHVQGIVLGNLVGLIDSDYQGQVMVSL WNRGSRNFSVKVGMRIAQIVFIPIIRPIFEIVTNFVVDTERKVQGFGHSG VK >bbp023 efp, elongation factor P MELCHSNQLKIGLKIIYNNEPCIVVSNEFIKPGKGQAFFRVRLKNLLNKK LIDKTCKYSDCFKIANVIEITATYMFTDKKVWTFMDKKSFEQIFVEKNII KNVLPWLLEQHDYIISLWNDQPISIVYSSNFIELIVVNTIPNARSGAINT YSKLALLNTGVTIKVPIFIQIGQIIKVDTRTSEYISKIS >bbp369 endA, endonuclease I MLIRSIFFFTILIFSTCLSSNENIKHHYHKNFNQIKKLAQKINIDAPGTF YCGCKIFWKEKKGIPELNSCGYHIRKNANRANRIEWEHVMPAWQFGHSKS CWKKGGRKNCIHDYNYQKIETDLHNLQPVIGEINGDRSNFMYNQFPKSTL NGQYGQCSMKIDFKNKLVEPPDISKGAISRIYFYMSDFYHFKLSKKQKKL FLMWNKKYNVTNWECMRDNLIFKIQGNHNPYVYSKCQKNNTNKNI >bbp549 engA, putative GTP-binding protein MVITIALIGRTNVGKSTLFNKLTGNRNDALASNHASLTRDRKHGFIIVNN TKIVLIDTPGINEDSKKKISLDKEIFEQVKFSIKQADLVCLVVSARNKLM HKDVEIIEMLRKFQKKIFLLVNKIEGLNFDLVKYEFYTLGLRNMHFISAT NGIGIDFLTNNICSFFTSQKNSLYKKNKDFDIIYSITNDKKNCCQNLNKT IKIAIIGKPNVGKSTLINVLLNEKRVIVDSNPGTTRDSNWSLIIRNKINY MFFDTAGIRKKNKISTYIEKISVHKTLKILNLVHVVLLVIDAMDGFSDQD FYLLNLIIKNGCSVIIILNKNDKLSEKMRINVLNSKMLKLISHVKCHFIS AKHNMGTSIIFKLINEAFFNSIKKIHTSKITEILKLAITKHQPPIYKRDR IKIKYAHIGKHNPLTIIIHGNKLEKLSNVYKKYLTNFFQSKLNLVGSSIV LYFKSSKNPFIK >bbp383 engB, putative GTP-binding protein EngB MILSYIFIMYLVDTIDYQKICCIIKTFEDNILFQKNYHSTWFLKSIANIQ KEKYNYGLEVAFVGYSNSGKSSIINALTNQKKLAKISRTPGRTRLINIFS VTSEIRLVDFPGYGYAQVSRSISKKWKEMIFQYLNIQKCLQGLVIITDIR CPIKEIDELVINLAVSLNIPILLLLNKMDKVTRSIQKSKLFSTREKMLNF SNNINVELFSSFKKIGIHKLQFVLNNWFSSDKKLCQ >bbp377 eno, enolase MSKIKKIISREIIDSRGYPTIESEVHLQNGSIGLASIPSGASTGSREALE LRDNDPLRYFGKGVKTAVSIVNTSISSAIYNQDAYDQENIDKIMINLDGT KNKSKIGANSILSVSIATAKAAAQSKKIPLYQYISELHGIKEELLMPLPM MNIINGGKHADNNIDIQEFMIQPIKANTIKEAIQIGAEVFYTLGLILKRR GFNTTVGDEGGYAPNLKSNESAFLILSEAVSQSGYMLGKDITFCIDCAAS ELYNSKTKTYKLTSEQKKFTSYEFTNYLSALVDKYPITSIEDGLDESDWN GFKYQTKKLGKKIQLVGDDLFVTNTNILKKGIQNNIANTILIKLNQIGTL TETLNAIKLAQNSNYNTVISHRSGETEDTTISDLAVGTNSGQIKTGSVCR SERTAKYNQLIRIEEKLGAKTKIFKNFYFNI >bbp238 era, GTP-binding protein era homolog MKQKYFSGTSVIIGKPNVGKSTIINKLINSKISIVSKKKHTTQSNITGIM NIGLQHQLIYIDTPGISKKYVYKNQNKTFRNTMALMHSIQFIFLILEKTS WTNEDEYILNIVKKYLKPIFAIINKIDKIKSKEHLLPHILTLSKKHMFQE IIPISGKTGENIHILSKVIQNKLKIVPKPTFPFDLKTNLDIKSIVSEIIR EKLILYLGDELPYSIQVSTKNIIDRNIKTSYIEAVISVNNTQHKKIIIGC KGKKIKLCGSLARKALEKFFNKSIYLSLKVIKKNKTL >bbp086 fabB, 3-oxoacyl-[acyl-carrier-protein] synthase I MKRVVITGLGIISSIGNNKIEVLTSLLETKSGISFSKEMERSGMRSHVWG NIKLDNYQENIDRKIFRFMNDASIYSYLSMKQAIEDAKLTSKMYQNNPRV GVIIGSSSGSPRCQINGVSIIKKTKRLKSVSPYTVIKSMTSSISACLSTL FKIQGVNYSISSACATSAHCIGNAMELIQLGKQDLIFAGGGEELSWELAC AFDSMGALSTMYNSQPILSSRVFDYYRDGFVISGGAGILVVEELNYALSR SAHIYAEIVGYGTSSDGYNVVVPSGNGAMRCMNIAMSNIQEPIDYLNVHS TSTKIGDLIELNAIQQVFRKTSIPILSSTKSITGHSLGASGVQEMIYSLL MLKYNFIVPSINIFKLDPKAKNCNILTTMMRKELSIIMSNSFGFGGTNVS LIIKKFV >bbp320 fabD, malonyl CoA-acyl carrier protein transacylase MFKYTLLFPGQNDINRKKILSPFFSKNKIVQSIFRESSEYIGYDIWKLIQ DDPKKKLKNNKYSQLVTLVSSIAIYELWKNKQCTHPNLVIGHSLGEYTAL VCSQSLKLSDAIQLIITRYKFMMEAMSKKIGLMTAIIGLNERTIRKLLKK YDYSHEVSIACINTDNQIVLSGERNSVKHINLHCKKAGAKNIINLYIHPP SHCTLMKKASKKLLYVLKHTTFKIPIYPVISSTSLKFQNSEQAIRISLAK QIYSTVRWNSIIKYIKKDIFIFLEVSTKSILTNLNKNIIKKSLSISLNCQ ANFLKALKIIL >bbp321 fabG, 3-oxoacyl-[acyl-carrier protein] reductase MKTTKKIAVITGANRGLGKGIAEELSNTNNITVIGTSTSQKGCKIINKYL KNNGIGIKLDITNPNEITKTMDFVYKNFGRVDILINNAGIIRDKLLINMK TQDWNSVLNVNLNSIFYMSKSVIRNMIKNKQGKIITIGSVIAHIGNCGQT NYSAAKLGLVGFHKSLALELAPKGITVNMIAPGLIKTGMTNNLSQKQLSK YLSKIPMKRLGTIKEISKITLFLISNDANYITGQVIHVNGGMYMP >bbp246 fabI, enoyl-[acyl-carrier-protein] reductase [NADH] MFTYLYMNYFIGSFMGFLEEKKILVTGISNKYSIAFGIAKALHKQNATLA FSYHTDRLKNKVYELAKELGVKIVIPCDVSDDNSIKRLFFNISKKWITFD GFIHSIAFAPKNQLSGDYVSSITRLDFSNVLDVSSYSFVGMAKACRSILK KGSSLLTLSYIGSKKVVPNYNVMGIAKASLESNVRYMASCMGLNGIRVNA ISSSPIKTLSSYHIKNFKKILNHTTSRSLNNNLTTVEDVGNTAAFLCSDL SKGITGQIIYVDGGFNITAMSNSE >bbp219 fabZ, (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase MYNSNITDITTLLPHRYPFLLIDRIIAYQKNFNILTIKNISYSEFCFTGH FYKNPVFPGVLILEAIAQSACLLVYKSFGMSYKNNLFYLTNIIDVKFKKK VIPGDQMLINVFVDKHHHRLIRFVGHVSVSKYIVCKATISCLLTNDVVSR >bbp401 fba, fructose-bisphosphate aldolase class II MCNILNKIKPGVITGNEALKLFKIAKKNHFAIPAINCINTDSINIVLETA KKAKSPVIIQFSYGGSNFISGPGLTTNILHKKAIIGALSGANHVHIMAKH YNVPVILHTDHCNKNMLPWIDELINVGTKHFKTYNKPLFTSHMIDLSNEK LDYNINICSKYLEKMRKINMLLEIELGCTGGEEDGINNTKINKSLLYTQP NEVNYAYERLSSVGPEFIIAASFGNVHGVYKSGNVRLTPDILKKSQNYVS KKHNLSCNPLCFVFHGGSGSSEKDIKKSIKYGVIKMNIDTDIQWATWQGI LNFYNKNNKYLHNQIGNLDNENKPNKKYYDPRTWIRSSQISVSNHLTKIF RILNSCNTL >bbp548 fdx, ferredoxin MPKLIILPHKILLPKGGVFNAMKGESILNVALRNNVEIEHACEKSCVCTT CHCYIWKGASSLSICEEKEEDVLDKAWNLQFNSRLSCQAKINNKDIEIEI PKYTINQ >bbp356 ffh, signal recognition particle protein MFNNLTQRFLKIIKKISNKGRLTEKNIKETLREIRIALLEADVALPVVKN FIPSIQKSVIGNQVNKSLTPGQELIKIVKKELTLILGKENHSLNLSVTPP AIILMIGLQGSGKTTTTAKLGQLIRTKYKKKVIVTSIDIYRLAAIKQLKM LSKQAKISFFPSNNTQSPKDIVQHAIQHAKLKFYDVLLIDTAGRLQIDKK MMNELLDVYNISHPIETFFVADAMFGQDSINVINEFNKYLPVSSFIITKT DSDTRAGIILSIKYLTKKPIKFIGTGEKLEELELFYPDRIASRILGMGDM LSLIENIENKIDKKHIKKFSNTIKKYNTFNFNDMLLHINQIKKIGGVNSI LGKLPKTQTIFNSFQNNIDENILLKMKTIINSMTISERHQPELIKGSRKR RISLGSGIPIPEINQLLKQFNNIKKIMKTIKKGGVTKIMQGINNIIKNKF >bbp476 fkpA, FKBP-type peptidyl-prolyl cis-trans isomerase FkpA MILLKIIHIIFVMIFLSIFFPKSLYASTSLIRKDHIIQKNLENFDDQSAY ALGVSLGNYINHSFREQKRLGVILDKNSLLSGIRDSLSGKTILSDQEISM ELIKLEKKLKYFEDIVLKKEAHNNKIQGDLYIKKMLKKKDARHTSSGLVF FIKKKGSGKFLHDSDVITVHYKGSLINGNEFDNSYKRGQPLSFSLDSVIP GWIEGLKYIKKGGLIKLVIPPKLAYGETGVPGIPGNSTLIFEIELIDIQS K >bbp277 fldA, flavodoxin MESIGIFFGSDTGNTENVAKLIHKYIGTNISSIHDIANTNKKDIELFNIL IFGVSTWYYGELQCDWDDFLPTLKKINFNNKIIALFGCGDQEDYSEYFCD GIGILYNVIRLSKNVRFIGSWTSKGYSFECSKALDKNKNFLGLVIDEDRQ PEQSNQRIIQWTKKIKTELNSLLN >bbp310 flgB, flagellar basal-body rod protein Flgb MLDKINNDFNINKILLNLHAYRQEILASNIANANTPGHKSSDINFSKTFG KLFSNALQGKKNNLTTTSNKHISNNDNVELSNYDEQTVKNNSYVSKNNAI NIDVDRINFVHNGLKYNADVVFINNKFKNIMNVLKG >bbp311 flgC, flagellar basal-body rod protein FlgC MSLFNIFNISGSALETQSKKMDVHAKNLANSDSYIYKNGTLYPYVARIPM LQFDPISENNVGGVKMHTVAGDTSSLKSIYNPNSPIADSNGYSKVSNVDI MSETINAITASKNYQTNLEILNTTKNMIMKTLTIGQ >bbp312 flgF, flagellar basal-body rod protein FlgF MLLKTQNSRNNIIFMESIVNAIITSTNKIFENQARIANNITNISTPGFKS ELELKILLPSQKDQNSQEDNFLYKQYKNKNQGTLRRTNQPLDCAIIDKND WFVIKIDPKTIAYTKNGHFKINSNRQLTVQNHPVLGEDGEIFIPKNENIV ISSDGYINIIKNNVLQHKVAQFKLKNFDINDLTYKTNGLYLLNKNNKLNH TNHKNVSNIKLVSGILEDSNVNLEENMVEMISNARKFDMQIKILSMYNEN TQAASRFLNLNY >bbp313 flgG, flagellar basal-body rod protein FlgG MIPALWIAKTGLDAQQINMNVIANNLANVNTNGFKRSKAIFEDLIYHTVQ QPGSKSSEETISPSGFQLGTGVRPITTEREHSQGNLSKTNSLKDVAINGN GFFQVQLPDGNAAYTRDGSFQINPNGQLVTNNGFLIQPVINFPANGNNMS VSRDGIITVRIPEQTQPIRVGKLYLANFVNDSGLSNIGENLYQETEASGN PSISSPGSHGTGLLYQSYVETSNVNIAEELVNMIQAQRAYEINSKVITTA DQMLQKLSLL >bbp314 flgH, flagellar L-ring protein precursor MVITLLNLNKKHYLLILFFILLNGCSIDKNIILNKKQKQHKIFNLPITHT SKETHNFNYQDNKQSNNNYLEPLFEDYKPRNVGDILTIILQENTSASNSV SNNSIHNGNSNFDIDIGNARAFDDPNGILNKIELNSSIKNNFLGKGSSSA NNTFVGLITVIVDRILPNGNLEVSGSKNITINDGIEKICFYGIVNPHTIS KNNSVLSTKVANTNITYISSGPINIGSKINWLQRLFVSLFTLSK >bbp315 flgI, flagellar P-ring protein precursor MFNQSFLKYMLFGFFLFSFHAHADRIRDLITIQGIRYNQLIGYGLVVGLD GTGDRTNQISYTTHALKNMLFQLGITFPNEQNAKFKNIAAVMVTTKFPNF THIGQQVDVIVSSVGDATSLQGGTLLMTPLRGTDNKIYAVAQGNIIINDK NSVERFKNILVNNHLNNGMIINGATIEREMHTDFGKNETLNLQLNNEDFT VAQEISKKINMQYPKSAVALNSKIIQVCIPNNNIEQVEMLATIQNINIPI PIQDAKILINAKTGNIITNQTININTCAITHKNISMTIAFNKLKINRLVP NPIIKSDKNNNKTLNDEQIYKNNYNTNNFQYLEKTSNLNTIICALNLFDI TTTELISILQSMHDAGCFHAKLEIT >bbp316 flgJ, flagellar protein FlgJ homolog MSTNFFTYLLNNTKINSEKKYNRLIQNKNNQKHSIHKSSNISQQVESLFL YIMFTNMKKSSYKNEFWTTSNSESIYQNMYDQFITQTYDKKGIGLAKIID NQIQKYKNQKHLTNLEIFDKFSNKLISFKTNNTTDDIDTIIKTSKLFRYL >bbp223 flhA, flagellar biosynthesis protein FlhA MANILSIFKTFEIKRLVKFQTLSGPVLILIILSMMVLPLAPFILDLFFTF NIALSIVVLLMSMFTTKTLEFTSFPTILLFSTLLRLALNIASTRIILLNG HIGSCSAGNVIQAFGHFLVGGNFTIGIIVFIILIIINFMVITKGASRIAE VGARFTLDGMPGKQMAIDADLNAGLIGEKQAKKRRIEINQEADFYGSMDG ASKFVRGDAIAGILIMIVNIIGGLVIGILQHNMTFSQAAQVYTILTIGDG LVAQIPALVVSTASGVIVTRVSTDQNVSEQIVSQLFCNPQVILLSGIVLG VLGLVPGMPNIIFLIFTTLLFFISWLIYRNPVIFTNFESTMKKIDNTNFC NISDASWNDVQLEGSISIELGNLLIPMIKVNSKKSNLLDKIRNVRKKCAK NIGFLPPLVHIRDNNNLPGNCYCILIKGIEISKGTVQCGKFLAINSGNAS GPLPLPAEETSDPIFKFKSFWITSELINQAKQKGYNIAEDSTVISTHLNH IILTHISLLFGRQEAQQLLDYVSKFCPKLIEDLIPNSINLTIFHQVLQNL LIENVPIRDMQTILETLITHAPNYQNDSQILTSLVRISLGKLIIQNIFQN NKIEVIKFDSKLEQILLKTIANKDSVLEPGLYNYIVVKLQQEYNNCKLKN IPCVLLVHHNLRVFIAKMLLKNIPKIFVLSNLELEDVTKIYTTNIIGDQT KT >bbp222 flhB, flagellar biosynthetic protein FlhB MNHDESEEKTESPTSYRLKISKETGHNRYYRELYSLLILTITLINFWYNQ RLILTLLKRIFYLSFTFNNSIFQNDLFLDHNFLMIFQDNLISLLGIIFFP MLIFMFPAMILCCSNFNFKFIKFDINKLNPILGFKNVFSIKSIVDLFKTV LKIVFVSIVVYLFISKYFLKVCFSSNFTFDYILNYSVRTIFLCFLTILIF FIPIIIIDLFWEKYNFYRSLRMTRKEVSDELKNMEGNPRIKSRIRQIMFS ISNRRMLSNVSKSDVIVVNPMHYAIAIKYNETNMYAPKILAKGIDELAIK IKKIGNNHSIPTLVSHSLAHVLYYRTEVGEYIPSVLYEAVAEVLAWVWKI RHWKIKGGVFPRTPEKFFIPSELYEKRIKKRG >bbp067 fliE, flagellar hook-basal body complex protein FliE MKIQNINNNLYSDDVIPYLSTEKITHPKNFYENFTNALKKTSANERNIFD KINNSQIDESNSSLNDIMVDLQKISISIQFLVQVKNKLVESYQEIMNMQI >bbp068 fliF, flagellar M-ring protein MNMGRTSNLNVKNRDLKRNFFSNLSLNVRVLLLVFLITLIVFYIFFFKPL NYSILYNNLSNDDEKSIVSRLISLKIPFKFNQNHSELLIPSNALKKVYLD LAEQGLPKEKKVGFELLDTEKFGLSQFNEEVNYERALEGELARSIQKLEN IKTARVHIVLSKSSVFIREKKIPSASVILEIKPGRYLNYNQINSILHIVA QGVSNLQIENITIVDQFGNLLSSMNDLYNDSYSNNQLKYSNEIETGYKNK IESVLVPLVGVNNIHAQVTAQISFDKQENSEERFTPNYSNEKQSVRSVQN KKNIEFSEKYSDNSFSSNQGVLSNKKLNDLSNSSLLFNHNNIPNFSEQVS STKNSKRNLSDESVIPQSSTNQNYIVNYELDHVISHNKFNVGNVKRLSVA VVINYVKDKHGKFVSLSTDKLNSIKKLVCESVGFSRKRGDSVSVVNFKFS TPEVYFQSPPSNYNKYISFNNLFEFFLICLGVIILCLLIIKLNFLKILFK NKKRIDISNNYAVKDNLTSQNKGVEDDKELKKKLSSVLESDPKEIAMVIR KWISG >bbp069 fliG, flagellar motor switch protein FliG MNLNGEQKSAVLLALVGIDKAIEILKELSIQEIENIAKCMSYMDVISSIT ADLVLSEFCNEVRINKDQNISFINNNFIISLLKKVLGEHHAVLLLDKFKN QKNISDNIKKLNLINPEKIVSLIKGEHPQIIATILIYLNRNHAANILSYF EDNLSLDIIRRIANFSSLKKLGQEEFVKIIDNLINKYQNSMLNQQGIVTA VELLKLIKRDQETKILTKMFSSDKVLAKRIKTKMLEFSDIINLDDVYIRR LIKVFPLYELSEIMKVEKEEFKKKFYKNMSLENTNLIKNYCSKKIFISND LIQKKRNNLLNSVKKILYNS >bbp070 fliH, Flagellar assembly protein FliH MSKNFLNKAWEKWNPGEIDTTTNITHNNFKKSDQVSNFSNTFTAEQNNDN LNNIKKNGYEDGFKRGKKEGFEAGFKKSFAEFEKKNREILNKMEDFLSNF RQSLSLFDEKVSSKIINTVLKISKKVLETTTLANDDSSFLKKIETIFQDR MFSLENPKLFISPNNQLLVKKYFGKIFSQYGWTICYNHYIPSGEFIISSG DTILDSTSSTRWNKLCKLVYFQEKQ >bbp071 fliI, flagellum-specific ATP synthase MNLRIKKWLEKLDQFEKILVHMPSIMYCGKLIGINGLVLEVSGLKLPIGT ICIVEKNNSILDSDMIEAEVIGFRRNLLLLLLLSNVSDLTADSKVTPKIL NGSYYNINKLPVCDKLLGRIVDGLGKPLDNFSKIDSKYNVSLTNVSINPL HREPVTHVLDTGIRSINGLLTIGRGQKIGLFASSGLGKSVLLGMMTRYTQ ADIVILSLIGERGREVKEFIDSVLTETVLSRSIVISAPSESSVLMQTRGA IYAMRIAEYFRDKNFHVLLIMDSLTRYAMAHREISLSIGELPVSKGYPPS VFSKLFSLIERAGNGKINSGSITAFFTVLTEEEERYDPISESARSILDGH IILSREYAESGHYPAINIENSISRVMPNIVDSSHYSFACHFKKIVSLYQR NRDLINVGAYISGTDPDLDMAITLIPKLNKFLQQGMLEKSNFLDSKKSLY SLFN >bbp072 fliJ, flagellar FliJ protein MYKKKRCFTLLKYLDVKSNYHIVLNLKKILSGIIQVKAQLDILMSYQCEY LKCLDQELKFYISGTRLAHYYNFIAFLIDGVNKQNDTMCKLYKQYNEYIY LWKKKQKKIKMWNNINSRLLLNRFKLSQLDDQDLLDSCCTYKYLLKNDRE DTDYV >bbp073 fliK, flagellar FliK protein MFKIEYNVSRNSTSVRRGQFYLNAFQLKKECNNYVVSKNKNTFFRDMILK MQQTIKFKDNMKSINDDYIYLKNNYCHSYGIKNKNFCSFDYFIFSKLFII KKTSSFSNLFVLPKISEFFVQKKCLFIGLNKSKYTNFSLGHNISSWFYDD KLCCLFSILNFLADTSLNSIFSLNRKRYYSIIYSLDRDKIFKFGKIYKLF DIFKKKFILSCDYKFWKKFVFKKMLVFLNNKTKCITFILNSKHLGSVFIY FKIINNKSIILDLVTCRNEIKKIFQSHIIYLKNVLKDCGIEVSSINVSSR EEFLNAVRTNYDRKFDSKILNHYNTVISKTKSHALRFYELDKNDYQYNYN NINMYV >bbp074 fliM, flagellar motor switch protein FliM MQSDVISRVKKIYIKNKIDISSKIFPYYQTTDYYLTYHNMKDRLENMHEC FLKQFTKHISEYSDVDCKISFYKFIIQKFKNIKKNIKNNSISDCFEISPY KKLGIIFVSDNISDYLIEYLFGGCELKNSSNGLFKKLTLSTINIVKKMFK IILEQYYFLWNKVSLCKMKLILNRLQNLNEISNVNFINSKDTFVTFLFRL RIANKFGMLGICLPTSLSFQCNNEADVNSVHNVSHISYDNVVNTEIRKRL FQVIVYNCKIVLKIVLIENYITLSKIIAFKVGDILPIHMLDNVVAYSENV PILIGKYKMFKNKYVFCVVDYYNSTLNYKNG >bbp075 fliN, flagellar motor switch protein FliN MDNILVNNKNKNLLDLNKEDIKKSCEIEDKIFHSKTVNDVDLNLNSKNDI SSKMKFIMDVPVHLTIEVGTVKITIKDLLELRSKSILVLDKHAGDPLNIL VNGYVIATGELVVTENKYGIRIINIIDNSVFKKL >bbp076 fliOP, flagellar biosynthetic protein FliP MLIDIMFEKIGISLFELVTSIIFISWIVKKFILDKNVIIQSYMKVESKIS LGYNEKIIIVDIKDVRLVLGVTSKRIVHLYTLPPIVYKKSQDSLIKSSNV GYKRNNYIRTMWNKTMVYQIASLCVFLLFCPSYAYAGIPDVISHTSSDGG QIWSIPIQTLVFITSLTFIPTVLLMMTSFSRIVIVFSLLRSALGTPYSPP NQILVGLSLILTFFIMAPIFDKIYQDSYLPFSEDKISIDTAIVRGAKPLH KFMVNQTRQVDLEFFSKLANISTFSRKEEIPMRVLLPSFITSELKTAFQI GFTIFIPFLIIDLVVSSVLMSLGMMMVPPSTISLPFKLMLFVLVDGWQLL ITSLTHSFYH >bbp077 fliQ, flagellar biosynthetic protein FliQ MTIESVMSLFYDAMKVTLMISLPLLLSALCCGLIVSIFQAATQINEQTLS FIPKIAAVLVSIVIFGPWMLVILSDYTHTLFYNLSYITYS >bbp078 fliR, flagellar biosynthetic protein FliR MFQFNFNDFILFIYNLFFPAVRILALFSTAPLFNSKFIEKKIKLIMAFVI SWIFSSFLPKVNIAIFSVDGILIIIEQMLIGILLGLTMQLIFSSIFMSGE IISLQMGLSFSSLFDFNSRSNLSALSHFVHIFLLLLFLEWNGHIWMLSAL FDTFITIPIQKIYLDPNIFLKVVNFSKYIFFDSIMLLFPIIIVQLLLNLS IGILNRVAPQISILSLGFTVTLLVGIILLYFFIPIFPSSCIVIFRRLQSF VLTLFNS >bbp440 fmt, methionyl-tRNA formyltransferase MILNTLNSLKIVFAGTDKFSKDHLKILVTNTTHKILGVITKPDQPLGRGK QITSSLTKKLAKKLKIPVFQPTALNTSTFYNQIYNLNADIIIVVSYGKII PQLILNIFPLGGINVHTSLLPRWRGPSPIQSALLNGDKLTGITIIKMNNN IDTGDIIYSSSCIINKSDTSVTLQNKLKILSCQGLIQVLKNFKSSYFPIR QSNLATYSNKINKEDAKLIWLKSAIQLERSIRAYNPWPICYFKINNQLSI KVWSANVIIHFNQHKYQIGEIILINKHGMQIKTSKNILNITTVQLPGKKI MHANNLCNSKNKWCIPGTKLTNT >bbp133 folA, dihydrofolate reductase MNISIIVAMSQNLVIGQKNSIPWNIPKDLSWFKKHTIKKSIIMGRKTWES IGRVLPMRQNIVLTRQKNIKNTNVLFVNSISKAIQSALYKNEIMIIGGSN LYNQMLTSANKLYITHIEKYILGDTYFPTYDHLPWKIIFKKKIIEHEKTK NSFYVTFKILKKIT >bbp157 folC, folylpolyglutamate synthase MINKKLARSFSLYEWLYYLDHFMLDNIDPTLNRVFYVAKKLGVLKSKAFV FIVGGTNGKGSTCHVLENLLLNSGYRVGLYTSPHLMRYTERVRINGFELE HLYHISAFNDVKYFQNDVLLTRFEFITLSALILFKSYNLDIIILEVGLGG RLDATNILSADVSVITNIDIDHSKILGVNRSSISVEKSGIFRKNKIAIVA DNNFPKVAQYLAKKKKVRLRIVNIDWIYKKIEFEWSFCSSKITWLHLPLP RNVSLDSVATALSAVSESGIKINQKVFRSCISEITLCGRFETISYNPIII LDVAHNPHSARYLFKKMSSFKKNGNIFAVVGILKEKNIKDIVSPLIPIVD YWYCITLLTHRSATSSEIIKYLPNHNSQISKNMTVALEKIFDKVTNNDIV LIFGSFITVCEANKFLANKVKNFKLL >bbp430 folD, methylenetetrahydrofolate dehydrogenase MLKKVLNGTRIAKKLEFKILKQVNYKLSLGQRPPGLAVILIGSNSASTIY VKKKRFMCEQVGFISKFWKFSKNIQESKILNLIYKLNYDTTIDGILVQLP IPPNINNQKLFSSIIPTKDVDGFHPYNIGSLCQKSPYLRPCTPFGIITML KHYKIKIRGLHAVVIGASNIVGRPMSMELLLAGCTTTITHRFTKNLKHYV KQADLIVIAIGHAHFLKGTWIKKGAIVIDVGINRLKNGEIVGDVDFKTAY KKSSYITPVPGGVGPMTVITLLNNTLKAYEQISKDCK >bbp527 fpr, ferredoxin-NADP reductase MNTWITAKIIKIKKWKNNLFSVIVNAPISPFTAGQFTKLGYQKKNGKIIQ RAYSFVNAPHEKNLEFYMVLIKNGQLTTKLYNLNNTDHIQIKKKSYGFFT LNEIPTCKILWMFATGTGIGPYLSMLKYQKNTEKFQKIVLIHAVRYRHDL TYFNEINNLKNIYNKKLYTQFIISREKTNFSLSGRIPQLLKTEELEKHIN LFIENNTSHVMLCGNPDMVKQTQNFLINNKNMKKHLRRKPGQISSENYW >bbp216 frr, ribosome recycling factor MERIKNFTSSKMDHCVHMFVNQLNTLRSSRASPSILDTILIDYLGQKIQL KKLSNIIVENVNTLRITLFDPKIKNNVEKAIISSKLDLIPIFINNYFQIK IPVLTEERRLQLIKLAKKMAENSRICIRNIRRLSNEKIKLFLKDKIISSD KERRLQHEVQDITNSYMEKINVILSKKEKDLLK >bbp195 ftsA, cell division protein FtsA MIKVLKKKLIVGLEIGTTKTTISVGEILEDDTINIIGIGLSKSIGIDRGI INDLKSIVECIKKVINQAETMANCNITSIYLALSNKYINCQNEIGIIPIL QEEITKNDIENVIHTAKSVRIRNEHKILHIIPQEYSIDERTGIKNPIGLS GIRMQAIVHLITCHSSIKKNIIKAVESCGIRVDYSVFSGLASSESVLTTD ERNLGVCIVDIGGGTTDIAIYTNGTLKHSCVIPYAGNTVTNDISYVFNIP FMYAEKIKIKYGYAMQSSDITEEEIKIVNEDNTIIQTFHKDKLTEVIESR YIELLTLINEEIKNTQKKLKKSGRIHKLGAGIVLTGGASNIKLFKNCAEK VFNIPVRIGCPKKNNINTAKLTNNTQTGSLSTVIGLLYFGKKYFYSHRNK NSYNFFKKWLQYINNWIKKEF >bbp204 ftsI, peptidoglycan synthetase FtsI MKYFFQNKKNIHIKNETFNNRITILLSLIIITIILVLSRITFLQIIVSKK LIYKSNLRSLRTQIEFNQRGNITDRLGYPLAINIPVKNICIDPKLLFSKQ THIYPNLKWKMLSTVLSIPLSEIFYRIKYSKNNHFIYLAHKVNPEISEYI SQLHIPGIYILDDFKRFYPFGKLTSQLIGFTNIDNEGIEGVEKSFNKLLM GKPGKKQIITDRYGRIIEQHNLVNKIQSHDIILSIDCSFQKFIYHILNQA VMSNKAKFGVAILVNIPTGEILSMVNTPSYDPNNSSELFKNNPLIRNKAI TDIFELGSTVKPMIIMKALEKKIITPETVINTSSLVVNKHIIHDVSYHHA LTASDILKKSSNTGVSRLALSIPISELIDIYSKFELGKSTNLGLIGERNG VLNTNKKHWSDLDKVTLSFGYGLMATPLQLARIYTTIGRYGLSKPLSIIV KNDTNLKNDIFSKQVFSKKIIKTVINMLEEVAKPGGAGFKAAIKGYRIAV KTGTAKKINSKGKYDNKYVSYIVGFAPVSNPTFCLMIMINEPKSNKYYGG EIAAPIFKTIMQKILKIKNIKPDAYL >bbp346 ftsJ, ribosomal RNA large subunit methyltransferase J MSKKRSSSSNRWLNEHFKDKYVKQVHKNKSDIRSRAWFKLDDIQSSNNFL KVGMTVVDLGSSPGSWSGYAVKRVGKKGRVIACDMRPMLPIKDVVFFQGN IKNKCFFNFIETYLCHKKVHVIISDMAPNMTGHYFIDHIQAILLSKLALK MSIKVLSKGGSLLVKSFYGQEFNSFIQDVHVTFSKVKICKPNSSRARSRE VYILASGRKM >bbp205 ftsL, cell division protein FtsL homolog MNKNYNLSKIIFNDLISFYKTQLILIFMIFISALLIITIIHKTRLLTSQQ EELDIIKKKQMPLNLEKYISTSRLKFKHEKIDT >bbp199 ftsW, Cell division protein FtsW MKTKLNIKLYDEKLLWCTLCLLLIGVTMVTSSSIPIAYRIYHDMLFFTKK QILYLVILFFIFKIFLDVPISFWQKNNKIILLISISTLLLVLIIGNSIHG SLRWITISYVSMQPSELSKLAMFCYLSNYLSQKNSEIVNNFGGFLKPIII ISFPLILLLVEPDLGTTIVILLTTLSLLFISGTKIQKFIPTILIIVVTTT VLIIKSPYRFERIMSFWNPWNDPFGKGYQLTQSLMALGRGNIFGMGLGHS IQKLEYLPEAHTDFIFAIIGEELGYIGACTILFMIFFISFRAFKIGKIAL KNKIFFSGYFAFSIGLWLIFQTLINVGTTIGLLPTKGLTLPLISYGGSSL IIVSIAIIILIRIDFELRMKNIQAFYKTDI >bbp026 ftsY, FtsY protei MFKKRVFSWFGFKKNKTKINDLDDHIKKNNQDNLSQKKCNNICSQDSIAK STKSDCCSENVANSSAVNESHSSSLMKLKLKQHVSHVNNKNSFLLTLTTK LVRTKEAFSIKLKNLFFKKKTYNSLLDDIEEQLLVSDIGVRTTRELVDSL IKVSTQHELKNLNLIIEILKSKMKKILNKVEGPLNINYKNLFVILVVGVN GVGKTTLIGKLAKNYKKKGKSVILAAGDTFRAAAIDQLKLWGEINSVSVI TREIGSDPASVVYDAIKIAKLKCIDILIIDTAGRLHNKNNLMEELKKIKR VIHKIDSTISQETMLVLDACIGQNSIKQVKIFHESLNVTGLVITKLDSTA KGGVIFSIAQEFLIPVRYISFGEDFEDIQVFNSNIFVNAILSNNTLK >bbp194 ftsZ, cell division protein FtsZ MFEPVELNNNAIIKVIGIGGGGGNAVEYMVQEHIEGVEFFAINTDAQALR KIEVEQTIQIGSDITKGLGAGANPEIGRRAAEEDSDNLKSILKDADMVFI ASGMGGGTGTGAAPIIAKISKKLGILTVAVVTKPFNFEGKKRMISAEQGV SELSKYVDSLIIIPNDKLIKVLSKGISLLDAFNTANNVLKGAVQGIAELI TKPGLMNVDFADVRTVMSEMGYAMMGTGIASGDERAKEASKIAISSPLLE DINLSGAKGVLVNITSGLNMKLDEFETIGNTIRSFSSDNATVVIGTSLDT NMNDSLRVTIVATGIGTYNDIKHNNNTENHTSKHVPKNLENLQTKESPKY NNPKQHIYDTFNQQGITNKEMNYLDIPAFLRKKHK >bbp470 fusA, elongation factor G MARITPVSQYRNIGISAHIDAGKTTTTERILFYTGINHKIGEVHDGAATM DWMEQEQERGITITSAATTTFWSGMSKQFLPHRINIIDTPGHVDFTIEVE RSMRVLDGAVMIYCAVGGVQPQSETVWRQVNKYNVPRIAFINKMDRMGAN FFNVVKQMNERLGIDPVPIQIPINSEENFSGVIDLIRMKAIYWDDLDKGI TFKYDNIPSDLTVLSDRWRQKLIESAVENDDFLMDKYLTGKKLSEYEIKN SLRQRVLNNEIVLITCGSAFKNKGVQALLDAIVEYLPSPMDVASYNVKKI SQKSNSKKSCSSNMDLSNDQEAFVALAFKIATDPFVGNLTFFRVYSGKVS SGDVIYNSVKKKKERFGRIVQMHANKREEIKEVRAGDIAAAIGLKSVTTG DTLCDPNNVVVLEKMDFPDPVISIAVEPKTKIDQEKMSVALNRLAKEDPS FKVHTDRESNQTIISGMGELHLEIIVDRMRREFGVGANIGQPQVSYRETI QSSVKNVEGKYIKQSGGRGQYGHVVIDLFPLKPLNQSGYIFINDIKGGII PGEYISAIDKGIQEQLLYGPLAGYSVVDIGVRLHFGSYHDVDSSEIAFKL AASLAFKSAFKKANPVLLEPIMKVEVETPEEYMGDVIGDLNRRRGMIEGM IDLSIGKSIRAQVPLSCMFGYATDVRSQTQGRASYSMEFLKYSEAPVHVA SSIIQNRDKN >bbp276 gapA, glyceraldehyde 3-phosphate dehydrogenase MTIKIGINGFGRIGRVLFRLAQLRSNIEILAINDLINVQYIAYMLKYDSI HGNFNGKIVIKNETLFVNGKKIRITNEKDPKNLMWGDLNIDVVIESTGIF LTTEDSYKHIQAGAKKVIITSPPKDNTPMFVRGVNFNEYVGQKIVSNASC TTNCLAPLAKVINDEFEIVEGLMTTVHATTATQKTVDGVSYKDWRGGRSA LQNIIPSTTGAARAVGKVLPELNGKLTGIAFRIPTANVSVVDLTVRNKKI ATYEDICQIIKYASNHDMKEVIGYTEDHVVSSDFNGNTLTSIFDAKAGLS LNNNFIKLVSWYDNECGYSSKVLDLSEFISTFS >bbp055 gcp, putative O-sialoglycoprotein endopeptidase MTCILGIETSCDDTCVAVYDTNNGVIFNQVYSQSQLYNYYGGIVPEFSAR KHLEILIVLLKNIFKKGKISKNLIDAVAYTAGPGLVGSLLVGASVGTALA YSLKVPVVLVNHMEAHLLTPMLENIKPTFPFLALLVSGGHTQLINALGIG EYELLGETLDDAVGEAFDKVAQALGLGYPGGSNLSKLARSGIPGTFNFPR PMINNSNLNFSFSGLKTFVLNIIQKNNNDFQIKANIAREFENAVVDSLVI KCIRALKKLKYTTLVVSGGVSKNDVLRMHINRIIKQYNYKVFYSHLKYCS DNAAMIAYVGSIRYKKFKSLNLEIKINPNWSIVDLAKI >bbp001 gidA, glucose inhibited division protein MLREQNFDVIIVGGGHAGTEAALACSRMKKKTLLLTQNINTIGALSCNPA IGGIGKSHLVKEVDALGGIMAKAIDKSGIQFRILNSKKGFAVRSTRAQAD RKLYSQTIKKTLLFQENLLVLQAEVDDVIVSNYKIMGVITQTKIKFFSKA VVLTTGTFLGGKIYIGSKCFLGGRINDYSSINLAQRLKDLPIKIGRLKTG TPPRINKHTINFSKLDVQYSDNPLPIFSFMGNQKEHPRQIPCYITATNEK THEIVRKNLKKSPIYSGLITGIGPRYCPSIEDKIVRFSDRNAHQIFLEPE GLHDIEIYPNGISTSLPEDVQVEMIHSIKGLERAQITRPGYAVEYDYCDP RTLKLTLESKFIEGFFLAGQINGTTGYEEAAAQGLLAGLNASLYASNKCG WFPNRGQAYLGVLIDDLCTKGTKEPYRMFTARAEHRLILREDNADLRLTN IAKSMNLIDNSRWTRYVEKLSNIKNETTRLENLKIRSKLYSITELNNFFS IKINTESTAKDLLKRPEINYSTLMLFKKFSPGIKDKEAYEQIEIQEKYCG YIKRQIKAIKNQLNNDYIVLSKIKNYKVVKGLSNEVVSKLNFYKPYSLGQ ASRISGITPAAISILLIYLKKKLYST >bbp028 glmS, glucosamine-fructose-6-phosphate aminotransferase isomerizing MCGIISAISKKNVTNILIEGMKRLEYRGYDSSGLAIINKKKEIIRLRSQG KIKNIINLIHKTKQLIGNIGIAHTRWATHGLALKKNAHPHVSKNIAIVHN GIIENYLNIKTKLQKNGYIFTSDTDTEVIAHLIHYEQNKNNKSLLKTIQT VILKLTGSYSMVIMDRYHPNILIAIRSGSPLLIGLGKQENFISSDQLSLL KITKKFIYLNEGDIAILSHKKITIFNKNSILVHRPIVISNIQNDSITKGH YQHYMKKEIYEQPYAIKNAIRNRITKNEKIQFSELNNNAHALLLKIEHID IIACGTSYNAGMVSKYWFESLSKISCNVEIASEFCHRKFIVKKNSLLLIL SQSGETADSLTALRNSKKHEYLGSLVICNSSSSSLVYESNFSILTNAGIE IGVASTKSFTTQLTILLMIAAKINNLKTNDEKIENKVAKTLRLLPEITKN VLKCDSLIYSLAKELSDKNNIIFIGRGHNYPIAMEGALKLKEISYTHAEA YAAGELKHGPLALVDSSTQIIVIAPNDNLIDKIKLNISEIRTRGGVLHIF SDNLTKFNDNTNVIRLPYDGILLSPIIYVIPLQLLAYYVALIKGKNIDKP RNLAKSVTVE >bbp029 glmU, UDP-N-acetylglucosamine pyrophosphorylase MNNHTLNIIILAAGKGTRMQFDHPKLLHLLGGKPILEHVINLAQSLCPKT ITVIYNKQYKKFKIKNKNNSITWIKQKKILGTGNAISQIINNYKDHENIL ILYGDVPLISKNSIQKMLLKKKNSTITLLTAKLNNPEEYGRIIRKNKKIV KIIEYKDATDEQLNIKEVNSGILIVSSTNLKKWIFQIHAKNNQNEYYITD IISLANKDNHKINSVRPEKNDEIQGINNLLQLVRAEKIYQKQQAKLLLLS GIMIYNPSNFSLRGTLKHGKNIKIDHGVILEGSVKIGNSVIIEPGCIIKN STIGNNCTIKAYSIIEKTIISNKCIVGPFTHLQHGTVLKNNTHVGNFVEI KKTTLGSYSKAKHLSYLGNSQIGQKVNIGAGTVTCNYNGKKKLDTIIGDN VFIGSSTQLIAPINIKKGTIIAAGTTVMKNIHEPSLVYNEKKQIHKKL >bbp375 glnS, glutaminyl-tRNA synthetase MKKQHSKISNFIQKIISEDIQNKKITHVKTRFPPEPNGYLHLGHAKSICL NFDLAQEFKGTCNLRFDDTNPKNEDTCYINSIIQDIKWLEYKWHNKIRYA SLYFNKIYQYAIKLIKKGLAYVDQLSPEEIRTFRGTLTTSGIDSPYRTQS IEKNLNLFKKMKQGKMLEGTACLRAKIDMASNCITMRDPVLYRIIFSKHH QTNKKWCIYPTYDFTHCISDALEKITHSLCTLEFQDHRKLYEWILKKIDI SCNTHQYEFSRLKLEYSVLSKRKLNLLVNNKVVNGWDDPRMPTLSGLRNR GYTPSSIKLFCKKIGITKQENTIQLSFLESCIRSDLNPIAPRYMAVIHPI KIQICNLSDNYEEILNIPNHPTKPNMGCHKSIFSNTLYIDQNDFYENKSE LLKKLAIGKEIRLRYSYVIKAHKIKKDQNNNIKTIFCTYDKNTLGKNPKN RKILGVIHWISEKNVLPARFFLYDKLFTIQSPETVKNFLQYINTNSLVIK YGFVEKDILTNISTTAYQFEREGYFCINKNFSITKNLTFNRIVTLKDKIK >bbp228 gloB, putative hydroxyacylglutathione hydrolase MKIIFTKVLFDNYVWIMFNSSKDCIIIDPGESNSVIKKIKKLNLNPKIIL LTHNHLDHIQGVKNLLYKYPEISIYGPLETQFCGTKNLIDNRNTIEILNT KFYIIPTPGHTNGHTAYYCPPFLFCGDSIFSGGCGRVKNGMMIKMYNSLR TISKLPNDTLIYCSHEYTRSNLEFFKKIFPKNLNILNYYNNIKKSKTQCT LPSTLKIEKKINPFLQLNNTNLRHQVKIHNDLSFSLNFFIYLRKIKDKS >bbp065 gltX, glutamyl-tRNA synthetase MIIKTRFAPSPTGPLHIGSVRTALYAWLFAKSMNGKFVLRIEDTDKRRST NAFTSEIINNLEWLGLNWDEGPYFQSDRLEYYRNIIKKMVEAGLAYKCYC TNDRLLKLRKFQISLGKKPKYDRKCRYLVKKDILSTDYVIRFCNPDFGCV TFCDKIRGKISIENKELDDLVIQRADGIPTYNFCVVIDDRDMNITHVIRG EDHISNTPRQINILRALNANIPIYAHVSMVLSEDKQKLSKRNNTITSISE YRLCGYLPESLLNYIVRLGWSHGNQEIFSISEMIKYFTLESLNKSSSCLN KKKLLWLNRFYINNLPETVIKKHLQYQFNKNNIDYKNDSDLLKLVKLLGS RYYTLQEIVDYSRCFYNKSICFNSNIMSKHLDNSSKLILKKIYDKFLDLE VWNVEVIRSLLNSSVCELQISFKKVSMTIRIAVTGHVFSPNLCSVICFLG KNKFLLRIKEALLYIKNMCFEV >bbp268 glyA, serine hydroxymethyltransferase MFIKNKTISNYDADVYRMMKQEYQRQENHIELIASENYVSSCVMEAQGSQ LTNKYAEGYPGKRYYGGCDYVDAIEKIAIKRAKKLFNANYANVQPHSGSQ ANYAVYSALLKPNDIVLGMSLSHGGHLTHGSSVNFSGKLYKFISYGLDIS GDIDYPQIRKLAHRYKPKMIVGGFSAYSGICNWKLLREIADEINSYLFVD MAHISGLVAAGLYPNPLKYAHVVTSTTHKTLSGPRGGLILAKGDNVSLFK KLNSSVFPGCQGGPLMHVIAAKAIAFKEAMEPEFKDYQYQVIKNAQEMAK TFISRGYKVVSGKTFNHLLLLDLSNKNITGKRADILLHSANIIVNKNSIP NDLLSPFITSGIRIGTPAITRRGFTELESRQVSNWICDILDNFNNIEISA KVKQKVLNLCSLFPVYK >bbp127 glyQ, Glycyl-tRNA synthetase alpha chain MLSNFKKEKMNTSTTFYEIICTLEKYWHNQNCTIIEPLDISVGAGTFHNK TFFGTIGSKPISMAYVQSSRRPSDGRYGKNPNRLQHYYQFQVIIKPSPHN IQCLYLNSLKKLNIDCKTNDIRFVEDNWENPTLGAWGQGWEVWLNGMEVT QFTYFQQVGGINCNPITTEITYGLERIAMHIQNKSNIYDVIWNQDMNNNI ITYGDLFLNNEIEHSSYNFKYADSKLHFDLFEKHLQESNRIMKLFNNLLF PAYEHLIYSIHYFNLLDAKKKFSTTQRQTHILNIRNTSKMIATNYYKKQK >bbp126 glyS, glycyl-tRNA synthetase beta chain (Glycine--tRNA ligase beta chain) (GlyRS) MKNTFLIEIETEELPPKSLKAIAQSFNKQIIEKSKTYYLKYKQTKWFATP RRIAVMILDINTSDTNFYLQTKGPSIKNAFDKLGNPTSIMKFWMQKMNIK IHEITYLNTNKGSWVTCSKITNKKSIQEILIELCRLAIKNISIPTFMKWS NNDIQFSRPVRNVIMLLNHEIIRNNVLGLETNRLLSGHKFMTNNKIILNH AYQYPELLLNSGKVIADYDARKHKIQKHASIAAQSVNGILKIKTTLLEEI TALVEWPTILLATFKKRFLNLPQEILVHIIEKKQRCLPIYSTNNGTILNS FVVVSNIETSYPNNIVRGNERVIHAQFVDAEFFFKKDTKKKLIDYKPLLK KIIFHDTLGTLLDKTHRIKKLITWISKFTHANVNDCIRAADLSKCDLVTN MTFEFPECQGIIGMYYALHDLEPKNIAIAIKEQYQPKFSKDNLPSNTISY SLALADKIDTLTGLFSINKNYNISEKDPFSLRRLATGIMRIIIKKNIHIN LYDLLEKSLKTYKKINNSDIILKKEIQFLFNRIYSIYDKNKYNHSIIKSI LENNTKILTNIDPKIKAITYVFKNHPKILQNLIITQKRVSNILKQFKENI SFNINMKTLEQIEEIKLIEQLNIIEKKYKHPFSKETYISMMLTLNSFCQL IHEFFNKVMINHKIVSIKNNRLAILFKIQNLFFTISNFSNININITI >bbp385 gmk, guanylate kinase MAKGLLFIVSAPSGTGKSSLIQALVNTHPLYSIKVSVSHTTRIIRPGECH GKHYYFISNTEFQNMIDKEEFLEYAKVFNNYYGTSKKQINYGLSTGTDVF LDIDWQGARQIRNKLPESKSIFILPPSKEELYRRLCKRGQDSDIIIKKRM NQAVSEMKHYIDYDYLIINDNFNLAVSDLYKIIRVAHLSIKHQIQRNNLL IRNLLNE >bbp101 gnd, 6-phosphogluconate dehydrogenase MAKQQIGVIGMAVMGRNLALNMERNQYTVSIFNRSLDITEKIILNNPNKN LFPFFSIKDFVLSLIVPRCIVLMIKSGVATDDTIKSLIPYLSKGDIIIDG GNTFYKDTIQRGYELLKIGVNLIGAGFSGGEKGALYGPSIMPGGRQEAYN YVSPILKKIASNSEGIPCVTYIGPDGSGHYVKMVHNGIEYGDMQLIAESY FILKTLLRLDNQSISKIFDIWNQGELNSYLIDITKDILIKKDDQNNYLID CILDEGSSKGTGTWTTKSALDLNEPLTLITESVFFRYLSSLKSQRLLASK ILCGPKDFFIVLNRDDFIEKIRQALYLGKIISYAQGFSQLNSASQKYNWN LKLGEISRIFQSGCIIRAKLLKNITQEYSSNNNFVNLLLTPYFREIANTY HSSLREIVSISVKYGIPIPALSSAISYFDSYRSAFLPSNLIQAQRDFFGA HTYKRIDKSGIFHTNWYS >bbp283 gpmA, phosphoglycerate mutase MKVYKLVLMRHGESIWNELNKFTGWHDVDLSNRGVQESLKAAKLLKKHGF YFDYAYSSVLKRSIHTLWNIIKFLDQSWIPVKKSWRLNERHYGALEGLNK DDVIQKYGNDKVQQWRRSFNIAPPKISYLEKKKLAHDSRYNNINFDILPY CESLKLTTQRVLPYWLNEIFPRFQKNTKIIIVAHGNSLRALIKYLNNIND IDILNLNIATGFPIIYEFNSEFKPIQYYYLKQ >bbp232 gpt, xanthine-guanine phosphoribosyltransferase MSKKYIVTWDMLQIYARELAQKLLPVNQWKGIIAVSRGGLIPSALLAREL NIRFVDTICVSSYDHNRLRDLKILKYAAGNSSQIIIVDDLVDTGGTGKII RNLYPKAKFVTIFAKPMGKLLVDEYIIDIPQKVWIEQPWDMGVTYQSPLV RDL >bbp347 greA, transcription elongation factor GreA MNDQIPMTILGVEKLRKELEMLKTIKRPKIIKSIIEARQHGDLKENSEYH AAREEQGFCEGRIKEIELKLSKARIIDITKVKNNGVIIFGSTVTILNLTS NQEFTYRIVGDDESNFKRKLISINSPMSRGLVGKKVSDVATIKTPVGDVK YKILKIEYN >bbp173 grpE, GrpE protein 2 MNDIDKHKKETQTESKNDLNNTTITQNNVSDDCQNQDKINSLKQKILEIK KHISEVKLREQAEIENINKNTKNKIKIIIDTQLENFFRNLIPIIDSLKNI RKDINKYNNIKDNNMIQGIPLILKSLLTVTEKFGLKINNKKGKLFDPKLH TTIPNENCKNINEYYVSEIIQDGYTFHEKIIRKAIVKLSKDKKT >bbp233 grpE1, GrpE protein MNIDNDLLSKNKEAKVVSENSTVEINDVTNSDSKNTDNDFQTEELNNFEK IFLNLNSDLLNQQLLVKNNLKLYKIRAEKEINRAYKFSLKSFISSLFPVI DSMEYALNLFKKDDKILCLIFNELDNVSQSLMNLLVKFGVTSIKDINIAF NPDIHQAITTQVSKDIKNNYVISIMQKGYLLYDRLLRPAMVIVSKNDI >bbp368 gshA, glutamate-cysteine ligase MIPKIYKKIKWLQSNPLILKKILRGIEREALRTDIHGTIINTAYPQDKIG SALTHKWITTDFSESLLEFITPTNASTNYILKFLNDTHKFVNDNLIQEYF WPFSIPPCKKYMHSIKLSKYGTSNLGQVKTLYRKGLKHRYGILMNIISGV HYNFSLPRIFWNHWKKIHHKNTQYNTTSEGYLCLIRNYYKFGWIIPYLFG ASPAVEPLFIKNKKHNYKFKKHHGMLYLPWSTSLRLSDLGHTNQSIKKLK LTFNSLSEYVLALEHGIKTPSKQFKNLGLYDQFGNFKQINTNLLQTENEL YTYIRPKQKLKNCESLSAALRNRGIEYVEIRALDINPFTSTGVDKNQILL LDLFLIWCVLADSPKISSQEFHFFLKNWHTIITKGRKPKQKININIYNTK NTIQTIGKTILYDLFYIAEILDSLSNNNNYQETCKNLILYFDYPELTYSE KLLNKFMCYGIYETGANLFVKYKQKLHNDSFKILSKKDLNNEMMKSNNSQ KLIEKQDTLNFKEYLNLYYTK >bbp490 gshB, glutathione synthetase MTINLGIIMDPISSINIKKDSSFAILLEAQNRKYKIYYMELKDLYLKDNK PYSHTKLLRIKNNKKQWFTLEQQKDVSLSNLDVILMRKNPPINRAYIYAT YILEQAERNGSYIINKPSSLRSYNEKLFTTTHFPQYIPKTLITSNSTKIH NFIKTYKDIIIKPLHGMAGLSIFRIKEHDPNTSVIIETMTKYETIPCISQ NYITDIQKGDKRILIINGIPFPWCLARIPKKHENRGNLSIGGYGNTQKLS KNDWEIALSIAPTLNKKGIFFAGIDIIGTKLTEINITSPTCIQEIEQDTG ISISTIILDNLEKNLKKRKTNRYL >bbp188 guaC, GMP reductase MRIEEDIKLGFKDVLIRPKRSILKSRSQVDLTRLFIFKHAQNKWSGIPLI AANMDTVGTFKMAIALSSFGILTAIHKYYSYLDWKKFIHTIPGTVVKHIM VSTGMLDEDFVKLKQILSLSSKLKYICIDVANGYSEKFVTFLKKVRECYC DKIICAGNVVTGEMVEELILSGADIVKVGIGPGSVCTTRAKTAIGYPQLS AVIECSDAAHGLGGQIISDGGCVVSGDIAKAFGGGADFVMLGGMLAGHKE CEGLIFKENKKRYMIFYGMSSKFAMDRHIGGVARYKTPEGKTVKVLFRGA VSETINNILGGLRSTCTYVGAFTLKELTKRTTFIKVSEQENIIFNNQEVS N >bbp169 gyrA, DNA gyrase subunit A MKEVAKEIIKIDIEDELKNSYLDYAMSVIIGRALPDVRDGLKPVHRRILF AMKVLNNDWNKTYKKSARIVGDVIGKYHPHGDTAVYDAIVRMAQPFSLRY VLIDGQGNFGSIDGDSAAAMRYTEIRMSKIAYELLNDLDKNTVSFFSNYD GTEKIPEVLPAKIPNLLINGSSGIAVGMATNIPPHNIKEVINGCLAFIDD QNITLKKLMEHIPGPDFPTAGLINGKRGIEKAYKTGKGKIYIRAKSIIEI QKKTKKKSIIIYELPYQVNKARVIKGIANLVKEKKIEGITTLRDESDKEG MRIVIEIKKETKAEIILNQLYSLTQLEISFGINMVALIHGQPKVMTLKEI LNAFINHRRKIIMRRSLFELNKIRKKIHILEGLIISLDNIDLIINLIKKS STLEEAKNKLKTYHWYSKHAQYTQILKKNAHSLTPYDKKLRPIDTQKFFL TPEQIQAILELRLQKLTHLEHKKLISEYKQLFKTSNNLENILKNNNILTK IMKDELIKIRDNFGDKRRTKINVNYSDINTSDLINKENVVITLSYSGYVK YQLLSSYEAQKRGGKGKLAVKTKEEDFIENLLVANTHDIILCFSSKGILY WMKVYQLPEASRHARGRPIVNLLPLSSNERITAILPISEYKDSINIFMAT SKGMVKKTSLYEFKKPRTKGIIAINLKADDELIGVSLTNGNNTIMLFTAQ GKAVHFSEILVRKTGRTAIGVQGIKIKKSDKVVSLVVPKKHGNILLITEH GYGKRTEIHEFPIKSRATQGTIAMKITKKNGIVIGTMQVVNQDQIIIITN AGTLVRTRVLEIGILGRNTQGVIIIRTSKKEKVVALQKANALHLNSV >bbp010 gyrB, putative DNA gyrase subunit b MKNTYTSSNIKILKGLDAVKKRPGMYIGNTDDGTGLHHMVFEVVDNSIDE ALAGFCKNIIVTIHDDNSISIQDDGRGIPTDIHDEEGISAAEVIMTVLHA GGKFDNTSYKVSGGLHGVGVSVVNALSKKLELFIYRDKKIYYQIYKNGYP KNTLSIIGYTKITGTKIRFWPNLEIFTNVTQFNWEILSKRLRELSFLNSN VSIYLDDAKKHINENFYQQGGLKEFIIYLNKNKKPIHSKIFYFSSKKNNV EVEIAMQWNKGFQENIYCYTNNIPQQDGGTHLSGFRSALTRTMNNYLDKE GYIKKNKINIIGDDTREGLTAIISIKINDPKFSSQTKNKLVSSEVKSALE SLVNEFLMEFLLENPQESKNIVTKIIESSRVRNAARRAREMTRKKGTLDL IGLPGKLSDCQERDPALSEIYLVEGDSAGGSAKQARNRKNQAILPLKGKI LNVEKARYEKMLSSQEVTTLITALGCGIGKNEYNPEKLRYHRIIIMTDAD VDGSHIRTLLLTFFYRYMPEIIQRGYLYIAQPPLYKVTKNNKTRYIKDKN TMENYKLSTALENTILESNTDKEIKIKCNYTLKKIISEYKIIQTIFFKIK DNFPLNILNEMLYHPKLNNLNDEVYVNNWINNFVIQLQKKSSSTRNYSAH ITFNSKDKIFEPLIKIQKNAEVKEYKFDITFINSYEYQKIYSLGKKLQEM IQKNIHIKKNNKTYSIKNFQKNFELLIQNSFKNVLIQRYKGLGEMNPEQL WKTTMNPETRRMLKITLHNIDTTNKLFNTLMGDSVEPRKLFIELYALKAS NIDI >bbp162 hemK, HemK MKIKNWLKYASLKLKKTSSSPNLDAEILLSYVLKKCRTWIISNDFIKLTY DNLIDLNVLLQRRMNSEPISYLIHVKEFWSLPFLVSNSTLIPRPDTEILV EKALIYLKNLSNAKVLDLGTGCGSIALALASERLDCKIIGIDCVKESISI ASKNAKILKLKNVSFLHSIWFSKVDNMFDMIVSNPPYLSFSEMKNVDKEV LFEPFIALFSSENGLGAIRHIIKYSKKYLYSKAWLLVEHGWKQKDKVQSF FYKYSFININTYRDYCDSDRVTVGQKQ >bbp345 hflB, Cell division protein MAKNLMLWLVIAVVLMSIFQNFSANNINNRKIDYSTFLSDVNQDQVREVH ISGREMNIIRKDNGRYITYIPISDPKLLDNLLVKNVKIIGAAPEEQSFFT AIFISWFPMLLLIGVWVFFMRQMQVGGGKGAMSFGKSKARMLPEDQVKIT FSDVAGCDEAKEEVQELVEYLKEPSRFQKLGGKIPKGILMVGPPGTGKTL LAKAIAGEAKVPFFTISGSDFVEMFVGVGASRVRDMFEHSRKVAPCIIFI DEIDAVGRQRGAGLGGGHDEREQTLNQMLVEMDGFDGNEGIILIAATNRP DVLDPALLRPGRFDRQIFVALPDIRGREKIIQVHMKKVPLGNNVDPMIIA RGTPGFSGADLANLVNEAALFAARNNRDVVMMSDFESAKDKITMGSERRS MVMTEKQKESTAYHEAGHVIVGRLVPEHDPAHKVTIIPRGRALGVTFFLP KDDVLSINKNKLESQISTLYGGRLAEEIIYGVNNVSTGAHNDIKVATNLA RNMVTQWGFSKKLGPLLYSEEEGEIFLGRTVTKSKHMSDETARIIDEEVK LLVEKNYNRAKKILEENLDILHAMKDALIKYETINSRQIDDLMKRKSIQS SNICTDDDNN >bbp512 hflC, HflC MRKVILIILIVVVIYFFTCFFIIKEGQRGIILRFGKISYDDNHHVLVYKP GLHIKLPFIESVKIFNSKIQTIDNRLDSVLTKDNKNLVLNTYINWKINDF CRYYLSTGEDNIYYAETLIKQKFNNRLRAQISHLNIKEIIFNVKDQLTSN IKYSLNASSKINYKNVIFKKAINGTSNQNINQENNLLQSISDLSEIGVQI LDVRIGKISVSEDFFSLICSRINSEYRAIAKHYRLMGDKQAEELKLRANY EVVKILSKAQRSALIIKSEGEALVAKLFSDAFSQEPEFFSFIRSLQAYEN IFKKKNQNLIVVNENNSSFLRYMYIK >bbp513 hflK, HflK MEKNMAWNEPSDSEKDKDPWNKKDKKLKNFDENKKSKLYLFLEIECLVNF LKRKKKIFFSESGSFKYFKNLITMIIFTTIIFLIGSGFYFIQESEYGVVT CFGKFSYLANPGLHWKPILIQKVIPIDVSTVREINTSGTILTYSEHFVQV NMTVQYRIVDPKKYLFSVTNPDNCLRQSINSALRSVISRSNIDIFLKNEF SLLAKNDIKVNIQKIIKPYHMGIVISDINFRTLYLPQAVKLAFEDIFSAI ESKKQSLNEARIYSNEIKSQAFYNAKKILIEAKSDRLRTILNAQGIIFKF LKILPIYKSSKKITTIQLYFDCMEKIFSHTRKVLTNSDNNFFLFSLNDLF LKNNYNSLTQSHSNSNKHSSMLNTVSSSHVKSIDHVNSNNLLISSNNIIN QRKLNSFRKDYLRIGRE >bbp098 hisA, phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase MIIPSIDLIEGNIVRLYQGNYDTKTFYQNNIYDIALKYYNQGAKIVHLVD LDGALCPNNKQTSLIKNLLNYFNFHIQVGGGIRSYKDVETLLLNGAKRVV IGSSAINNITEVEKWLLEFGYKSIVLALDVYVRNNGYKEVVINGWKNRSN VSLESVLERFSTLGIKYVLCTDVKKDGTCLGPNFTLYKNISKLFKNVCFQ LSGGIGTISDVISAKKSGIKDIIIGRALLENKFSLLEAIRC >bbp096 hisB, histidinol-phosphatase MSEKVLFIDRDGTLISEPLDNFQVDSFDKLEFKQDVISSLITLKKFNYKF VMVTNQDGLGSKNFPYKSFIRPHEFMIDVFLSQGIKFEEVLICPHELKSG CQCRKPNLGMVQHWLLNDMLDKQHSCVIGDRKTDMILANNMGILGIRYGT KQGNSWSDIVFKLTKKHDRHAKVVRNTKETNVSIEVWLDKQGGSLINTGL NMFNHMLDQIAVHSCIRMKIISSGDICVDDHHTVEDVGIVLGKAILKALG NKLGINRFGFALPMDDSSSYCLLDISGRPFLKFRSYFKHQYIGDMSSEMV RHFFQSLAFAMKCTLHLRSMGINDHHRLESLFKVFGKTLKQAIVVSGKNL PSSKGLL >bbp095 hisC, histidinol-phosphate aminotransferase MDIKKLVRKNILQLVPYQSARSIGGNGDVWLNANEFPISSCLSLINISLN RYPEFQPKKLLNAYAFYLGICSEKILVTRGSDEAIELLIKTFCEPRKDKI MYFPPTYDMYDISAKILNVESIGIPLLKSFQLDLNLIFRNICGVKLIYLC NPNNPTGNLIKKQDIIALLTYTKGKALIVVDEAYIEFCAMHSIVQLIEKY SNLVVLRTLSKAFSLAGLRCGFLLSNSNIIKMLSKVINPYPISLPVSDLA TQSLSKKNIDIMNSRVLDLNKTRVWFVKQLRTMYCINTIFDSVANYFLVK FHDSKLVFKELWENKVIVRDQNKKTNLKNCIRISVGTRLECFEVIRILER IDRLYKNVRR >bbp094 hisD, histidinol dehydrogenase MEVYIPIIYWKSCSEKEKREILFRPVVNDNSQIKEVVKEIITNVKNSGDK ALYDYTKTFDKIRLESIQVSYGEIVDSDSFVNEEIQKSISVAKNNIKIFH EKQTHNVVNIEIQPGVFCRQIIRPIQSVGLYIPGGCAPLVSTVLMLAIPA KIVGCKNIILCSPPPITKEILYASKICGIHNIFQVGGAQAIAAMAFGTKT IPKVNKIFGPGNVYVTEAKLQINALLNDLSIDMLAGPSEILIIADFKANA CIIASDFLSQMEHGIYSQAILVTPSYDLACNVIFEINIQLKNLSRKKVIN KSLKYSRIIVTKTLLECFEISNLYAPEHLIIQCENSNRLLVYVINAGSIF LGRWSAVASGDYVTGTNHVLPTYGSAIVNSGLTVMDFQKIISVQKLDQQG LIDVSSSIISLSEVERMDAHTNSIKQRLIALQDVK >bbp099 hisF, HisF protein MLAKRIIPCLDVKSGIVVKGVQFRNHEIVGGILSLAKRYTQEGADELVFY DIEASSNNRLIKKKWVSQIAEIINIPFCVAGGIQTIQDVQSILSSGADKI SINSPAISDPYLISRIADRFGVQCVVVGIDSWFNKEESQYYVYQYTGDNT KTIKTSWKTCDWVQKVQALGAGEIVLNVMNQDGMKNGYDLVQLKKIRKIC NVPLIASGGAGDYFHFYDVFNEAKVDGALAASVFHNRIIKINQLKKFLMK KGLEIRVC >bbp093 hisG, ATP phosphoribosyltransferase MISNNRLRIAMQKTGRLSDDSKDLLTRCGIKINLHKQKLIAFAENMPIDV MCVRDDDIPGLVMDKVVDIGIIGENVLEEEVLNRQVQLDNCSYTKLKRLD FGICRLSLAVPINIEYNNIHCLNHTRIATSYPHLLKRYCDKKKLTFKSCM LNGSVEVAPRAGLSDAICDLVSTGATLEANGLREVEVIFFSKACVICKTG FISLEKKNVIDKLMTRIQGVIKARESKYIMLHAPIEKLEKVMNLLHGAEN PTILKLAGDNTRVAMHMVSSETLFWETMEKLKLLGASSILVLPIEKMME >bbp097 hisH, amidotransferase HisH MSIVIINTGCANLSSLKYAIQRLGYNVIITSNHKNILNAKKVFLPGVGTA FSAMKMLNQFKLKDVLYKYQQPVLGICLGMQLLCSFSSENNGIKMLDIIH APVNILKSNKFPLPHNGWNNVSVCDENPLFIGIKNNSKFYFLHSYALYEN DYMIAKTFYNVYFSAAVRKENFFGVQFHPEKSGLVGLQLLKNFLEI >bbp100 hisI, phosphoribosyl-AMP cyclohydrolase MLKKINFIDINWNKVDNMLPVVIQHNLSGKVLMHGYMNQEALKRTQNEGI VTFYSRTKQRLWTKGETSKNFLYVTDIRLDCDQDALLIFVRPVGKTCHLN HVSCFQVPSENLFFLHDLDCMLKFKKHYGLENSYTFNLHKNGVNRIAQKV AEEAIETAISAVSKNKVELINESSDLVYHLLVLLHSYDLDLYDVIKNLKM RSNKQV >bbp267 hisS, histidyl-tRNA synthetase MKEIIRSIKGMHDYIPDDVITWQYIEYIVKRILKNYCYNEIRFPLIEKTS LFAHSIGNITDIIEKEMYSFKDKKNKKITLRPEGTIGCMRACINKGLLRT SKQKLWYLGPMFRYERPQHGRYRQFHQFGIEVLGMSGPDIDLEIILLVER ILRTLNISNYVQLELNSIGSYESRLHYKKILFSYFKQYEACLDEDCKRRL YVNPLRILDSKDKNIKAIINNAPILMDFIDDNSLIHFENLCKLMKNIGIS YVVNYKLVRGLDYYNKTVFEWKTNLLGAKDAICAGGRYDNLSKSLGVTFI PAIGCAIGMERLVLLIKSLKLKPKTNNAIDVFIIFLKDNIQIEAIKLSEL VRTQFPKKKIMLSILSSNLRKQFSTANKIKARIVLLLGPNEVKNNLILLK DLTSGYQKSFLKNKIIEELELAFKN >bbp396 holA, DNA polymerase III delta subunit MKIIHSENLFSYSFKTLSSYYVIVGNVKHLIQQSTNIILNLAKKNGFSKM SKIIFCDPIYINNIILSAKSQNLFFKKKIISISFKKYISIKEVQNYILKL KKYLHTNLLLIIYIYSTNTNILNKINTKIFPPNGTMITCTFFNQNNISIW TKYKIKNIKMNITKNAENLLIQYHQGNVLHLNNTLNILSLVWKNKLINTL SITNFIEDCSIFKPLQWINALLNNNLQFSIKILNQFENQNFNPIILIRYL QHDLLTILLIKRDDVKNYYNILKNRNTNKNRHSLIINYARRKHYKTIYKS IKLLTLIELQIKKNNTKLIWLPFYTLSIIICL >bbp324 holB, DNA polymerase III delta' subunit MNLYPWLQHSYKQIIYPHYINKGHHSIILESHKNIGITCLAKHISLWLLC QKKNKSIYHCKTCHSCQLMNSKNHPDWHYFGSNTCLSKNSSKTIGVNEVR NFTNTIFNSAQQGQNKIVYIPNIKKLTEFAINSLLKIIEEPPQNTYFLLI NYLPHKIITTLRSRCIIHNLYGPTKENRIEWLKEQNINTNQKIHMSMLYS NEISFISKCKHSLFFLYQERLNFFETLLTSFQEKNFLKMLNVLNNKKCLD QIFIWICGIILDSIKWKHDINTIIINTDQTKIIQILASNFSILSLDNSYK SWIYCYNNIKNIPGINIELLFVKQLLYWEEILNIFN >bbp547 hscA, chaperone protein HscA MITLKTIKKKYNIEQKNTKLSIGIDFGTTYSLVASALEDNIYIILDQNNR ALLPSIINYTSKKPIVGWEAQKQAINDPKNTIISIKRLIGHSYDEINKLY PNLPYHLTYDKNGILSFIVQDNLINTINVSSEIFKTLKNRVNTIFNQKIL GAVITVPAHFNDLQRQEIKKSAELANLNIIRLLNEPTSAAIAYGLHLNKN KIVAIYDLGGGTFDISILKLNQGIFEVLATSGNTNLGGDDFDQLLVNYIQ KKTHFSYSKLDFIFQRKLLYLAKSIKIKLTSHNSVQFQFNNSKMHTITRF EFEKMIEPLILKTLNICQHVLHDSNTNLTHIEEIILVGGSTNIPIVQRKV SDFFKQLPLCTINPEQVVVAGAAIQANMLTNGSKYNNFILLDVVPLSLGI EVIGNIVEKIILKNTPLPISKTKTFTTFKDKQTTMLIHVLQGEHKLVNKC QSLCRFVLKEIPKKPAGKIIVLVNFQIDVNGLLSVTAEIKSTKIRKNITV NASIPIKKYRN >bbp546 hscB, chaperone protein HscB MNYFKLFNLPQKFELDVNNLTSQYYNLQKKFHPDSYQDKNIYTKKYLEKS MLLNQGYQTLKNMLTRAEHLLFLNNYKVDKKKKIVFNAKFLEMQIELFER LEIHKNKNNKHEINKILLEVSQIEKNYIKKLKNFCNLEKWKIAHSILYKL LFLTKFIKKTKKIQHEIIN >bbp524 hslU, ATP-dependent hsl protease ATP-binding subunit HslU MSEMTPREIVKELDRFIIGQKKAKRAVAIALRNRWRRMKLNKELRYEITP KNILMIGPTGVGKTEIARRLAKLAKAPFIKVEATKFTEIGYVGKEVDSII RDLTDSAIKMIKSTAIKKNKKRAKELAEERILDVLVPTIKNNWKKTNTNN NSEATLQIFRKKLREGTLDDKEIEINVAVTPMGIEIMAPPGMEELTNQLQ SLFQNLTGNKRNIKKLKIKDAMKLLIEEEAAKLINLEELKKEAIYAVEQH GIVFIDEIDKICRNHGSSGPDISREGVQRDLLPLIEGCTVSTKHGMVKTD HILFIASGAFQVSTPSDLIPELQGRLPIRVELQALTINDFELILTEPKAS VTMQYQALLKTEKVKINFTKEGIRHIAEAAWKVNESMENIGARRLHTVLE RLMEDISFHASDHRNEITITIDEKYVQKHLDKLISNEDLSRFIL >bbp523 hslV, ATP-dependent protease HslV MTTILSVRLNKQVVIGGDGQATLGNTIIKSNVKKVRTLYNNKVIAGFAGG TADAFTLFELFEKKLLMYQGQLQRSAIELAKDWRTDKILRKLEALLAVAD KETSLIVTGNGDVIQPENNLMAIGSGGSYAQAAAIAMIENTSLTAKQIVE KALKITSGICIYTNNIFTIKELTSEK >bbp427 htpG, chaperone protein HtpG MTANKNQKKTYNFKSETKELLHLMIHSLYSNREIFFRELISNAADAIDKL KFNAISAPELYENDTNLYIRIFSNKNNNSLTISDNGIGMKYEDIINNLGT IAKSGTKEFIKTLNKNNKIKNDLIGQFGVGFYSSFIVSEKVIVKTRFAGL KENQGVIWTSDGKGTYEVNEINKKERGTEVTLYLTKDHYEFLETWKIQNT VSKYSDHISIPIELNTYDEKEKTYFWKQINQAEAIWTRPKSEITELQYKN FYKKIANDTNDPLTWTHNKVEGNQEYTILLFIPSKSAWDIWNRDNKHGLK LYVKRVYIMDDAEQFLPNYLRFVKGIIDSNDLPLNVSREILQDHKLVYNL KKSLTKKVLQVLHSLSQNVSKYEIFWKQFGLILKEGPAEDSENRTSISNL IRFSSLLNNTQKPTMSLENYVKNMKQNQEKIYFITADNYASAVSSPHLEF FKKKNIDVLILSDKIDEWMMNYLIEYNEKKFQSVSKDDKSIEKLVHEQNS QNETYQENMNDFLNRAKKTLSDKIKDIRFTHKLTNTPAMVITDSNEMSTQ MAKLFSAAGQTVPTIKYILEINPNHLLIKKINNEKNEKKFKNWINFLFEQ CLLAEKNTLDNPNKFIARINDLLINN >bbp299 htpX, putative protease HtpX MMRIILFLLTNLAVVCVFGFILSFTKIPPESISGLLIFSSIFGFSGSIIS LLMSKWIALKSVNGQVIYQPSNNTEQWLIDTINSQSKKMGIKTPTIAIYH AFDMNAFATGAYKNSALIAVSTGLLENMSYDEAEAVLAHEINHISNGDMV TMTLVQGIVNTFVIFISRIIAQFASSILSENREDNNSNRNTWVYIICSTI LELIFGIFASIITMWFSRHREFYADAGSAKLVGRKKMISALQKLKLSYEP QEKSNIIAFCINGKHSSFLNLFMSHPSLDKRIQALYNRDYM >bbp210 htrA, serine protease MKKITMIFNTVLIFLVFLLISGFSWHKSEIPTQEKFFESKSFSLSTVLEK VIPSVVSITVEGNVTQSTRIPRQFQSSFNKKVLDCFGISRCMTRQGKFHA LGSGVILDSKNGYIVTNSHVVDRANKIQVQLSNGCKHEAVVIGKDARFDI AIIKLKKVKNLHEIKMSNSDILKVGDYVIAIGNPYGLGETVTSGIISALH RSGLNIENYENFIQTDAAINRGNSGGALVNLKGELIGINTAILTPDGGNI GIGFAIPINMVNNLTTQILEYGQVKQNELGIVGMELNSDLAKVLKINVHR GAFISQVLSKSPADVSGIKPGDVIILLNRKPIASFATLRAEIASFPIKTK IELGILRNKKVKFIIVELKQKIQSKIDSSVLCKLISGASLSNFRIHGQNK GICVNYVNNGTPAYRTGLRKNDIIFEVNKYQVSSLSNFQKVLKTKPLILV LHVKRGNDVLYLVTH >bbp033 hupA, DNA-binding protein HU MNKSELINIISKKSNLSKIQIKNILEITLTAIIQSLKDGNSVQLVGFGTF KVNNRAARIGRNPQTGQTIHISATKTPVFISGKTFKTAIKTI >bbp139 ileS, isoleucyl-tRNA synthetase MKDYKTTLNLPKTNFSMKGNLSKKEPFILKKWNDNNIYSLIKKQNIGKKK FFLNDGPPYANGNIHIGHAINKILKDIVIKFKTLSGFDTYYTPSWDCHGL PIEHKVEKTIKKENILITKKEFRIKCRNYAQSQVNNQKLEFIRLGVFGDW ENSYLTMNFKNEANIARTLMKMFKYGYVYQDFKPVHWCINCKSALAEAEV EYHNKLSNSIIIKFKLAHNINFWNQIFKNDHNQDIHLVVWTTTPWTLPAS QAIALNPNFKYQLIQTNNNLFIISEKSVPDTMNKMGIQKWKKIHIFLGKN ISNLKVIHPFLNTTIPVILADHVTQELGTGIVHTAPEFGQDDYYACKKNN INFTPTIDKKGHFLNNIHPKLNNINIFKSIKIVIKLLNNNNALLHSEKLV HSYPYCWRHKTPIISRATQQWFININHNNLRNRCIKYIQEVKWIPHWSKN RMIEMIINRPDWCISRQRTWGVPIPIFIHRKTGKLHPDTIKLSQKIIQNI ETNGIQAWFDITEKSFLGELFKQYKKVTDVIDVWFESGSIQLSNIYNKIQ HQHNNISDLYIEGLDQHRGWFMSSLIISAAISNQTPYKKVITHGFVVDKN KKKMSKSIGNTVHPSEVINTLGSDILRLWTASTNYSKEMSISQETLIHIS DYYRRIRNTARFLLANLHEFNPENDLINAKNMIILDKWAIGKALHIQKKI IKSYKNYNFHDVIKYLMNFCSLDMGTFYLEIIKDRQYTTQKNSIARRSCQ TAMYLILTAFVKWITPILPFTSDELWEYIPGTNKNKFVFLELWSNQLFDL NHKDTMNHEYWNQLLIIKTEVNKALEHARQNKIIRKSLEAHMTLYVNETI KCNLKLLNKELKFLFITSKVEIKNFYEAPKDAFQSETITNFKTIIKKMNG IKCPRCWHIITKIKNNKNHEICKRCILNTIGPGELRQFL >bbp541 ilvC, ketol-acid reductoisomerase MGSNYFNSLNFRQKLIQLRQCTLIRKEEFSETFKILKGKNIVIVGCGSQG LNQGLNMRDSGLNVKYALRKNSIISQRSSWKRAIDNKFLVGTCEELIPTA DLVINLTPDKQHEHVVDVLQNLMKKNSILGFSHGFNIIEFGQKIRQDITV IMVAPKCPGTEVREEYKRNFGVPTLISVHLDNDCHNIGLEVAKEWATAIG GHRAGVLHSSFSAEVKSDLMGEQTILCGLLQTGSVLCYDKLISQGHDCHY AVKLVQSGWEVITESLKHGGITLMFDRLSNTAKIRAYKLSNDLKKILSPI FKKHMDDILSGYYSKNMMLDWKNDDKQLKIWRRSIQNTSFEQCSISHITL LEHEYFENGLLMVAIIRAGVELAFEIMIEAGIKEESAYYESLHELPLIAN TIARKRLYEMNLIISDTAEYGSHLFFQSAFPLLQDFMNTLEHGDLGNKML DQAINNVDLNYINTTIRNHPVEHIGQKLRRYMTNIKQINCY >bbp542 ilvD, dihydroxy-acid dehydratase MPKYRSSTTTQGPNMSGARALWRATGMSSDDFNKPIIAVVNSFTEFVPGH IHLRELGQLVSQYIISSGGVSKEFNTIAIDDGIAMGHSGMLYSLPSRDLI ADSVEFMINAHCVDAMVCISNCDKITPGMLMAALRLNIPCVFVSGGPMES GKIVISDKEIKLNLVDAITCGVNPDSSDDMINEIEKSACPTCGSCSGMFT ANSMNCLMEAIGLSLPGNGTILATHIDRKKLFVQAGKLIVKITQEYYKNN NEKFLPRNVATKEAFCNAMALDIAMGGSTNTVLHLLAAAREGCVDFTMLD VDLLSRKIPNLCKLSPNTTFYHIEDFHRAGGVFGVLDELNKVNLLYKQTF NILGLNLEEMLSKYSILTGNDKNIIKMFYAAPSGQKTIKPFSQSCRWNSL DIDRKLGCIRDYNSAFSLDGGIAVLYGNLAKDGCIVKTAGVHEKNLIFRG KAVVYESQDEAVHAILNNKIVKGNVIIIRYEGPKGGPGMQEMLYPTSYLK SMKLDQDCALITDGRFSGGTSGLSIGHISPEAANQGIIALVRTGDFIDIN IPNRKIHLDITDNELLLRIKNEKDRGIDAYTPSHRKRIVTSALKLYSKFV TSADKGAVRNIR >bbp207 ilvH, acetolactate synthase small subunit MKHRILSILLENESGALSRVVGLFSQRGYNIESITVAPTEDLSISKITIQ TFGDKKVIEQIGKQLHKLIDVLKVTEIEDEEHFKREIMLIKINNTYDQYR KVQDITNAFRGYIISATSNISIIQLSGTNKNLDTYIEIMKKLTNIIEISR SGIISIYKN >bbp208 ilvI, acetolactate synthase large subunit MKMLSGSDMVIRSLIDQGIKYIFGYPGGAVLDIYDSLKQMHGIKHILVRH EQSATHMADGYARATGKIGVVLVTSGPGATNSITGIATAYMDSIPLVVIS GQVASSLIGYDAFQECDMIGISRPIVKHSFLVKNTEDIPKIFKKAFWLAS SGRPGPIVIDLPKDILNPLIKKPYIWPKLISIRSYSPVLQGHQGQIKKAL HILIKAKQPIIYIGGGIITSNSHKELKLLAETLNIPVTTSLMALGALPQN HPQNLKMLGMHGTYEANMAIHNADVILAIGVRFDDRTTNNVDKYCPNATI IHIDIDPTSISKTISAHIPIVGHARNVLKQILNLLKNQFSKKNIYNLEHW WKQINCWKSKNSLEYDRKSKKIKPQNVIEIISALTNGNAFVTSDVGQHQM FTALYYSFNKPRRWVNSGGLGTMGYGLPAALGVKLALPKETVLCITGDGS IQMNIQELSTAMQYKLSILILNLNNRSLGMVKQWQDIIYSGRHSHSYMKS LPNFIKLAESYGHIGISIHNPEDLEKKLKLALLKLDQGNLVFVDITIDPE EHVYPMQIRSGGMNEMILRTTEHTSL >bbp292 infA, translation initiation factor IF-1 MTKEDCIEMQGVVIDTLPNTMFRVQLDNKHIVTAHISGKMRKNYIRILTG DKVTLELTPYDLSKGRIIFRSR >bbp340 infB, translation initiation factor IF-2 MEMINIQDLANEVDMSVDRLVQVCIKIGILKTKYDTITQLEKLTILNYLN ENLKNSNKNVLMLKRKIRSTVKIFSSGGKNKCISIEIRKNKRYSKSNDDI KTFLEKNKDINLNKSEIVLSAKEDSKIFVSHSKDNINSNINDTCTIRKKF NKNFKKQQKINILSEKEDKNNLDNVLNVEQGSKKKINFKNVVLEEKKENK VKFSNYIKLSEKYNTRKVSNFLTSKNIRDHNNVEKHRRNRNKILRNKHQK DNFSFEKNLSDKNIKLDNCIHKKSIKNKKESLLKQVFKKPLRAINRNIIL SSAISIFNLANKMAVKSSEIIKMMARLGYTVTINQIIDQDIAQLVAEEMG HKVTICYENKLEDKIMRDRDFGDGIKKTRPPIITIMGHVDHGKTSLLDKI RLTRVADSEPGRITQHIGAYHIKINNKIITFLDTPGHSAFTAMRARGAQV TDIVILVIAIDDGIKPQTIEAIQHAQAASVPIIIAINKIDKLITNIEKIK NELTKYNILPEEWGGDNIFVNISAKSGEGIESLLNAILTQSEMLELKSIS NGMASGLVIESYLDKGRGPTAIILIKEGKLNKGDIVLCGFEYGKVRSIRD DLENEVNSIGPSIPVKILGLSGIPLAGDKIVVVRDEKQAREVATYRQKKF KEQKMSKQRQLKSLDIFEDVKRSSNPSLNIVIKSDVQGSLEAISYSLLKL SNDEIKINIIGKGVGGITETDVLLAAASNAIIIGFNVRADSSAKRIIEFE NVDFRYYSVIYQIIDEIKNCICGMLSPKYQQKIIGLANVRSIFKSPKIGV IAGCIVMEGIIKRNSIIQILRNNVVIHKGELISLRRFKEDVSEVRCGVEC GIGMKNFNDICIEDIIEVFETIEIKQ >bbp120 infC, translation initiation factor IF-3 MKGGKKKIQIITKPNKINHEIGAEKVRLTDVNGRQIGIVTLKSALYKAEE VGMDLVEISPNSEPPVCRIMNYGKFLYEKSKSIKEQRKKQKVRNIKEIKF RPNTDEGDYKVKLRNLVRFLEEGDKVKVTLRFRGREMVHQKLGIDVLNRI KSDLIELAVVEVFPSRVEGRQMIMILTSKKK >bbp545 iscU, putative NifU MAYSKKVIDHYENPRNVGSFKTIDANVGSGLVGAPACGDVMKLQIKVNKN GIIQDACFKTYGCGSAIASSSLVTEWIKGKSLIEAENIKNTNIAEELDLP PVKIHCSILAEDAIKAAITDYKNKNK >bbp255 ispZ, putative intracellular septation protein MKFLLNSIPTISFFIFYKFYDIFIASFSLMIASLFTFIITSILFNSINKH DLINLIFVIVFGFLTLFYHNSSYIKWKVTIIYFLISIVFLINYLFIKNNL LNIIFKNTIQLSKNVWRKLSLFWSIFFLICAVSNTYIILYFSEQTWVTFK IFGLTILTLIAVIINGFYIYFLKSKIIQ >bbp131 ksgA, dimethyladenosine transferase MVKKNTFFANKNLGQNFLVDSEVINRIINVINPKSHDFMIEIGPGLGALT YPICKILHKLFVIEHDNNLGTRLLKDISNIEVFVEDVLKFNFLNLINNSF KSVRIIGNLPYNISIPILFYLFKFHNNIIDMNFMFQKEVASKLLAIPGTK SYSRLSIIAQYYCDIDFLFDVVAQSFYPIPKVTSSFVRLVPRKVFNLYVR DINQLSNVTALAFQQRRKIVKNSLSSLFNDDALRKLGIDPLLRAENLSVK QYCLLSNHVC >bbp241 lepA, GTP-Binding protein LepA METIRNFSIIAHVDHGKSTISDRLIQICGGLSKREMHSQVLDSMDLEKER GITIKSQSVTIEYKSKCNKIIQMNFIDTPGHVDFSYEVSRSLSACEGALL IIDATQGVEAQTIANCHTALDMNLKVIPILNKIDLPTADPQRVKKEIEDI IGLSTNNIILCSAKTGTGITNLLETITHNIPYPKGNPNDPLQALIIDSWF DCYLGVVSLVRVKNGYLTKKTKIQIMSTKKIYNIEKIGIFTPKPIFKDIL KCGEVGWIICGIRNITGAPVGDTITQHPNSAKKVLSGFKKIKPKIYAGLF TIQSNQFSLFRDALGKLSLNDASLFYEPEHSLALGHGFRCGFLGILHMEI VQARLEREYNLQIIATSPTVIYKIIMIDNTNYYLDTPHKLSTLQKIKEIR EPIAKCLILLPIKYLGNTLLLCSQRRGVQNDISYYNNQILLDYSIPMSEV VLNFFDQLKSVSSGYASLEYNFELYKVAHVKCLDILVNYKKIDSLSTIVH KTKILNQAKNVVEKMKNLIPRHQFDIIIQAVIGTKVIVRTTIKQLRKNVL AKCYGGDVTRKKKLLKKQKIGKKRMKQIGNITIPQEVFLKILNNN >bbp240 lepB, signal peptidase I MSNYLSSFLLASSLITGTLWIINKILSHNLLDSKIPFNIKKSKIYYKSKQ VVQTFASFFPILIIVFIIRTFICEPFQIPSESMMPTLLPGDFILVKKFSY GIKNPFSNNVIVFINTPKRGDIVVFKHPNNNAINYVKRIVGLPGDKINYN ILTKRLTITPNNINEQHTKNISINYKYIKPNDFTKHFKLNNIILNNVHSL ESSNNNLLQLEMYQEKIEKIAYNIFFKKKLIDQKDLYFKQFSQKQGTWIV PKHKYFVLGDNRDNSLDSRYWGFVPEKNLIGKVVFIWMHLIKKEGQWPTG IQFDRIGNIY >bbp493 leuA, 2-isopropylmalate synthase MTQKIIIFDTTLRDGEQSLKMSLSVKKKLKIAFALEKLGVDVIEAGFPIS SPGDFESVKKISERIKDAKICSLARCIDGDIDIAAKAMKKANSFRIHIFL GTSALHVQSKLKKTFDQIIDMMVSSVKRAQKYTDDVEFSCEDAGRTSLDD LCRIIELAIDLGVKTINIPDTVGYTIPYEFSNIISSIYKKVPNIDKAIIS VHCHDDLGMAVANSISAIQVGARQIEGTITGVGERAGNAALEEILMAIKI RKDILNFKTNIKYQEIYSTCRVISSICNIPVPVNKAIIGSNAFSHSSGIH QDGILKDKKTYEIIVPESIGFVSQPLNLTSRSGRAAVKYRMKKIGYKDSD YNIDILYSRFLKLADKKGRVSDSDLKQLVCFNNKLKNLKD >bbp496 leuB, 3-isopropylmalate dehydrogenase MKRNYKIAVLPGDGIGPEIMREGYKILRILKSKLSLNIMTQEFDVGGVAI DKYGVALPKKTLQGCRDSHAILFGSIGGPKWEDLPSHLQPERGALLPLRK YFNLFSNLRLARIYSGLEKLSPLKSRISNLGCDILCVRELTGGIYFGDPK GSKVSKSLNCAFDTEVYYQFEIERIAHMAFDLALTRRCKVTSIDKANVLE SSMFWRKIVNRISTQYSQVKLSHLYVDNAAMQIIKNPSQFDVLLCSNLFG DILSDECAAITGSIGLLPSASLNDKNFGLYEPAGGSAPDIKGKNIANPIA LILSIGMMMRYSFKLYDVADLIDWAVNKTLKLGYRTQDISENNKFINTSS MGDIIAEILANRIHKI >bbp495 leuC, 3-isopropylmalate dehydratase large subunit MKKTLYQKLYDSHIVYEEKSQSPILYIDLHLVHEVTSPQAFFSLCSKNRV VRQPKKTFATMDHNVSTIDRNIDSSGLLAKKQMEALIKNCTKFNIKLFDL NHPHQGIVHVIGPEQGITLPGMTIVCGDSHTSTHGAFGALAFGIGTSEVE HVLATQTLKQNRLKSMHIKINGDIDIGITAKDIILFVIKQLGVSRGLGYV IEFSGEIVSKLSMESRMTLCNMSIEMGAKSGIIAPDSVTFSYLCNRKYVP KGKNWNLAIDYWKTLKSDTGAIFDQEFNIDISNLSPQVTWGTNPSQVISI NDTIPHLESYSDPIERRSAELSLLYMGLEPGMSLIDVNIQKVFIGSCTNS RIEDLRAVAKIVMNKRVCNSVHAIIVPGSGMVKMQAEKEGLDKIFKNSGF EWRYSGCSMCLAMNDDRLNNKERCASTSNRNFEGRQGRGGRTHLVSPVMA AAAAIFGRFVDVRTIYNSLDK >bbp494 leuD, 3-isopropylmalate dehydratase small subunit MSKFIQHTGIVVPIDVSNVDTDVIIPKQFLQKITKKGFGKHLFNDWRYVD EKGTILNRKFILNNDIYKNGTILLARENFGCGSSREHAVWALVDYGFKTI IATSFSDIFYSNSLKNSLLPITLSKETIDILFQEVYKNMGMFISVNLLNN KIFVREKQYSFKINSFNKYCLMHGLDDIDLTLKYSSKILNYETLIPEFLK K >bbp395 leuS, leucyl-tRNA synthetase MKQNYCPKTIEPYVQSIWKKKNTFKVTENSNKEKFYCLAMIPYPSGKLHM GHVRNYTISDVIARYQRMLGKNVLHPMGWDAFGLPAENAAIKNNTHPAQW TYENIKYMKQQLISLGLSYDWDREITTCKPEYYQWEQWFFIELYKKNLVY KKKSWVNWCEYDKTVLANEQVINELCWRCNNKVIKKKIFQWFIKITKYAE ELLNDLDNLPEWPEKVKTMQHNWIGRNHGIKIKLKLANQHTILNDVFISK PSTLMGATFITLSPSHELSFKIARKKHKIQEFIENCSSNTNTYNDINNTN IGINTNEFALHPITKKKLPIWITNYVLSDYDTNSILCVPAHNQHDLNFAI KYNLKIKAVILNLDGTEPKIKNTAMTSMGKLFNSNQYNNLNYQEGSYRII QDLENNHIGKKITYYRLRDWSISRQRYWGAPIPMAVLENKKNVPIPKQYL PIILPETIPFKNIKPLSNNILLKKIYIDEKIAICESDTFDTFLESSWYYA RFTCNNFHKGMISQKLANYWLPVDQYIGGIEHAVMHLIYFRFVHKLLRDL GLVYSNEPVKKLLCQGMVLSDAFYYFDHNKQKQWISAKSITIKYDSNHKI QSHFYSNNKKIFHAGMIKMSKSKFNGIEPEDIIKKYGTDTIRLFIMFAAP VESALEWKESGVKGIHKFLKKLWVLSYNHIKLYNHKIKLRINLFTEQQQH IYSELHKTIKIVSQYITDTQSFNVAISKIMKFSNTLMSISLKNEQNQALM QESLLAVIQMLYPFIPHFSFAIWEFLSPKKENIDFISWPKYNFKAILSKL KYTIIIQINGKKRHKILALKNSSQEKILEIILNENKIKKYLNNKPIQKII YIPNKILNLVI >bbp387 lgt, prolipoprotein diacylglyceryl transferase MRNMYIHFPQFSPIIFSIFSIPIRWYGLMYFLAFIFALWRGKTRAEYYNL TQIEVENLLYSCFIGLFIGGRIGYIIFYNPVFFFENMSHILKIWEGGMSF HGGLLGVIIVLLFFSKKLNKHILEISDFIVPLVPFGLGAGRLGNFINGEL WGRIAPDFKFSVLFPNSREIDLNVAANNLELKSLIEKFGVLPRHPSQIYE FVLEGLVLFFVLNYFSKKSMPFGFVSSIFLILYGCFRIFLEIFRQPDRQI GLFLNTFSMGQLLSMPMIVLGILIAINIYVKVL >bbp062 lig, DNA ligase MKDIKNYILKLQDEIRYHAYLYHTLNSPKISDEKYDFLVIELQRLEKKCK YSVRFKDSPTQSVGSENLPEFKKFSHITPMLSLNNVFIKNDFLKFYKKIV NNITVEKIFFCSELKFDGVAINLIYINGLLFRAVTRGNGYEGEDVTSNVN MISSVPKKLIGIDIPETLEVRGEIFMLKSDFKKLNVRLTKFKKKLFSNSR NAASGSLRHKNAKVTELRSLTFYCYGCGYCSYENFTDSHFLRLKKLKSWG FPISDYNFLHSSYDEILRFYNFIQNERYFLNFNIDGIVIKVDSICLQKSL STTSKAPRWAVAYKFSDKIKITTIMNILYQVGRTGVITPVAQVTPIYISG VLIKKVSLHNFNEIRRLNLNIGDSVFIKRSGDVIPHIIEVASKCKLQRNE DISIPKFCPECGSKLKVDSFSNIKIRCMAGLKCLSQFKKLLHYFCSKKGL NILGLGPKIIDKLVDLGYVSDLSDIFDLNVSLLTKVENIGIIKSQNIIRS INNSKNVSFSKFLCSLGIFEVGSIVARSISNYFFTLDKFMNSSKEEFLLI NGIGVNIADNLYNFINDEFNKNIIFKLSKKLNISSDINAIIDNNNTLFRK KIVFSGSFSNFSRSKIIELSKKLGIIVVSSVSKSVDYIIIGKKPGRKLIK AKKFSIPGIYEKEFLNIINVYL >bbp250 lipA, lipoic acid synthetase MRTKNSKIINSEQDIFRNKVIPIKFLSNYNNEILKKPQWMKIKFPVSTNK IKNLTLILRQHNLNTVCEQALCPNLAECFNRGTATFMILGSICTRRCPFC AVSHGKPSLVNKNEPQQLARVIFDMKINYVVITSVVRDDLKDRGAQHFSN CIQEIRNKNNVKIEILVPDFRGMMRESCKIISMNPPNVFNHNLENVPRLY KLIRPGASYIRSLKLLEFFKKLNPNVPTKSGLILGLGETYKEIVHVINDL LDHGVTILTIGQYLQPSSKHFPVQKYITPDEFKKIKNYALSIGFKKVFCG PLIRSSYHAEKYFE >bbp249 lipB, lipoate-protein ligase B MYKKNIKIRNLGLRRIQDVCSSMNDFTITRKISTPDEIWLVQHYPVFTIG VSGTKHDVLVSNNIPIIFSNRGGKITYHAPGQLIIYVLINLFRRKLTVRR LILLMQNIIISTLKSFSIDSYILNNFPGVYVNNKKICSLGLRIRNGCSFH GMALNINMDLLPFEYINPCGNSFKMTQVIDIKPNLCFKIIKLMLMHKIRE IFS >bbp421 lon, ATP-dependent protease La MNPERSEYIEIPVLPLRDVVIYPYMVIPLFVGRDKSIKCIEASMNKNKKI MLVTQKEAEIDEPTDNDLFTIGTTASILQMLKLPDGTVKVLVEGLQRAKV KKINNENGYFTAQIQLICTPEITEKEQSILIRTTLNQFENYVKFNKKISP EILNSLNNITNASQLSDMIAIHMPLKLSEKQSILETYNTNERLERLMAIM ESEIDLLQVEKRIRNRVKKQMEKSQREYYLNEQMKAIQKELGEMDETLDE HEILKRKITTIKMPKEAQEKMASELHKLKMMSPMSAEATVVRSYIDWMIQ IPWNIRSKVKKNLTQAQKILDSDHFGLDKVKERILEYLAVQSRINTVKGP ILCLVGPPGVGKTSLGQSIARATGRKYIRMALGGIRDEAEIRGHRRTYIG SMPGKIIQKMAKVGVKNPLFLLDEIDKMSCDIRVDPASALLEVLDPEQNV AFNDHYLEVDYDLSNVMFIATSNSTNIPAPLLDRMEIIRISGYTEFEKLN IAKSYLKPKQIKRNALKSNELTIEDSVVTNIIRYYTREAGVRNLERELSK ICRKCVKNLILNKSLKKIKITTDNLHDYLGIKKYDFGKTNYKNQIGQVIG LAWTEVGGELLTIEAACISGKGKLIYTGSLGEVMQESIQAALTVVRSQAN KLGIKKNFYEKNDIHVHVPEGATPKDGPSAGIAMCTAIVSCLTGIPVKSD IAMTGEITLRGQILTIGGLKEKLLAAHRGGIKKVLIPYDNEKDLQEIPKT ILKGLFVHPVKHIKEVLNLSLENTPYFSSK >bbp191 lpdA, dihydrolipoamide dehydrogenase MISKKVDTQVVIIGSGPSGYSAAFRCSDLGLNVVLIEQYYSLGGVCLNVG CIPSKYLLHIAKVIKDVKKLSRIGISFEKLDINLKEIQCNQKKIIESFSS GISNLARKRNVRIIFGYAKFLDANSIFVQGEHDSYVVSFNKIVIATGSLS KKLSYIPYDDIRIWNSSFAVSIPSIPKKLLIIGGGIIGLEMATIYSALGS NVDIIDNSHDILPHLDRDVIDIFKRSVNHDYNIFFNSNVIKIVQEKNGLL VHIAENDNKNKRFELYDIILVAIGRVPNTDMLDISKVGLKTDNNGFIKVN EQFCTNIPNIYAIGDVIGQPMLAHKGTHEGHIVAEVISGKKHYFNPFVIP CVSYTEPEIAWVGITENEARKNNINYEVSSVLWNTLGRAVSSQCSEGVTK LIFDKKTNKIIGGCIVGSNAGELLGEISLAIEMGCDAEDLALTIHAHPTL YESINLSAQIFQGTITDLINKKIKK >bbp138 lspA, lipoprotein signal peptidase MKIPLIYNRILILFFFIANIIILDQVSKKWIINNLLLHEKKPLISIMNIF YVRNYGTAFNFFSNNPGEKNYILCLISSIAILIILKTMYNNTTIENFFYN IPSAFIISGAIGNFIDRCYLGYVIDFIDFHINNWHFATFNIADVSIFIGS VLFIYHNKYFLKN >bbp388 lysA, diaminopimelate decarboxylase MSGLLKKKQRFSCNDILKIVSKYGTPLWVYDSNIIVKKIKELSQFDVIRF AQKSCSNIHILNLFYKYNVKIDAVSLGEIERALISKYRFTMDQDVVFTSD IIERETLNKVVQYKIPINIGSIDMLEQVGKISPGHNIWLRINPKFGHGHS KKTNTGGENSKHGIWDINLAFPYITKYNFKLIGLHMHIGSGVDYCHLKRV CKAMIDQVLQCKFKIHVISAGGGLTVPYHCNDEPVNVKNYFFLWNKARKI ISNYLNRPIRLEIEPGRFLVAESGILVSEIRVIKKTNNRTFILVDSGFND LIRPAMYGSYHHISVIPRDGRCVNYDDTIEAVVCGPLCESGDVFTQNEYG DIKTRILPNVQIGDFLVFHDTGAYGASMSSNYNSRPLIPEILFKDNEFHI IRRRQTMKELLELEINCI >bbp389 lysS, lysyl-tRNA synthetase MLINEEKERREKLNYIKKHGYNFPNDFKPKNNFSDLTQRYKDYTRDQLFS LKICVSVAGRMTNKRIMGKSSFFILKDFEGEIQLYIQENLFALNFYKQFV KKWDLGDILGAKGKLFKTRTGELSIHCTEIKLLTKALKPLPSKFHGLSDQ ETRYRQRYLDLISNRTLCSIFKIRSLIFINIRKYMLKKKFLEVETPMMQN IPGGASARPFITHHNTLEIDLYLRISPELYLKRLIVGGFNKIFEINKSFR NEGISTRHNPEFTMMEVYMAYSNYHDMMNFTEKLLMFLVKEIVGNSQVKH GTNIIDFKKKFFRCTLKEAILKYNPSIRLSDLNDEVKMNKIVKKLGINVK KKLNAGQLILEIFNKTVEKKLIQPTFILDYPVEVSPLSRRSDVNKNVVDR FELFISGYEIGNGFSELNDADDQKKRFLMQCKLSHNINNLNKISSFDKHI LYDSDYITALEYGLPPTSGLGIGIDRLTMLLTNQKSIRDVIFFPILKPSV >bbp137 lytB, LytB protein homolog MKILLENPRSFCVETKRALSIVNLALKTWGKLIYVNHKIVHNNYIINNLK LKGVIFSKNINSILESSKLMLSKHSVPNKIKKTTLEKKIFIIDATCPLVK KVHKKIHYKNKNTYNVILIENSQHPKIQGTLERYQKNLKNSIYIVKSKKY AIKLTIKNTRNSIITAQITLSSEKIYPIITILRKKFPAIINSHENNICYA TINRKTAIKHISKKIRHYSCH >bbp212 map, methionine aminopeptidase MTCIFIKNINEINKMRLVGKLVADVLDMIKEYIVPGITTEELNNICHNYI TYKQHAKPACLGYQGFPKSICTSINDIVCHGIPNKNSILKNGDIINIDVA ILKDKYYSDASKMFFVGKPTELGKKLCYVAKKSLYLALYTIRPGINLQKL GKVIQNYVKKQNFSIVKEYCGHGIGRSFHEPPQILHHNYYKSNTTILQSG MTFTVEPMINSGSCEVQCTNDGWTVKTKDKSLSAQYEHTILVNEEGCEIL TLQKGEQISRILKNLT >bbp423 mdlA, putative ABC transporter MQLLKQLKWYFIQEYKNYTIAIFLLISISILQLYPPKLIGMLIDISIRKQ TQKAPILPLILIILFISIIIYILRYMWRLFLFGASYKLAIKLRIEIYNYL CQQKNDFYLKHKTGDLIARITNDVDKVVFAAGEGVLTLVDSLIMGVSVII VMITQISWKLTIISLIPMPIMAIIIKRFGKKLYSSYHDAQTTFSHLNNYA QENLNNIHMIKAFGLENYYSKKFLKIAHKTRKKNIKIAKIDSKFNPIIHL FISISHLLAITIGSYMITYNEISTGELMSFILYLGLIIWPMLAFAWMFNI IERGSASWDRIKSMINNNLFIHKKKYKNISNIPGILEVKINYFKYSKSNK TILKNINFKIRPGQILGICGPTGSGKSTLLKLIQRQIELYDGKISYHSIP ITQFNIVEWRKKMSIVNQTTFLFSDTIANNIKLGKPYASQKEIEQATTFS DLHNDIMTFPQGYNTQVGERGIMLSGGQKQRISIARALLLKSEILILDNA LSSVDNKTEINILENLKTWKKNKNTIIMCTHRLSSLINSDLIIVIENGSI TQIGKHKLLIQNLKQWYGKTYLHQKLSNH >bbp424 mdlB, putative ATP transporter MNNVIDFWPTLKRLLYYGTNVKKYLILGFTLLLFSSIFEVLNPILISCFI KHYFINNTVNYSLKIITYYLILQILAAILNYHQNIIFNKISLTVIQKLRY DVMSSTLQLPIKMFDQRPIGQFISRITNDTETIKELYDTVIKSLFQNIIL ILITLITMFILEWRMACIASIIFPIALIIMLLYQYFSKPILRKIKVYIAN IYNIFNEIINGIDVIQQFHQEQKFRKSIKKISISHYYFRMKILKLDSFLL RPLLNFCSTLILCGLILIFGIYPIGFFEIGTLYAFITYLNRLNEPLITIT SQQSIFQQAIVAGERIFEIIHTPKQQYGDDSLHFREGNIKVKNLYFSYTN NNVYVLKNINIFIPSKQFIAFVGRTGSGKSTLSKLLIGHYPATLGKICLD ERNIQTFTHNVLKKNISIVQQDPIILNDTILENITLGRNISTKKVLKILK TIKLIQFVNSLPKGLKTLLGENGNILSIGQKQLLSIARTLISCPKILILD EATSNVDLDTENNIKKILSSVKHLTTIIAITHRLSTIKHADNIFVFNNGE IVESGTHYNLIRKKSYYKNMYYSQAIKN >bbp104 mesJ, putative cell cycle protein MesJ MLKDFIKNTNILNILLAYSGGIDSTFLLYQLLKLKKNNLNFTFRAIHINH QLHPDSEKWSDHCKKICINHNIPIIIKKITINSNKNRIEEIARKKRYQAI YKIIKPKEVLATGHNLNDQCETMLLALKRGSGITGLSSMSYKLNTIYKIK IVRPLLKISREDIKTWIYKHKIHWIEDTSNNDTKHDRNFLRLNIIPKLKN RWPYFEKNCSRSIEILNIEKKILKQEIKKKLNKYLVLNSILNISNFRYID KNICSIILRHWIKINQNTMPTFKIVKEIYNKVIFSKIDSQPKIIIKNYQI RRYNNHLYWTKKIPRIENIILIWNNTQKKLTLPFQLGNIVQNDFGTTLPH PNNNETINIRFYTSHKVLITKNTKHKKLKTIFKEYKLPPWYRKKIPLIFY NNKFICALGLFVSNTHKKSNNEKNLKLSWISSIHNIIV >bbp031 metE, 5-methyltetrahydropteroyltriglutamate- homocysteine methyltransferase MINNHTLGFPRIGLFRELKVAQEKYWSRKISKEELFSVGKTLRVRHWQQQ KELGINYIPVGDFSWYDHVLGTSMLLGNIPKRHKNGNDLVTLDTLFRVAR GVAPTGASVSASEMTKWFNTNYHYIVPEFSIKSEFCFSWRQILDEIDEAL LLGHQVKPVILGPLTYLWLGKVKGKKFDRLNLLKEILPVYKYLLSEINDR NISWVQIDEPILTLELPEKWKNAFRFAYQSLYGYNSLLLTTYFGSVQHNF SLICELPIQGVHLDLVHGKYDLVFLNSFIPEKWLISLGIINGKNIWKADL VMWFKRLQLFSKLRHSLWIGTSCSLLHVPIDLKLENKISSEVRSWFSFAL QKCQELTLLRDALNNSNTVTEDIRVWSQPIHSRKKSAIVHNVDVKERLKS ITSNDFKRNNVFSVRKQKQHKNLKLPILPTTTIGSFPQTADIRKARFDFK KGNINHDQYNTFISKHIQNAILKQEKLGIDVLVHGEFERNDMVEYFGEHL NGFVFTEFGWVQSYGSRCVKPPIIIGDVSRSKPISLDWIKYAQTLTSKPV KGMLTGPVTILLWSFVREDLSKKIISRQIALALRDEVLDLEQSGVKIIQI DEPALREGLPLRLSLRNEYLSWAVDSFKLSSSGVCDETQIHTHMCYCEFN DIMNAIVLLDADVITIETSRSDMELLEFFKEFKYPNDIGPGVYDIHSPNI PSIEWIMTLLRQAMHYIPVKRLWVNPDCGLKTRTWDETYYSLENMVRAAK ILRKKL >bbp047 metF, 5,10-methylenetetrahydrofolate reductase MKLVYKNYHETLNQHLMNICEKVNISFEFFPPNNILSEKNLWQVIDKLKL LTPKFFSVTHGTNSKIRATCTSNIVKKIKKYTGIETVPHLTCINSTEEEL KVIAKTYWDSGIRHILALRGDIFNTNCKPKIYAVDLIKLLKSIANFEISV AAYPEVHPEAVNAKYDIINLKRKVEAGATRAITQFFFNIDCFLRFRDLCV KNNITIDIVPGIFPISNFKQLLKFSSVSNVSIPKWLCCMFHGLDNDLNTS RIIGSSIAIDMVKVLYSEGIRSFHFYTLNKSEISFAICKILENKS >bbp103 metG, methionyl-tRNA synthetase MKKRILVTCAFPYANGSLHIGHFLEHIQADIWVRYKKMRGHEVWFICADD AHGTPIMLKSQSLKMSPESFISDIYKDHVNDLEKFNINYDNYYSTHSSEN SYFLKKIYHILDKKGLIQTRNIFQLFDNTKRVFLPDRFVKGACPICHTKD QYGDHCEVCGSSYSAVELIKPVSMLSGNCPILKKSLHFFFNLPYFESMLR SWVMSGVLQASVVKKLDEWFKLGLREWDISRDSPYFGFNIPGFLDKYFYV WLDAPIGYISTFKNLCTQRNNLNFLDFWKKNSECELYQFIGKDIVYFHSL FWPSILEASNFRKPTKIFVHGHVTINGLKLSKSRGDCILAKNWIKNLDSD SLRYYYASKLSSKIQDIEVNAKHFLYKINSDVVNKIVNLASRVSSFINIY FNNELSSRIDDLALYKRFVTSSSYIEKMLENCEFNSAISMVISLADIANS YVDNKKPWNLTKNIKNSNTLHDICTTVLNLFRILMTWLKPVMPDLAKNSE KFLNIKLEWANICIPLLNHKISIFKALRHRIEDKQIKFLLPNNFE >bbp275 mfd, transcription-repair coupling factor MLIKSLVQKNQVYFTNNSLDEKNICDLSKLKINQPIVHFEHGVGRYQGLT TVTTRNIKTECVVINYAQNSKLYVPITYLYLISRYIGTSKKDIPLHRLGN DLWNKEKKKANEKAYDSAAILLNIYSHRISQKGFSFKKHHTKYKIFCERF PFTLTPDQDSAINSVLSDMYKSTPMDRLVCGDVGFGKTEVAMRATFLAVC NQKQVAILVPTTLLAQQHFNNFTLRFKYWSTKIEILSRFQSETKCNEIIN NVNIGNVHVLIGTHKILLKNLKWKNLGLLIVDEEHRFGVHHKEQIKLISN NIDVLTLTATPIPRTLNMAFVGIRDLSIIATPPKQRLIVKTFVREFSYTV IRKAILREILRGGQVYYIYNNVNKIERKKIELKKLVPEANIRIGHGQLRS TDLESIMNDFYHKRFNVLVCSTIIETGIDIPNVNTIIIENANNFGLAQLH QLRGRVGRSQHQAYAWLLVPSLKDIKSDAKKRIDAITSIESFGSCFELAN RDLEIRGIGEILGNNQSGHITKIGFSLYMKLLMNAVRNIKNGYYKPLNDI INTYPKIELNVSNLLPDSYIKKVNHRLFFYNKIATSNNFLDLEKIRLTLC KNFGNLPNSGDYLIKIAKIRLISKKIGVKKIKSDVKGGYIEFFEDSKINI QNLLKEFKKEKNCWKFDTSNRLRFSKNFKNNSERIDWILNMLININN >bbp514 miaA, tRNA delta(2)-isopentenylpyrophosphate transferase MIVKFEKFEKLKKPLVIFLMGPTACNKSLLAMTLKDILPIELVSVDSALI YRGMDIGTAKPSNMELLKYPHFLVNIRDPLQTYSVGEFYKDILKIIDYIH SINKVPLLVGGTMFYFKILLTGGLSNLPSSNDNIRKYLLTLLQKKSKFFL FNQLKSIDPISAERIHFNDVQRVLRALEVFFISGKTLTELCRLKNFVSPY NIVQFSLMPESKEWLFNKITIRFKKMLSCGFEYEVKKLFNRGDLHKNLPS IRCVGYRQMWDYFMHNLTYDDMICESLKATKRLVKSQLTWLNNWKKLNVL SSSDTLKNLITKIISVINANIFV >bbp304 minC, putative septum site-determining protein MinC MKILPIKIKGSIFTLLVLYLQNHPVELFKNNLRDKIKNFPTLFKNAPIAI NVEKCSNEINWNNIKNAIISCGFNIIGVSGCKNGKLKNNIIKSGLPILSE GKEVFNFFNNINLDDKILSFEKKNYNKTPIFNSPIRSGQKIYANNSDLII TNNVNSGAEVIADGNIHIYGEVRGRVLAGAKGDNTCQIFCTKLFSELVAI SGEYLLSGDFSEDTIGNSVKIYMKNKKLHIVKLN >bbp303 minD, septum site-determining protein MTRIIVVTSGKGGVGKTTSSAALATGFAKKGKKTVVIDFDIGLRNLDLIM GCERRVVYDFINVINGEAILNQALIKDKRTEGLFILPASQTRNKNALTKS GIDRVFTQLVNMNFDIIICDSPAGIESGAVLAIYFSDEAIVITNPEVSSV RDSDRILGIIASTSQRSSQNFKPIKEHLLLTRYNPKRVSNGDMLSTEDVL DILRIPLIGVIPEDTSVLKASNQGTPVILNYNSNAGQAYYDTVNRLLGIN CPFRFVKDEKKSFLRRLFRR >bbp302 minE, cell division topological specificity factor MALLDFFLSRKKNTANIAKERLQIIVAERRRMDTEPQYLPKLKKEIFQVI CKYIKINPEKIKIQLDQTNKNISILELNVTLSE >bbp245 mltE, membrane-bound lytic murein transglycosylase E MKKVILFTYVIIFLVFLSGYSVVTKNIVHNIKNNYKNNVCSMKVMHLWFK IINLFSKKYNVDKKLITAIICVESSGNTHAVSISKAIGLMQIKPFSAGRE VYRFRGLLNQPSDVDLYDPKINIDIGTSYINILRNKILSGIKNSEILLYA TIISYAHGASKLLKSFSYNKTLAIKKINKMKIKEFLDYIHNKYSEKKAWD YLSKVMYVYHLV >bbp021 mopA, chaperonin GroEL protein MAAKDVKFGNEARVKMLRGVNVLADAVKVTLGPKGRNVVLDKSFGAPSIT KDGVSVAREIELEDKFENMGAQMVKEVASKANDAAGDGTTTATLLAQAIV NEGLKAVAAGMNPMDLKRGIDKAVISAVEELRIMSVPCADSKAITQVGTI SANADEKVGSLIADAMDKVGKDGVITVEEGTGLQDELEVVKGMQFDRGYL SPYFINKPETGIVELENPYILMADKKISNVRELLPILEAVAKSGKPLLII SEDLEGEALATLVVNSMRGIVKVAAVKAPGFGDRRKAMLQDISILTSGSV ISEELAMELEKSTLEDLGQAKRVVINKDTTTIIGGIGEKYNIQSRISQIR QQIQEATSDYDKEKLNERLAKLSGGVAVLKVGAATEVEMKEKKARVEDAL HATRAAVEEGVVPGGGVALVRVAAKISNIVGQNEDQNVGIRVALRAMEAP LRQIVSNSGEEPSVVTNNVKDGKGNYGYNAATDEYGDMISFGILDPTKVT RSALQYASSVAGLMITTECMVTDLPKDEKSDLGNSSAPSAGGMGGMGGMM >bbp020 mopB, chaperonin GroES MKIRPLHDRVIVKRKEAESKSAGGIVLTGSAAGKSTRGTVIAVGNGRILD NGNLKSLDVKVGDTVIFNEGYGAKVEKIDNEELLILTESDILAIVEE >bbp201 mraY, phospho-N-acetylmuramoyl-pentapeptide-transferase MIIRFILSFFTSLLLMLIFGPHLINWLNKYKIQQIIRNFGPKSHFNKKNT PTMGGILIIFSIIISTIIWTKLSNPYVWLTLTILIGYGIIGFIDDNMKIY YKNSKGLSSLHKFSLLSILACIIIFLIYYIINDHSTIKLIVPFSKNIIFN TKMICILISYFAIIGTSNAVNLTDGLDGLAIVPIIFVTTNLSIISFISGN VNLSYYFNTIYIPYSNELTIICAAIIGSSLGFLWFNTYPAQIFMGDVGSL SLGGTIGIISVLLRQEILLIIVGGLFVIETLSVIIQVLYYKITKKKLFKM TPIHHHYELNGCPETRLIIRFWIISFILMLLGLLMLKVHQ >bbp186 mrcB, penicillin-binding protein 1B MYPVNLKLSIKFLFYFFLYFLLIIIIYGVYLYFKINQVIHGKIWKFPISI YSRIVTLEPGNNYSKKDIIAILKSNRYKQVNFLTMPGEFLVKRNSLILIR RSFNFPEGFEDKISIKLLFDKNKLVRIVHLSNNRNFSILRLDPQLIAMIY SPKGEKRLFVSQKNYPKALIQTLLTIEDKCFYNHYGINFYSMFRAFFVNL ISGHSIQGGSTLTQQLVKNLFLTNIRSLWRKINEIYMALILDFQYSKEKI LELYLNEVYLGQDKNEQIRGFALASLYYFGRPINELRLDECALLVGMVKG ASLYNPWNNPVLTLNRRNLVLYVLFKHKVINRTLYEKLKSKPLNIQSRGN IIWFRSAFVQIVEKEFQKKVGYYFQNFSGIKIFTTLDLISQIAAENAIRH GIQQLKKKYKLQDLEASMVIIDRFSGEIRGVLGSSNPNLLGYNRAIQAKR SIGSLSKPITYLAALSQPEYFRLNTWIPDTPIKIKMQNGKLWKPQNNNFE FVGKVMLIDALKNSMNVPIVHLSMKLGLKKIVQTWIQLGLSSNHIFKYPS IALGSINLTSMEVAKIFQVISSGGNKANIISIRSVLSENNKLIYHSFPQS KQVISAQASYLTLYAMQSVVSSGTAKHLGKFFKNMHLAGKTGTTNNLVDS WFVGIDGRQVVIVWIGRDNNKTTKCYGSTGAMKIYHNYLKLNNPKPLLLI PPRDVYFLNINKSGDFMCFRSYSKYFRAIPVWIRNHNIFCT >bbp344 mrsA, putative phosphoglucosamine mutase MIKYFGTDGIRGVVGKTPITADFFFKLGAVIGKILYFYDVKKIIIGRDTR LSSYMLEEALQFGLSLVGVSVISVGVLPTPAISYFTKLFNLEVGVVISAS HNQFRDNGIKFFVKNGVKLSAKFERRIEKQLNKTIILKQFVDLGHISYKR ALQQKYINFCISTLPNNFRLNNFKIVLDCANGSTYELAPIIFRELGANVV LMSAAPNGLNINDKCGTTDLQEIQRLVLSEKADLGISFDGDGDRVIMIDH FGNSVNGDQILYILAKNYKKNKKLRGGVVGTKMSNGGLSLALSKIGIPFI TVNIGDRYIFKKLKEKQWRLGAESSGHVILLDYAPVGDGIITSLQILKII FDENSTLKSLCSDIHMLPQIIINIKNNIDISFLKNFKIQSVLSKYKDFLG KYSRIMLRLSGTEKCIRIMIEGCCSKKINIFSKMLINVINSVKKSRFSII TMF >bbp517 mtlA, PTS system mannitol-specific IIABC component MSVPMTVKVQNLGRFLSAMIMPNISVFIAWGIISGLFIKSGWCPNQTLEK VLSPISVYLFPILIANTGGYLINGKRGAIVGSIAVVGAIISTAIPMLLGA MIIGPIGGWITYYFDKISKYKVKSGFEMLVNNFSVGILGVLLLFISFLCI GPMIEKLSCFLGYVVNLMINNHLLPFIAILIEPAKIFFLNNVINHGVLFP LGIQEVVKFNKSIFFLIESNPGPGIGVLMAWFFFGCDNIKKSLKEAIVIQ LFGGIHEIYFPYVLKNPRLILALILGSITGIFILIVLRGGLISAASPGSI ISILAMTPKGLYVINLLAIIISFLVSFLVSCMLLKISNRNHYVKGSNTKI EKDNFLINSSFQKNRTCIKSSLDSHKCIRNIIFACDAGMGSSAVAAGILR NKIHDLNIFNITVSNAAIDSIPNFGVDLIITHYSLTDRARKRNSNAKHLS LNSFLDNAFYNELSKYLVENNLDNNSSILDFSVRNQNNFSSKKNVFSLTK ENIFLGQIASSKEEVIRFIGRQLVNQGYVKEEYIEAMLEREKMMSTWLGE SIALPHGTIQSKDFILNTGIIFCQFPNGILFGDDPEDIAHLVIGVAARNN EHIPVVSNITNILDNNDVIKSLSITKNIDDVLYLFSRKNI >bbp516 mtlD, mannitol-1-phosphate dehydrogenase MNALHFGAGNIGRGFIGPLLLKSGFNLTFVDNNQAIVDAINRHQKYDITV VGNNFSYITTVKKVKAIYINDPNIYFKIAKINVITISVGVHAINSLVVFF EKLIRYKIETNDFVFLTIIACENVFRCASKLKENIKILLPGIYHKYLDKN ISFVDSVVDKIVCPNDKNNSDDINLSVKVEKFSEWIVDCTQFKHDRPNII GMIYSNHLDAFFERKLFTLNTGHAIAAYLGLLIGYKNIYQAILDPLIFNI VYGAMKESGMVLIRKYNFFTDSEHKNYILKILSRFKNIYLTDSLKRVGRN PLQKLKKDDRLISPLIDTIKYNLPNANLMKGIAAALCYIDEKDIEAKKLR NMIINKGIKYVLSKISSLDSSLLIISEISIYFNIFMKVNI >bbp349 murA, UDP-N-acetylglucosamine1-carboxyvinyltransferase MNRFHISGPKNLSGEIKISGSKNAALPILLTSLLISEPIKLKNVPKLTDI MYAIKILTKLGVKIKVEKKVLYIDAKTIAICTIPDYLTKKTRASIWILGP LLARFGQAKISLPGGCKIGKRKIDLHLSGLKKLGANIAIKNNYIIGSVIT KLIGNTIVLPIASVGATITIMSAATIATGITIINNAAREPEIIDVANFLN KLGAKIIGAGSKNIFITGVLKLHGGSYTIMPDRIETGTFLVAAAISNGSI ICHNTKPNVLINLTKKLCETGAQIKTGTNWISLNMKGIYSKAINIKTAPY PGFPTDMQAIFSLLNLVSHGNSIVTETIFENRFSYVSELKKMGAKAQIKN NSLFCYGVKKLYSATVFASDLRSCASLILAGCIADGTTIVKNIHYIKRGY ERFQEKLQSIGAKICN >bbp046 murB, UDP-N-acetylenolpyruvoylglucosamine reductase MKTYYTSLKKFHTFKINVFAKKIIIVKTIKTLIKTWKKCNQENLPFLLLG KGSNVLFTKNYNGFVVVNRISGITIHEQKDYWLLHVKGGTKWNNLVKYTI QKKIYGLENLALIPGTVGAAPIQNIGAYGVEFKDVCQYVDVLYLNNSKIV RINSNNCLFGYRDSIFKKKHNPNSIILSVGIKLPKTWKPKISHLELQKLS FKNITSHQIFHYICKLRKKKLPNPKKIGNAGSFFKNPIIKKNKAHKIICE YKDLPFYPEPHGMIKLSAGWLIEKCKLKNFSVGNAKIYHKQALILINKNN LATSKNIIKLAKIIISKVKKKFDITLELEVQIIN >bbp197 murC, UDP-N-acetylmuramate-alanine ligase MNNKKKNINTISIIKMNDIKNIHFIGIGGCSMGGIAEILLKSGYNISGSD IVSNNITQQLSKLGAKIFFKHTEKNINRSDVIVISSAISCNNPEIIKAKK LNIPVISRAEMIAEIIRYKYNIAISGTHGKTSTTAIIFSIFEDSNLSPTL INGGYLKSINSNIKIGKNPFYCIVEADESDASFLHLKPITIILTNIEKDH IETYNGSFHNLKLAFIKFIHNLPFYGTAIMCIDNHAVQTILPYIKRNIIT YGFSSNADVRIDRYVQKKFTSRFIVIRVNKPTLNVTLNLPGRHNALNATA AICVATQENIDDKNIIQSLKNFQGVQRRFELSKTFTINSKSHRKKEIMLI NDYGHHPTEILESIHTARFGWPKKKLLMIFQPHRYTRTKNFLFSFSKTLS NVDELFILEVYAANEAIIPGADSTSLYKTIKKNKKNFVTLILDLNKLFLN IMSKLSDSNLILVQGAGNVDNIVKTFFIKKLKQYKN >bbp200 murD, UDP-N-acetylmuramoylalanine-D-glutamate ligase MTRNYLHKKILIFGMGLTGISCLNFFLSKGIYPKIMDTDKRPKHIEKIIK FKNICYHTGSVNYSWILQSNLIIVSPGITPSHPALKFATKKNIEIIGDIE LFVQETKVPIIAITGSNGKSSVTKIVKEIIQKAGFTTYIGGNIGIPALNI VNKFAHFFILELSSFQLERTFSLKAYIATILNITPDHLNRYSSDIKEYEK AKQKIYKNSKICIINVDNPVTINRQAQLTKCISFGVHSGDYHLSHTYTNT WLCYKSLKLINTKKLKLSGRHNYINMLSALAIVHELKISFKISVRILKNF LGLPHRCQKVYKNNNITWINDSKSTNIASTKSAIQSINTKGKIRLILGGD KKSSNLNLLKPILKNNAIVIYCYGKDKKELFNLYPHKSKIFETLQEVMQH ISVQVQPGDVVLLSPACSSLDQFSGFEERGNTFVKLIQELIH >bbp203 murE, UDP-N-acetylmuramoylalanyl-D-glutamate-2, 6-diaminopimelate ligase MTILIKNNNLQQLLSSWIKLSYSYTISGIQSDSRLVKPGYLFCVLKKKNI NETNKHMIHAIKNGAKIILYDTKQKFKNGTLKKIINHVPIIYFFKLSKNL PQILKKYYHFENNFTLIGITGTNGKSTTTHIVSQWANLLNVKIGIMGTLG HGINNNLKKTDNTTESSANIHQFLYHMLKQNIKTFAIEISSHGIVQHRIE QLPFKIAILTNITPEHLDYHRTMDNYINAKKAFFFKYNINTLIINADDLI AKTWIKKLNHKNVITITTKDQNFNSISPKKWIHANKIIQKQNCTNIHFNS SWGHGILNSTLIGHFNVINILLALATLLELNYPITDLVKVCKYIKTISGR MEHIHIVNKPKVIIDYAHNTNGLKNLLSTLKEIFNKKKIWCIFGCGGDRD KTKRPYMGSIAEKMSDQVILTNDNPRNEHPLKIIKNILSGCKFKNKIRII PNREHAIKFAVNNADKEDIIVVAGKGHEKYQIINNKYYHFSDHKIIKKLL NKKNYDFN >bbp202 murF, UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopimelate-D-alanyl-D-alanyl ligase MISINLIKLTSITNGILYCSNYATLHSISIHSITTDTRKITPKCLFIALI GKNFDAHMFVNEAISKGAAALLLEKQCYPKNVIPQIIVQNTTIALGKIAS WIRDQTNATVIAITGSSGKTSVKEMTSSILKNCGNTISTFQNLNNNIGVP LTLLNLNKSHKYAILELGANYPKDIEYTTKITKPNIALINNIYHSHLAGF KSLFGVAQAKQEIFLGLRKNGIAIYNKDSNYWSKWKKNLLTQKIINFSIK KNSTIFASNITTSNQGSKFKIHSPNGEIYVTLPLLGYHNISNALAAATIA ISINIPLEIIKIGLSSLPILKNRLQIIRLNKYKTIINDTYNANTASMIVA IKILENISGYKLFVAGDMLELGKNDVLYHKIIGNTIYNSNINEVFSIGKL SKEISIASKKGHHFYNSDELLKNLKNKLLNKKIITILVKASRSEKLDVIV EQLIKEYHKA >bbp198 murG, UDP-N-acetylglucosamine-N-acetylmuramyl- pentapeptide pyrophosphoryl-undecaprenol N-acetylglucosamine transferase MKKIIIMAGGTCGHIFPGLEIAKSLINKGWKVFWLGTSKNIESKIVPKYG ITIKYINISGVRGKNLFELMAIPFKLIIACYQAKKIIENINPDIILGMGG YVSVPGGIISYLYKKPLIIHEQNKIAGLANKLLSKFTTINMQAFANTILT SKSITVGNPLRTSITNLKKSWDRFENRSGPLRILVVGGSQGTQIFNFCFP KVALVLKNKIKLWHQIGKKNINIIHKLYDIHNNLAIYKITPFIKNISKAY FWADLIICRAGALTVSEIQYIGLPAIFVPFPHKDQHQYWNAYPLKMIGGA KIIMQERFNVNVIITLLKNLNRQKLIVMAKKLRSSYKLNSIKTITKIIEN ITH >bbp502 murI, glutamate racemase MNLKNYIIIFDSSLGGLSIYKQIKKKFPYMNYIYVCDNKNFPYGEKDEIF ILKRSIKIISTITKKITTILVILACNTITVTSLTTLKNFFNFPIIGVIPN LNKARKITKNNIIGLLGTKITIHHYYIQNHISLFVPKYKIKLLANNTLVK IAEQKIKNQLISTKNIKFILEPLLKKHNMPDTLILGCTHFSFLKEEIKKI FPKKIQIIDSKVHIPKNISTILARNLKTTNNNIAFFSKKIITTKTIHYLL KKYNFKKIKELNT >bbp018 mutH, MutH MCVFCEKKLFMHAIGLSGYSIREIVSSLDQPVSNSLVRNKGFVGKILELI LGVNVLHGYKCIDFPSLGIELKSIPINSSGYPLEPTFICNIPLKNNSLNI TWNNSYFYRKIKKILWIPIIGNRVVSFLDKIVGEAFIWTMSSVQEKILKK DWEEFMDLIIIGKVEYISSKHGQVLQVKKKCKNKHVCIKFINYNGCVKFT NPRAFYFRKSFTWSLLNLSK >bbp515 mutL, DNA mismatch repair protein MutL MFIKILPLSTSSYISAGEVICNPASVVKELMENSIDSSATCIHIEIKKGG LQSIVVKDNGCGIDKSDLKASLLHHATSKIYSVCDLNNITTLGFRGEALA SISAVSRIILSSCNISSKKVGWSIYSDGFGVISVPKLVVHNKGTICTVLD LFFNRPVRQKTIKSEYSEFLRIDEIVRSLSLSNNKLSVSLRHNDKLIRYY DNCNIDFCNINMLNAIYGLSSVIKVVPVDYFLNTMKITGWLYLLGSYHTS KKKFQYFYINGRIILNRSVHHAVYQAVSEINHYQYSVSYILYLKLNCNEL DVNIHPAKKIIKIINIRLIHVFICQAILYSLKKECILKKDCTKIIKNISN NKKKNNLNYNFQSNLDITSCIVQENSYSIPQKLFNLDNVSIIETELKFKR FKCKDYLNTIFGNVLMVIKNFYLLIEKNDELFLFFLPRAKSLICELKLKF GVKNGLLIKKLRKKYFYFFKNNTEYHFFLRFYEILSHVGLNFNITLKYAE LNSIPFMIDDTNLGIIISEILYFFKIKREMSLSRLVTTIMNHSKILVKYW DHLQVLSVISECEKYYKSILELNVISYILQPINFDSTVNFFKNDSKV >bbp380 mutS, DNA mismatch repair protein MutS MSKIIMNKKNNDTPMIKQYLSLKLHYPNMFLFYRLGDFYELFFDDAKRIS LMLDITLTKRGYSSQKEIPMAGIPYTSLNRYLSKLLKIGESAVICEQTHI IDKRTGLIERKISRVVTPGTVIDEEFLSETKNNLLGSVYYSKKRFGYATL DLCSGNFYISEYDTFESFISELQRTDPEELLIQEDFLYMNFFEKRKGIRL CKLNDFNIDSAYQQLKCHFKTKNLKSFGVYQNNLAISAAGCLLKYLKFIQ YSLLPHVKSIKVRYDCNHIFMNSATRKNLEIINNISGKKEHTLLSILDNT ATPMGGRLLRKWLSAPIKDIKIINKRHNIIKSLKTVYMSLSLLLKGIGDL ERIISRIACRSASPKDFVSMRSALLQFSKIIFVLNSTKSKTLELISCKIK EYNSILILLRRSLKVCPSKTIKEGNVISENYNKDLDKWRKIANNASEYLQ YFEVSERKRLHITSLKVNNNRVLGYYVQISKKDIKLAPNNYKKIQTLKHC VRYSTLELLDYENNVNNAKDKVLEIENYLYNELFDFIIPYIDSLKISVNT ISELDVLNNLTERACVLNYVCPVISDEYGILLTDSRHPVVENLLKTPFVK NSINLSKSSNMLIITGPNMGGKSTYMRQIALIVIMAYIGSFVPAKYARIG LCDKIFTRIGSADNLAYGESTFMMEMIEMSSILRNSTSNSLVLIDELGRG TSMHDGLSLAWACIEYLAGKINAMTLFSTHYFELTKLKNYYSNIRNMYFD VLEHNNEIVFTYVIKNGFINKSYGLVVAALAKLPKCILLSAKKKLKEFYP >bbp500 mutY, A/G-specific adenine glycosylase MTTLVFYQTILNWYHHFGRKTLPWQIKKNPYKTWISEIMLQQTQVKTVIP YYCKFIKRFPNIDTLSDSPLDSILNLWSGLGYYTRARNIYKTAKILKQKF NGIFPNSYAEIIKLPGIGKSTAGAILSFGFNLYSCILDGNIKRVLIRYYS ININNKYIEKLLWKTIESITPIYHTNKFNQALIDIGALICLKSNPKCNIC PLKSTCKSYLNNKLFQINCKKNKKHIIPKTKYWFLILQYKNYIFLEKRQN LGIWKKLFCFPQFIRQNDILSWIQKNNTKIKKINILNEFKHKLSHLTLYI NPIWIIINKISIFSNNNKTIWYNLNNPQCIGLPTPVTKIITKIKKFNTHH E >bbp309 mviN, virulence factor MviN MNILKSLISLSLITFISRILGFMRDLLIAYSFGASGITDAFFLAFKIPNL FRRIFAEGAFSQVFIPILSEYKNNKNIELTRNFISNILGLMIIILSLFTA FGIYFANDIVKICAPGFINSHEKLYLATKMLKIMFPYIFFVSLGSLTGSI LNAWNYFSVPAYSSIFLNLSMIMFISFVTAYFNPKILSLAWAVIVGGVFQ ILYQFPYLKNINMLIFPKFNILNLGVLKFLKQIGIVALGMSVNQVSIIIA TISSSFLISGSISWIYYSDRLVEFISGIFGVSLSTILLPLLSKSVNNINI KEYSRLLNWALRLVCILVIPSIIILFTLSESLITLLFKYGAFTYNDVIMT KNVIEFYSIGLLPFVLIKILLAGFYSIRNVKTPMKISIFILVLTQLMNIF FIKYFQYTSFALAISLASWINFFLLYRKLCQSEFFIPSTNWLRFLLKIFA AAMVMLILLFINKNLILSANTHSIFFKILRLFYICASSGGGYLFTLFCLG LRFNHFYLKSYKY >bbp128 nfo, putative endonuclease IV MKYIGAHVSAAGGLDQVIFRSKELGATAFSFFLSNPLRWNLIQFRDETIK KFIFLCKKFNYVSDQILPHSSYLINLGHPSDEHLKKSRLLFVNEIINCKK LNLSLLNFHPGSHLRKISEQHCLIRVADSINFALQNTVGVKLVIENTAGQ GSNIGYCFEHLAQIIHKVKEKDRIGICLDTCHLHASGYDLKTELGCRQTF KAFNDIVGLHYLSGMHINDSKTKRNSRIDRHHNLGQGYIGKSSIRWIIRN INFKLFPMILETTNNKLWKDEINWINSL >bbp544 nifS, cysteine desulfurase MKFPIYLDYAATTPVEFEVMKEMMNYLTLEGEFGNPASRSHKFGWKAEEA VDIARNQIAELIHADSREIIFTSGATESNNLAIKGIAEFYKKKGNHIITC STEHKATLDTCRYLENKGFDITYLNPLQNGTINIYELQEKIQKNTILVSI MHVNNEIGVIQDIHKISKICQSNNILFHVDAAQSIGKININLKQLKIDLM SFSAHKIYGPKGIGGLYIRRKPRVRLSAQIHGGGHEKGMRSGTLPVHQIV GMGIAYKIAKIKINSDFNYIKHLRNRLWNGIKNIEEIHLNSNFENTVPHI LNVSFNYVEGESLIMALKNLAVSSGSACTSSSLEASYVLRSLGLKDELAH SSIRFSLGRFTTKEEIDYTIQLIHQSINRLRNLSPLWEMFKSGVDMNNVN WTHN >bbp106 norM, multidrug resistance protein NorM MKKHLHEIKMLLKITIPIFLAQISQTSMSLINSIMIGHLKENNIAAISVG ISIWSPIILFGHGLLLSLVPTVSRIHGSGKINKIPEQINNAYWLATLISL VIMIVLWNSDVIIHTISQVNPIIEQESIKYIRILLWSTPGYLYFQVIQNQ CEGLLKPKPAMVIGLIGLLFNIVVSYTLISEKFHCFNYGSTGCGISAIIV YWFMFIAMKKITKNDILINYNIKNKNISNLEMYLPNYKIIWNLFKMGFPI ALSLFCEITLFTLITLLIASMETFQIIAHQIALNISSTIFILPLSIATAA SIRLGFYLGKKSFSKISTIILSSQIIGLIISTTISTFIILFHYQIITLYT KNANIIKLTKQMLFITASYQIFDFFQIIGNGILRSYKDTNIIFIITCTSY WIVGFPFGYFLALTNYIVPHMGAIGFWYGILIALITSSIMILFRIYILQK K >bbp168 nrdA, ribonucleoside-diphosphate reductase 1 alpha chain MNQMLFVTKRNGKIELINLDKIHRVLNWAAKGLENISISQVALKSRIQFY NNIKTTIIHETIIKAAADLISENSPDYQYMAARLTIFHLRKKAFGQFNPP NLYDHVKNMIKLEKYDQHLLNDYPKQDFLIMNSFIKHRRDMNFSYAAVKQ LEGKYLIQNRVTKKIYESAQFLYILISACLFSKYPNETRMKYIKNFYDAI STFKISLPTPIMAGLRTPTRQFSSCVLIESEDNLNSINATTSAIVKYVSQ RAGIGINAGRIRALGSPIRNGDTLHTGCIPFYKHFQSAVKSCSQGGVRGG AATIFYPIWHFEIESLLVLKNNRGIEENRVRHMDYSVQLNKLMYQRLILG EHITLFSPSDVPNLYDSFFNNQEKFERLYIKYENDKTIRKKKVKASYLFS LMMQERTSTGRIYIQNVDHCNSHSAFNPKIAPIRQSNLCLEITLPTKALQ DVHDKNGEISLCTLSAINLGSLNNLNDLSKLSNLIVRALDSVLDYQEYPI LSAKKSALSRRTLGIGVINFAYYLAKNGVRYSDGSANNLTHRTFEAIQYH LLNASCVLAQEKGACHWFSHTNYYKGILPIDTYKKNVDEICNEPLHLDWE LLRKKIKKYGLRNSTLSALMPSETSSQISNATNGIEPPRGLISIKASKDG MLRQVVPEYKRLKNNYELLWNIPNNTGYLQLASIMQKFVDQSISANTNYD PKLFPNNKIPMQQLILDLLTAYKLGLKTLYYQNTRDGASDHQTEDIQFSK NENCNHGACKI >bbp167 nrdB, ribonucleoside-diphosphate reductase 1 beta chain MTYTTFSKNKNNQLYEPMFFGQSVNISRYDQQKYEIFEKLIEKQLSFFWR PEEVDLSRDYIDFQNLPQHEKHIFVSNLKYQTLLDSIQGRSPNIALLPIV SLPELETWIETWSFSETIHSRSYTHIIRNIINTPSLIFDDIIDNKNIANR AKDIAKYYDDLIELTSYWHLFGEGKHTINGKKIKIDLHELKKKLYLCLIS VNALEAIRFYVSFACSFAFAEREKMEGNAKIIRLIARDEALHLTSTQHIL NILHNDKNNEGMSDISKECYEECYHLFIRVSDQEKIWAKYLFQNGSMLGL NQEILSQYIEYITNIRMKAIGLPSPFKILSNPIPWINSWLISDNVQVAPQ EISVSSYLIGQINSEINDSDFEKFKL >bbp114 nth, endonuclease III MEIKKLNHKNRYKILKMFSNIYINFKTGLVFTSNFELLISVMLSAQTTDR MVNKTTQRLFGIANTPSGFISIGLHAIRENIRKLGLYNKKSSNILRTCEI LLKRYGGKVPNNREDLESLPGVGRKTANVILNVIFKKKTIAVDTHVFRLC NRIGFAKGTTVLTVEKKLLNIVPEKFKLNFHAWFIMHGRYICTSRVPKCS KCIISSLCEFKDKNI >bbp143 nuoA, NADH dehydrogenase I chain A MLKSSVIAAQYWAFFTFFFIAVSICVFMLSISWILGGRSSSRYKNTPFES GIVPTNTTNMYCSVKFYLVAIYFVLFDVEALYLYAWSVSIVECGWIGFIE ALIFILFLLSGLIYLISSKLLVWKSKNNIHVT >bbp144 nuoB, NADH dehydrogenase I chain B MKYTLTRVNISDDDQNYPREKKIQVSDPTKKYIQKNVFMGTLSKVLHNLV NWGRKNSLWPYNFGLSCCYVEMVTSFTSVHDISRFGSEVLRASPRQADFM VIAGTPFIKMVPIIQRLYDQMLEPKWVISMGSCANSGGMYDIYSVVQGVD KFLPVDVYIPGCPPRPEAYIHGLMLLQKSISKERRPLSWIIGEQGIYKAN FNSEKKNLRKMRNLVKYSQDKN >bbp145 nuoCD, NADH dehydrogenase I chain C/D MKKEIKRDDVNVIEKDFGNNNSIILKLFKKFGEDSFFIQTTVTDIIVLWI DGSLLLALAKFLLTINNPYNMLFDLYGIDERMRLYKHNLPLSHFSVVYHF ISINRNSDIILKIALLEEKLSLPTLTKLYPNANWYEREIWDMFGISFENH PNLIRILMPKTWVGHPLRKDHPARATEFDPYVLNKYKEDIEMEALKFKPE EWGMKKNKQSKYMFLNLGPNHPSAHGAFRIILQLDGEEIVDCVPDIGYHH RGAEKMGERQTWHNYIPYTDRVEYLGGCINEMPYVLAVERLAGIEVSQRI EVIRIMLSELFRINSHLLFISTFIQDVGAMTPVFLAFTDRQKIYDLIELI TGSRMHPAWFRIGGLAHDLPKGWNALLKEFLLWMPKRLLKYINVALKNSI LISRSKGIAEYNKHDALLWGVTGAGLRATGINFDVRKKRPYSGYQNFDFE VPIGAGISDCYSRVMLKLEEIWQSLAILKQCLENMPEGPFKMDHPNTTPP HKVRTLQHIETMISHFLKVSWGPVLSSNESFKMVEATKGINSYYLISDGN TMSYRTRIRTPSFPHLQQIPSVIRGNLISDLIAYLGSIDFVMSDVDR >bbp146 nuoE, NADH dehydrogenase I chain E MLTVEVYEMSKKIDIKFKLTIQEKIEIFNIIKNYRTVRSSLIEILKFVQK SYGWISNELITELACILKISKCDIEEIATFYSQIFRQPIGRNIIKYCDSV VCYVNGCEKIRCSLEKNLNVNVGETTKDFKFTLLPICCLGNCDKSPTIMI NDDLYSNVTEYSVIVLLESYQ >bbp147 nuoF, NADH dehydrogenase I chain F MKKLLSRTSETHPLTWRLNAQQDTVWIKEYKRKNGYRAFEKVVNHMTSED VIDLIKQSGLKGRGGAGFLTGLKWSLMPPLNDEYGYTRYLLCNADEMEPG TYKDRFLMEKVPHQLLEGILISAFALSVTKSYIFLRGEYVNTERILKQSI IEATNYGYLGKNVCGSNLTFEIFIHTGAGRYICGEETALINSLEGRRANP RFKPPFPAYVGLWGKPTCVNNVETLSNVPAIFLNGVKWYKGLSKSLDTGT KMMGFSGSVKFPGIWELPFGITAREIFERYAGGMKNNKKLKVWQPGGAST SFLIDKHLDVPMDFVNIKKVGSRLGTALAMAVDDSVSIVSLVRNIEEFFS RESCGFCTPCRDGLPWIVKILKVLEQKIGVPEDIEILEQLCEQLGPGRTF CAHAPGAIEPLKSALKYFRLEFELCVNSNSTIKCKYIHSSISEY >bbp148 nuoG, NADH dehydrogenase I chain G MTIIFVDNEEYNVDKSDNLLQACLSSGINIPYFCWHPVLGSIGSCRQCAV TIYKDLEDKVGQLVMSCMTSVLDGMIVSTSDKISRNFRKGIIELLMLNHP HDCPICEEGGSCHLQDMTVMAGHTVRRYRFTKRTHKNQYLGHFITHEMNR CISCYRCVRYYKDYSGGTDLGVFGISNNVYFGRYNDGCLESEFSGNLVEV CPTGVFTDKTYSKKYSRKWDMQYAPSICQHCCVGCNISVGEKYGKISRIE NRYHNAINHYFLCDLGRFSYDYSNVDERLTYSIYRSQNKTKIINDVNKTI DKLAMKFKKSSKIIGIGSCRASVESNFSLQKLVGSENFYLGISQKEYDCL MLIKDILKDNQIHVPTLREIEKSDVIFLLGEDVTKTSPLIALSIRQSIKG QVKTQDVSKNIPIWHADAVKNSFRNNKNKLFITNLMNSSLDDIADESYYA STFDQVLLGAEVYKCISNNCISNVTLLKQDLLSCAKRIATALTLSKCPLI ISGSHSYNLDLIKVSFNIAKSLKVIGKNVGLILLSSNVNSIGVSLLEGIS IEKVINKVLLKQIDKIIVLENDLYRYLPESIVDTLFKSSSCTVVIDHLNT RTLKQADIAIPTCNSFESSGTVVNYEGRAQRFFKTYHPNSSENKKSILES WKWLHLLYCKLHKISVFWHSLDDVIEEISLKIFSFSKLKDVAPNSSFKIF GQKLARSHHRASGRTALYSNINIHEPRPPQDNDTMFSFSMEGCQNVQNYL PYVPFSWFPGWNSVQSWNTYKKINNENYGKHLFQDTTKFVLTYYKLNCKN VNKIEDLYLIVPCYFLFCNNELAQYSPVIQENVLKNAYGIINTEDAKVLL IESGSKIEFSYLNKNFSIKVQLSKEFKKGQLGLPLGMADFPFFLAEKQVK VFRKISI >bbp149 nuoH, NADH dehydrogenase I chain H MIFLPISSIETKTYIFQSIVILVCVLITASIMSVVERRVLGLLQNRYGPN RVGWQGTLQVVADMIKLFFKEDWIPTFSKKITFLIAPILAFISLLLVITI IPLSPSIVIVNLDIGVLFFLMMASLSVYSVLLAGWSSNNKYALLGSIRAT AQTLSYEVFLGLSCMGVVARAKSFNMIDIVDSQIGLWNIIPQFFGFLAFF IAGLALCHRHPFDQPESEQELADGYHIEYSSIKFGLFFIGEYISIIVVSS LISTMFFGGWLGPLFPSYFWFILKTLCFMMIFILIRASLPRPRYDKMMLF GWKVCFPLTLINLIFTALIMLY >bbp150 nuoI, NADH dehydrogenase I chain I MILFKFFLACFSQIKSVWLTFINIFSKRETRMYPEESLSLSSRYRGRIIL SRNSFGKERCVACGLCSVVCPVSCISLKKSTLKNNKWYPKFFRINLSRCI FCGLCEEACPTLAIQLISDVELSEYKRQDLVYEKDDLLISGQGKYLDYDF YKFSGVEVGTKNKGELDFESHPIDVKTLLP >bbp151 nuoJ, NADH dehydrogenase I chain J MEFFFYSSSLATIVFTVCSIFSRNLMYSLLYLILSFVFTSCVFFSLGATF AAALEVIIYAGAIMVLFVFFIMMFNFKKSTLYAEKIFDKNNYYYINFLFL LCILIFPFFFILSYLYKEKIFYMVVSTKLVAIKLFSDYILVIELSSIVLL SALIIVSHIGKIRR >bbp152 nuoK, NADH dehydrogenase I chain K MIPLSHGLILAFFLFSLGFVSLVMHKNILFMLISLEIMINSAALALVVVG NYWNQVDGQIMYILILTLGASESSIGLALLIQCYRHFKTLNIDKLSEMNG >bbp153 nuoL, NADH dehydrogenase I chain L MNFVYLVVLCPLVSFCLLLFFIDYLPKMLVKKIGIVSIFISMIITFYSLF DFLNCGKQCVFYIPLWVWISIDYLKIDFNFMLDGLSITMLTMTTSIGFLI HLFSSWYIKLQDEYTRFFSYMNLFIASMVLLLLADNLLVMYIGWEGVGLC SYLLVGFYYSKINSGYAAIKGFIITRIGDIFLILAIFFIYKNFGTLNFRE LKLIFETTNVVENFKFLNYVSLFLLIAAIAKSAQVPLQTWLIDAMAGPTP ASALIHSSTMVTAGVYLIARMNFLFSLSPIILYILGIISCLTIIMSCLSA LVQKNIKCILAYSTMGQVGYMFLALAMKEWTLAINHLVTHAIFKTLLFLS AGAVIILLNNEKNIFNMGGLRKKFPMLYFSFLIGGASLASFPILTSGFYS KGNILFSALENNYYLFLVLGLLGSVLTSIYTFRMIFLVFCGAQKYRAHYV FFSRTLANTLPLLILILLSTVIFVLIHLPLSSVFSKTTPSFLINNNKLLF EIGCSVLSLLGMFISYYLFLVNRMLVDLLLNTKLGNFIYNFWYDSWGFNS LYNILCVNPYLYVAKRLKHDPINIFMSIPITFCFFVSKNLKYIHNGYLRV YVFSIMFGLFLFILMAIRLYK >bbp154 nuoM, NADH dehydrogenase subunit 4 MLLPMLVSIPFFGGFLCLLFNQKNAKISYYLALTSMALVFILSLILLFNT INVIVSSISNSSWSFEYIVPWIEKFGISFHLAVDRLSILMLNLTSILGLV SVFCSWKKVQKNIGLFYFGLLWTLGSIIGIFISVDLFLFFCFWELSVLPT YFLMIMWGYKDNDRKFYYNNIFSANKFFIYSQISGLVLLLSTLVLVYTHY IYDHILTFDYDVLKHTSMNIVLESCIMLGFFLAFAIKIPIVPFHSWLPDF HCYSPVIGVVDISGILLKTSIYALMRFNIPLFPHSTEIFSSIIMFFGIIT IFYGAIVSLFQNNIKRFIAYVSISHMGFILIAIYSINQVAYQGAIIQLIS YSLSTAALFLLSGHVFKSISTFDIDKMGGLWSKLRWIPGFLLIFSIINLG VPGTGNFVGEFMIFMGCFNSHLMIVILSIFSLILLALCSLMFVQKICFGP INNRYDFLCDLNVMTICDFLIFVFLLVLILIIGLYPNIIIDVSYSPLCSI RNIFSNFI >bbp155 nuoN, NADH dehydrogenase subunit 2 MIITGQQLVALSPLLILMSIAIVVMLFIAYNRNRYIVFLLTSFGFLSVFI SLFIVKKIVPIHATTLFHIDKYSLLYIGIVIISSFLACIFSHYCSLTNYL YNFEEFYLLLLFCTIGCVSIIISNNLCTFFIGSELISLSSIGLISYTFFE KKALEASIKYMVLSGIMSTLLLFGIALIYSVSGSLEFSSIIYELTMITKS FHNAIILFFGVSLFIIACSFKLSLFPFHIWTPDVYQGMSSEALMIFSTSV KIAIFSVLFKIFIVLSYFHIEEVFYYLVSIISCLSMIFGNIMAINQTSIK RLMGYSSISQLGYLFIVLVISRNMQFSLEVTGIYLINYALSNIGMFGIMS VLSSLYKNFNVDSIFSYRSLFWSSPILSGVMTVVMLSLSGIPMTVGFLGK FYLMSLVVKEHMWLFICLFIISTIIGFCAYLKIISCLFVAPSDSYCHKNI IISSQNINNKFLIGLLTTISIFVLFLGIFPQITIHLVKYFWIQW >bbp341 nusA, N utilization substance protein A MNKEILAVVEAVSNEKSLPREKIFEALECALAIATKKKYDQEIDVRVKIN RKNGNFETFRRWLVVNQVLQPTKEITLEAAKFEDVTVKVNDYIEDKMISV TFDRITTQTAKQVIVQKVREAERAMIVEQFRKYFGKILTGIVKKINRESI TLDLGNNAEALILKEDMLPRENFRLGDRVRGVLYAIYPESRGAQLFVTRS KPEMLIELFKIEVPEIGEEIIEIKSAARDPGSRAKIAVKSNDKRVDAVGA CVGMRGARVQAVSSELCGERIDIVLWDKNSAQFIINSMAPAEVSSIVLDE DRHTIDIAVDSNNLAQAIGRNGQNVRLASQLSGWEINVMTVDDLKLKHQE EKDKILNIFTKYLKIDQKISNILIDEGFSSIEELVYIPFNELLNINSITQ ELAYSIRESAKKALCAIELENKKVINERKLHKDLLNLKGMNQKLAFKLAK KNIFSLEDLAEQGIDDLIDIENLNSNTAGMLIMAARNICWFGNKTSA >bbp409 nusB, N utilization substance protein B MKSKTKTRRKAREYAVQALYSWQISKNDIYDVINHFKKNKTINEIDQIYF YELIIGITKNLKYLDELMRPYLSRTIQELGQIEKAILRISFFELDKRYDI PFKVTINESIELAKLFGAKDSHKFINGVLDKASLKLRKNNSNKN >bbp040 nusG, transcription antitermination protein MYKSYKKRWYVLQAFSGFEGRIAQSIREHVKLKKMEKLFGEVMVPSEEVI EIKAGQRKKSEYKFFPGYVLIQMIMNESSWHLVRSIPRVLGFIGGTPDRP LPITDQEVNTIINKLKQVGDKPRPKTLFEPGETVRVNDGPFSDFNGIVEE VDYEKNRLKVSVSIFGRSTPVELDFSQVKKN >bbp519 orn, oligoribonuclease MNTDIKNLIWIDLEMTGLNPNIHKIIEIATLITDKNLKILSYGPVIAIYQ NNHQLSFMDPWNNKMHTKNGLITRIKNSLYTEHLAEIKTITFLKKWVPKN TSPMCGNSISTDRQFLFKYMPTLEKYFHYRQIDVSTIKELALRWKPKIYN KLKKKTLIKH >bbp282 pal, peptidoglycan-associated lipoprotein precursor MKSKKIFKILTLLLPMITTFSCSFPKNKLNSNNVDTFYEQETNKSKQQLT NFSEDNFDETLEKLKKGNTIYFPFNNHQVNSKYAKNLNDLAQFLCHHSNQ KIMIEGHTDSRGTNKYNMYLGQKRADSVKLYLESKGVSNQQITTVSYGSS KPVAHGNKENSYSKNRRSVIIYQ >bbp332 pepA, cytosol aminopeptidase MRYHISTNFFKKKYSDCLVFGIFDDLQLCESVKVIDSGSDGYVSRLIKDN EISGQINESLLLHSIPNFQKLKILFLGCGKKERFNINLYQKLFKTSINII KKLSVKALIYFVTDFHIKNINTYWKIRHAVSEIQDNLYSFKNFKTSNNKN KFKISLEDIYFYLSDHDEINSGNNAIQHGYAISKGKKIARDLSNMPPNIC NSSYLADQAMKLSQYYPDLIDVEIINDIDMNKLGMNAYLSVGKGSKNKSL MSIIKYHGISFSQCKNIILIGKGVTFDSGGISIKTSRDLDEMKFDMSGAA IVFGLMSIISDLKLPLNIIGILAGSENMVSSMSFRPGDILTTMSGKTVEI LNTDAEGRLILCDVLTYVERFSPEVVIDIATLTGACVVALGHHTTGLLSN NDILAKDLQKASKQTRDLIWRMPLFEEYYKDLDSNVADMANVGTNSAGMI TAACFLSKFSQKYAWAHLDVAGTAWISGKNKGSTGRPINLLTQFLLNKLY K >bbp284 pfkA, 6-phosphofructokinase MIKRIGVLTSGGDAPGMNAAIRGVVRTALSRNLEVFGIYDGYLGLYENRM ILLDRYSVSDIINKGGTFLGSARFSNFFKKDIRSIAIKNMQQRNIDFLVV IGGDGSYVGAQKLTEMGFPCISIPGTIDNDVAGTDYTIGYFTALETVVEA IDRLRDTSSSHQRISIVEVMGRNCGDLTLSAAIAGGCEFIVLPEIEFTKE ELVKEIKNGIKKGKKHAIVAITEYICNVEKLAKYIQRETCRETRATILGH IQRGGAPVVYDRILASRMGEYSVDILLQGFQGRCIGTINEKMVHHDISDA LKNMKRPFKFDWLKTAKQLY >bbp192 pfs, 5'-methylthioadenosine/S-adenosylhomocysteinenuc leosidase MKKEIKKNYRIGIIAALQQEVQILFNKLKNYKINKISNITFYIGNIHNIH VVLAKSGVGKVFSGITCALLLQKYKVKFIINIGSAGSLNKNLKPGSIIIP TNVCYHDVNLTAFGYSIGQIKNCPKTFLSNTLMLKLTEKYLFENKIKYQK KLMISGDIFIDTCEKKSLLKKRFPKAIAVDMEAAAIAHVCYQFNIPILII KSISDSSDINAADNFKYFINLASKNSSLVTINVLQTLFKNTKNILFDNNN RC >bbp518 pgi, glucose-6-phosphate isomerase MKKINPNNTESWKMLQNHFYEIKSFHIKELFKKDKNRFKKFSLKFDNRIL VDYSKNRITSFTIKLLLKLANEMDLNNSIKSMFSGKIINETENRAVLHTA LRNRSNSSIIHNGCNIMFDINKVLEKMKHFSNLVINRKWLGYTGKYITDI VNIGIGGSDLGPKMVIKALNSYRNHLNIHFVSNVDGANIFNVLKKLNPES TLFIIVSKTFTTQETIVNANTAKKWMLNAVNKNEFLDQHFIAVTTNAQEA MNFGIRYKNIFLFWDWVGGRFSLWSSVGLSIVLAVGFKNFEQLLDGAYMM DQHYLHTKFDNNIPVLLALIGVWYNNFFKSETEAIFFYDWNMNYFSSFLQ QMNMESNGKNICRSGEFVNWQTGPIIWGEPGTNGQHAFYQLLHQGTKLIP SDFIISIIPKHPFKDHHKYLLSHFFAQTQALAFGKFNQKCNVHINDKKTF DERLSSISFHKVCKGNQPSNSIVLDQLNPYNLGILIALYEHKVFTQGVIF NIFSFDQWGVELGKLLAKEIFLNMNTTGSKNYEYDSSTNGLINFYKIHSN NT >bbp400 pgk, phosphoglycerate kinase MSIIKITDLNLLNKKVLIRSDLNVPIKNNKISSYARIHASLPTIKFALKN LAKVIVTSHLGRPTEGIYKKKFSLFPVFKYFKKILPETNIYFSQNLTECS SIKSGELIILENVRFNQGEKENSKILSKKYATLCDIFVMDAFGAIHRNEA STNGIIKYAKLACSGLLLESELKTLNSALTNPVRPMVAIVGGAKVSTKFK TLTTLAKISDTLIVGGGIANTFISIDHNIGKSLHDPKFIEQAKILKEKYN IFIPTDSRVSTTFTYDSIATIKSTSDIHANEEIMDFGDISIKNMINIIKK AKTILWNGPIGVFEFKNFSKGTEQLSKAIASSDAFSIAGGGDTLSVVEMF KVQNNISYLSTGGGSFLKFLEGNKFRIIELLEKHFNKFKNNNF >bbp355 pheA, P-protein MTLKNALLAFRNAINILDKNLINLLAKRKQLSLNIAHTKVKNNYPVRDIE REQMLLKNLTILGEKHFLNKKYIESLFSIILEDSVLTQKKWIKKYNLNKY KLEKISFLGSFGSYSHLAAQKYAKKHSKILTDKIYKNFSDVITSVEQQQS TYAILPIENQSSGLIIEVYKLLQKTPLFIIGNIYIHANHCLLAKKYTPIL KIQKIYSHIQPFKQCSKFISLFPNWKLSNTTSTSEAIQHVAKENDNTIAA LGNESYGELNKLEVIAKNISNKRNNITQFIILAQKKTYITNKKTHLKTII LISKKNENCEKIIRNILHKNKITLLKLKYYVTSKVLLEKIFFIEIENIYC IKHILKQFTIEIKCIKILGCF >bbp123 pheS, phenylalanyl-tRNA synthetase alpha chain MCDALKSIKKIKKEIQRTTTVEELKTLRIKYLGKKGYLASKMQKLFSLSL DKKKIYGSIINKFKSDLNIELDLHKKILDMIAVSSLNKKEKNFDVSLISR KNDIGTIHPITYVISSIENFFLKLGFSVITGFEIDDDYHNFDLLNIPKYH PARADHDTFWFDANRLLRTQTSNMQIRTMKNETPPIKIIVPGKVYRNDYD ATHTPMFHQVEGLIVDHDVNFFHLKWIIEMFLKFFFNKTVKIRFKSSYFP FTVLSAEVDILGNNKKWLEVLGCGMIHPKVLSNANINPKMYSGCAFGIGV ERITMLRYGISDIRVFYENNLKFLTQFK >bbp124 pheT, phenylalanyl-tRNA synthetase beta chain MEFSEKWLLDWLGFSISNVFYEQMTKSGIEVEAIAKISKNFERVIVGEVV ERLYVNTMHNIVFLRVKLSEKKMIFSISSNDIEFSRGTKIAIATQDSKLF NNRLISMLRFKEKISEGMVCSFKDLGILNIKNKIVEICSEVPVGTDISKF LWFDDDRIIKVSSAPNRADGMSILGIARDMSALNNLCLPTLKEYHINITN HEKFRILINIPDVCLNFIGRTIQSVNLNRQTPLWILERLRRSSISSENVL VDIINYVLIELGQPIFSFNIHGIVQNIIIRTARDNEQFFDSCSQRVPIDK RTILLSDDKEILVLGNHTNSYNSRLSLSSHNIFLGCALFNPEYINNDSHF NFGFKNKITEYYSRGVDSDIQYKALNYVTYLVLKICGGNASNVVLANSSR VTVIQKKIFVLKKTLHRYVNNIISDTLVVKYLLQLGYLVEKQKHCWLVIP PSWRFDIQIQEDVISDLVRVFGYHNIPACALVTNYKLVHDDNIYTSLNRI KLLLVDLGYNEVITYSFVDSQIQKYLFPKRKQFFLLNPISRKMSSMRLSL WNGLLSSVLYNQNRQEKVMRFFESGLCFEEDGNEYLGVKQDLYLAGVISG YKNETDWRSFNKIVSFYDLKGDIELIMALLRKLDKVSFKKMLFQNLCPKQ SAAIYFEREMIGVIGVISSNISKKMGLKYKTIVFELIWKKIAQSNDYRIR DVSLYPRCSRDISIIVNDSIAADEILKVSKNVFLDKIVEVKLFDVFYGKN VGLNKKSLSLRFIFGSSKRTLSEEIISNCLNECIRILQEKFNAILRDRNF LF >bbp278 phrB, deoxyribodipyrimidine photolyase MNVNLMWFRNDLRLSDNSALHFSCRNNASTVLALFIATPKQWERHCLAPK KKMLIYKNIVALKKKITELGIIFYYYESTDYLESTNYIIEFCKIHKVTSI FFNLEYEFYERQRDKIIKKKLKKNNIIINCFHDSVLITPGSIKNSYGKMY KKFSYFKYKCIKQLQLNIPSCFPKPQNKNLHDHYSLDFTIPIFHTYLEKF DANIFPIGEDIVYEKLKFFIKYAFNKYNFDQEIFELNSTSMLSAHLSIGV ISPRQCVTLLFKEYPDIIHKLEECKWINELLWREFYQHLLYFYPNIGQNQ SLYHWENRIKWDNNLYYLNLWKQGNTGYPIIDAGMRQLKQLGWISNRLRM ITASFLVKNLLIDWRKGEEYFMSQLIDGDFASNNGNWQWIASVGTDSMPY FRIFNPMLQSKKFDINAKFIRKYIPELSNVSTYNIHNPCDNNKTNKIHSK YPQPIINYYHSKKKTLLVFKHAKCSNKL >bbp531 pitA, putative phosphate transporter MSYYFSFFCYNSSVVFSCFSLLFIFIYEVINGFHDSANAIALIIYTRSMN EKMAILISGILNFLGVFFGGLSIAYAIIYLLPSNLLLNINTSCGLKAIFS ILLSAILWNLCTWYLSLPTSSSHTLIGSIIGINFVNAFINNFSILSLISF NKIIYVFLSLILSPICGLIIAGSLVFLLKKYYNSKYKEYCINISPVYYRI QKKKQSLLWIKITLILSSFGISYFHGANDGQKGIGLIMLVLICIFPSKYL INLNTSTYDIINTRISIDSFEKYYLRNQTLIKQNVSNIMFKEIIQPLLFL KNIDNTKNDNVLVIINFMRNLLHNISSYKELNVIQCHQLRQSLLCIGNFM EVLSHFSIVQVKDKHFFYCLKKNLLSTIEYAPNWVVTFIALSLSIGTIIG WRRITNTFQNKLGTQDITYAQAISAQLTTACSVSLASCSGIPVSTTHIMS SSLVGTMLVNRSGLRINTIKKTIIIWILTIPISMLLASFLYWISLKCFN >bbp083 pmbA, PmbA protein MMKLSDITTQENDLKKIVEYILNLAANHSVFSEVVIEKNCGVDVLIRKNS VNSIEFNKNNILTITVYKNNRKGMVSSTDLSFKSIHNVFSSVMGIVFYSS PDEFSGLPDRKLLAINKVKDLDLYHDWDWNINHAIEIAKLSEREAFKEDK RIINSEGSCFNSLVRTRAFGNSLGMIECYSTTLYSTSCCVIAGDNGDMQR DFSFSVSRDMNDLNLPEKVGQDSAKKALSRLNSKKLLTMKTSAIFSSEIA FEFFINFAKAINGNNVYQKSTFLLHSLNTQVFPNWLTIEERPHIKKGLSS KCFDAEGVMTKTKKIVNKGILKTWLLDTYSARKINLVSTGNSGGIHNWLI LGNSNEGLQSLLKSMNTGLLITELLGQGVSITTGNYSRGAVGFWVDQGVI KYPVNEITISGNLKNMFKDIVSIGNDIDKRHSIQSGSILLSQIQVSGI >bbp336 pnp, polyribonucleotide nucleotidyltransferase MLNPIVRKFQYGQHIVTLETGIMARQATAAVLTSMDDTTVFVTVVGQKKL QTEQKFFPMTVNYQERTYAAGRIPGGFFRREGRPSENEILIARLIDRPIR PLFPKRFFNEVQIIATVVSLNPQVNPDIVAIIGASAALSISGMPFLGPIG AARIGYINNQYILNPNVNEIKSSSLDLIISGTEESVLMVEAEANMLTEEQ IINAINYGHEQQKIVIKNIEHFAKKVKIPVWEQCLYPVNDDLEKRIIEIS EQEIVKAYNIFDKVIRLDVLDKIKSKAIEIIISEYSGIDEFEITSIISNI ERKIVRNRVLKNRIRIDGRNKDEIRTLDVRTGVLPRVHGSALFTRGETQS LVSVTLGTSRDAQNLDELLGDKTDNFLFHYNFPPYAVGEIGMVGSPKRRE IGHGKLAKRSILAVMPKLDLFPYTIRIVSEITESNGSSSMASVCGASLAL MDAGVPISNAIAGIAMGLIKEGDDFVVLTDILGDEDHLGDMDFKISGSKK GITALQMDIKVKGITNEIMKLALYQAKNARIHILNIMKKSLNVPRKDISI FAPRIHTIKINPEKIKDVIGKGGSVIRMLTEETGTTIEIEDDGTVKISAV MQEKAKCAIQRIKEITAEVEVGSVYTGKVTRIVDFGAFVSIGIGKEGLVH ISQIAHKRVDKVSDHLRLHQEIFVKVLEVDRQGRLRLSIKGAK >bbp382 polA, putative 5'-3' exonuclease MIIYKKNVNYLLIDGTSYLYRAYYAFLKFKNNFNKPCGAIYGMLNMLRSM LLKYPYSNIVVIFDSPQKTFRNELFIPYKKNRPKMPNDLKEQILPIHHII KHIGIPIISIPHVEADDIIGTLATKLYKKKYFILISTNDKDLAQLVNIHI HVLIGTSNIVLDESKVKKKYGIIPKLIPDLLGLMGDNSDNIPGVPTVGKK TALILLKTFGSLENIYNNIEKIPKCLIKKAKTIYNNLHTYKKLAFLSQKL ATIKTDINVNITTKKIKMLPPCTTEISNFFLHYKFYNWNKLLKQGLWLKN CK >bbp082 ppa, inorganic pyrophosphatase MTLNTVLSGKNIPEDIYVIIEISAHSNPIKYEVNKDLGLLFVDRFIPVPM FYPCNYGFINKTKSNDGDPLDVLVHTPYPILPGSIIRCKPIGVLNMFDES GEDYKIIAIPHPKVCLEYSSINDICHLSPTLKQQIIHFFKHYKNLENNKW VKIIGWENKKNAEKIILSACEKFHK >bbp422 ppiD, peptidyl-prolyl cis-trans isomerase D MHKLTSKLSNLILLLLIIIIFISLILTNFNNYLLENLSEYEIKINNTEIS REEFIQRYNLECFYNDKNFKNDIITNPKNPKYISEIYNITLSNIIYESLL QQYVHQLHFNIDYSHVKNYIYKQTIFRQNQKFNKEKYYEYLKKLQISSNE YIKKVMTYLEIKEFIKTLTNTDFILNNEKNNILKLFEQGRIVNKSYVNLN NLKLIEHISNKELKRYYINHKHQFLSPKKFKISYFLINKNNVFVPCIKKF YFKNKDNTFQHELFLQHKKSKKQNDNIIKKLLTTHTNTSQFKNIIQKNNI CIHHTPWLTQTLYKHEKLPKKLLKYIINNNILFHNNKNTIKNYPTIIHMN NNNAYVLWIQKYEKATIENFSKKIRKKIINILKNEHSKKIRYQIVQKIVY QLNHGDTNLFSQLKLKFSNSEYYSRFNTNTLTNKIFSLPIPKKGQKIYFI FHDQKKLFLYQFSNIFYFKLTKKQKKMIASYISQSHSEIILNAILENLYK TAHISYKGYIN >bbp174 ppnK, putative inorganic polyphosphate/ATP-NAD kinase MKYYFSSIGIVGHPRYDSALNTHKLLHSWLVNKGYNVIIENKVAHKLRLK NINFDSLANIGKKCDLAIVVGGDGNMLCAARILSCYNIKIIGINRGNLGF LTDLNPDTAFQQLYNVLSGEYFIEKRFLLEVKIVKENGTALINTAINEVV LHAGHVAHMIDFEVYINNEFAFSQRSDGLIISTPTGSTGYSLSAGGPILV SSLEAMVLIPMFPHTLSSRPLVINSTSIVYLKFKKHIHSELKISCDSQVI LPLNSKDNIFVKKSKKFLCLLHPKNYNYFNVLSSKLNWSKRF >bbp161 prfA, peptide chain release factor 1 MKSSMMKKLESLHRRYEEIESMLSDRTVISNQEKFRELSQEYLKLSDINY CFVQWKNCNHDVIETKLLLLDSELHDVAEQELQMLSKKMKKIETEIQVLL LPCDPNDQQNCFLEIRSASGGDEAAIFSGDLFRMYIKYSEFQNWKTNIIH MTHSLKGGYKDIIVKITGKGSYGKLKFESGGHRVQRVPKTESQGRVHTST CIVAVIPVVPKKEIEKVNINDLKIDTFRSSGAGGQHVNTTDSAVRITHIP SGQVVECQDERSQHKNKAKALSVLVSRIKAAELYNQRKKNAIQRRDLLGT GMRSDRNRTYNFAQNRVTDHRINLVVYCLDEVLDGKLDVLIEPIIQEHNA DVLSNLSNIEFL >bbp390 prfB, peptide chain release factor 2 MKKNRLLEINMELKLPETWKHPSLIKKINKEKNQLISVVTQITKIDNDVQ ELIDILNLENSNNINSILDNVLYEFKNIEKSIHELEKCSMFLGKYDYLSC YVDIQSGSGGVEAQDWASMLLRMYVRWAESKKFKIDIIEQTYGEVVGIKS ATIEVLGKYAFGWFRTETGIHRLVRKSPFNAHHRRHTSFSSVYVYPILDD AINVDINTRDLKIDVYRASGAGGQHVNKTESAVRIRHLPTGIVVQCQNDR SQHKNKDQAMKQLKAKLYEQLINEKKCQQKILENNKLNIGWGHQIRSYTL DNSRIKDLRTGVESKNIQSVLDGGLDLFVECSLRNGL >bbp485 prfC, peptide chain release factor 3 MITINTYALQKRRTFAIISHPDAGKTTLTEKFLLNGKIIRTSGTIKARRS KKYAKSDWMEIEKKKGISITTSVIQIPYNRYLINILDTPGHQDFSEDTYR VLTAVDFCVMIVDAAKGVEERTRKLIHVARTHRTPIITFINKLDRNSLDP IEILDQLEIELKIKCSPIIWPISCGKAFKGIYHIYNNLVYFYSYKTSEGI NDTNNFLLKTCCLNDVFLDKIIGLELAQEFREEVELVNSIYKAFNKRIFL ESDLTPIFFGSALKNFGVNFLMQGILDWAPSPVFKKSNIRKVQPYEKNFS GFVFKIQANMDLRHRDRMAFIRIVSGKYRKRMKLYHVRIKKYIIQTEVFS FVAGDRFIIETAYPGDIIGFHSYNSIKIGDTFTEGEKLKFFGIPNFAPEL FRLVSLVDPFHKKKLLKGLTQLSEEGAIQVFKPYENNELILGAIGSLQFD IVIERLKIEYNIFILVHKVNIFSIRWISSNSLDTLSTFKNQNKSCLALDI NNHLVYLASSEINLRLVQSRYPDIIFNVTCEN >bbp221 proS, prolyl-tRNA synthetase MQARKYLFSTLKETPHNSDCISHALMLRAGIIRQNTSGTYIWLPTGLRIL KKVIRIIKNEMKQCGAMEIAMPFLQKKNLWDLSKRVITYGQELFQVTDRT NKKFILGPTHEEMITYFIKNELQSYKQLPLILYQIQTKFRDEIRPRFGII RTKEFMMKDAYSFHINMLSLEKTYNLMYQTYIKIFKKMKLKFYAVEADSG LMGGLKSHEFQAPSNTGEDVIVLSTQSNYLANIQVATSIQNNHIKYSTNN YFKKIKILRNNNDIYKKLSNTPNFKKSNTIKTILVKTKNFSKHLFVAILI REDHTINEYKLSKINEIEYPLIFASKQEILNVTGTTKDFIGPINLDFPVI ADFSVINLENFTIGSNITNKYFNNMNWNKDISIPQTYDIRYVLEGDPSPD GAGELKMQKSIEIAHIFQLGKKYSKIMNVKIQNKIGKKDTLIMGCYGIGI TRIIAAIIEQNNDKNGIIWPDSIAPFTIAIIPVCFHKSTLVKQQSEKIYN FCKKNNIDALLDDRKQNLSITLSEIELIGIPYSIIISEKLLKNDMVEYRE RHKNVKKIINKNHVFKIILNNSLK >bbp159 prsA, ribose-phosphate pyrophosphokinase MSDMKLFSGNSVPKLAESIANKLYVNLGNASVGKFSDGEINVQINENVRG SDVFIIQSTCFPTNDNLMELVVMVDALRRASAGRITAVIPYFGYARQDRR VRSSRVPITAKVVADFFSSVGIDRVLTVDLHAEQIQGFFDVPVDNVFGSL ILFEDMLKIDLKNPIVVSPDIGGVIRARAIAKLLHDTDMAIIDKRRPHIN FSQVMHVIGEVFNRDCILVDDMIDTGGTLCQAAEALKKRGARRVFAYATH PIFSGNAVKNLQNSNIDEVVVCDTIPLSKIIQELPNVRTLTLSSMLAEAI RRISNEESISAMFEH >bbp165 pta, phosphate acetyltransferase MTRTIMLVPIGKNIGLTTISLSVISAMKRCKFNVKFLKSAIEYSNTNYNI DDTSLILKDTQSLSYINPLIVDFINQFSLKQIKQRIVDYILSKVYAKKEK YDIFLIEGFDTKSHTYVLSNDINYYISKSINVEIVFVCAVDRSSQLDINN IVYIINNVFKKNKNINIRGVIINELCQKVRNDYGNVNLFDMFKSSVKKIN FGDVKYDFLFQKNGIEVLGCVPWIHKLMEPSVKILCDKYLGANIIYDRCM NSQYIKTFIIYDTNEDIKNAKKFHRSLLIIPAISNDKIKEICVQINKNKI LISAILLTNFLNVHDKCTDFIDQLKIANCTICSTPNDVFTVVSLLHKFNF KLDNKNYQLNIIENDMSRHINLDWIRSLKHSYQYNSICLPSLFIYNLKHL AKKFMKNILLPEGCELRIIKAASICSKNDIAYCTLLGNPKKIKNIAESNN IVLNSNIEIIDPKLIRKNYVERLCHLRRHHGITLAHANELVKDNSILSTL ILESKKVDGLVSGSIGTTSSIILPALQLIKTSPGSSLISSVFFMLLSDYV TLYADCAVNINPDATQLAEIAIQSSNTARLFGIFPKVAMLSYATGCSGFG DTVDKVKEATRIVQERSPNLIVDGPIQYDAAINRSVAKLKCPHSLVAGNA TVFIFPDLNSGNITYKAVQRSANILSIGPILQGINQPVNDLSRGSSVQDI VYTIAVTVLQSSLSH >bbp179 pth, peptidyl-tRNA hydrolase MKEIKLIVGLANPIKKYNDTRHNVGSWLVNSLVTQQNKKLKKNNKFLGYS TEINILSKNIHVLVPDTFMNLSGISVLAISNFYNIKLHEILVVHDELDLK PGNVKFRLRSSHNGHNGIRNVLAVLGTNIKFLRIQIGIGRPINSGYKISK FVLSKPNVSEKLLINRAILCAIRVIYDSINQRNVIMTESSLNSMLDHYMN SCVIHHN >bbp326 ptsG, PTS system glucose-specific IIBC component MFKNAFSNLQKIGRSLMLPVSVLPIAGILLGIGSANFKIIPHTISNIMTE AGSSVFSNMPLIFAIGIALGFTKNDGVSALAAVVSYGIMTKTLSITIPIF SNLSDINVNQKYLLDTGILGGIIAGSISAYIFNTFYRIQLPEYLGFFAGR RFVPIASGLISIIFGCILSIIWPPIGNVIKTFSEWAAYQNPTLAFGIYGT VERALVPFGLHHIWNVPFQMQIGEYNNSIGQIFHGDIARYMAGDSTAGKL SGGFIFKMYGLPFAALAMWHCANKKNKAKIGGIMMSGALTAILTGITEPI EFSFILVAPILYVIHAILAGLAFPICILLNMRSGTSFSHGLIDFIVLSGN SNNFWLFPIVGLFYGILYYGIFYFMIKKFNLKTPGREKSITYINQKTIKE TALLVISILGGKTNIINLDACITRLRITVLDISKVNQKKLKNLGASGVIV SGSGIQIVFGTQSDHIKTEIDNYMSNTNQ >bbp061 ptsH, phosphocarrier protein HPr MFQRDIKITTPNGLHTRPAALLVKEAKKFISEINIISNGKSANAKSLFKL QTLGLVQNSLITISAHGIDEKVAVEDLAKFLTTLK >bbp060 ptsI, phosphoenolpyruvate-protein phosphotransferase MISGILASPGITFGKALLLKNEILSINYKKISNQDIHQEVKKFINGKNKT ICQLQEIKNKTQQKFENTQSNIFEGHIMLLEDDEFQQKIISLIQDRNISS EYATKIIIEEHAKTLEQLNDEYLKNRAIDIQDIGNRLLKNILNIDIKDLN NIKNPVILIARDLTPSETAQINLKKVLGFITDLGGQTSHTSIIARSLELP AIVGTKNITEKAKNDDFIILDSINNKISINPSLEEIHRIKQKKKKYESEK KLLIESKNLYAITKDKHKVEIGANISTIQDINNAKKYGAECIGLYRTEFL FMNRNYLPSEEEQFNTYKTIAEEMKNKSIIIRTMDVGGDKNISYMNIPKE ENPFLGWRAIRIAIDRKEILHAQLKAILRASAFGKLRIMFPMIISVEEVR TLQYELEKLKQLLHHQKIPFNAKIEVGIMIETPASAIIAHHLAQEVDFFS IGSNDLTQYTLAVDRGNDLISHLYNPMSPSVLSLIQQVINASHKVGKWTG MCGELAGDEKATLLLLGMGLDEFSMSAATIPKIKKIIRESTFLDVKKLAK KVLLQPTYNEVNNTINTFININNKNK >bbp511 purA, adenylosuccinate synthetase MSVNIVVIGMQWGDEGKGKIVDFLATHADYVVRYQGGHNAGHTLVVDNKK IVLHVLPSGILHNNIISIIANGVVLEPQSFINEIKLLEAENLCIRKRIFI SESCNLIFPYHVFMDLAREKQKYRNFIGTTGCGIGPAYEDKVARRGLCVG DLLDLSFFSRKLEENVNFYNHQFTNFYHTEKVSFKEIFSNLLKVSDVIIS MINDIPDLLNNAINDNKSIIFEGAQGTLLDIDHGIYPYVTSSSSVSGSVC SGAGVGIKNLGDIYGVVKAYSTRVGNGPFPTELFGELDAYFCRFGNEFGA TTGRRRRTGWLDIVLLRRVISINSITKICLTKLDILDNLEKILICTSYHL KGVKNKKWDSVPFCRNDWDKIKPVYETFLGWKQNTRGITEFDELPKLAKK YIHRIEELIKVPVYIISTGPDRQDIIIRN >bbp244 purB, adenylosuccinate lyase MIASPLFAISPIDGRYSSKVIKLRNIFSEYAFLKFRVTIELLWLKKISLL QEFKIVYNKDVLNCLDRIIDNFSKKDALEIKILEKKTNHDVKSIEYFLQK KIFKCLGNHDILGLVHFGCTSEDINNLAYALMLKVSRRDIILPLWNKIIF EIKKIALLHHNVPMLSRTHGQPATPSTIGKELINFAYRLERQLKQFKNIE ILGKINGSTGNYNALHFSHSSVDWHKISQEFVTSLGLFWNPYTTQIEPHD FISEFFSCLARVNTILINFNRDIWGYISLQYFNQTPKLDEIGSSVMPHKI NPIDFENSEGNLGLSNAIISHLIEKLPISRWQRDLSDSTVLRNVGTVIAY SIIAYDSIILGLKKLKVNTSRLLQDLNHHWEILAEPIQTVMRKYGINDTY NELKNITRGKRVTSDIILKYVNSLKIPRNEKEKLLQLTPENYLGLSSKLV KIFNNSSELK >bbp032 purH, phosphoribosylaminoimidazolecarboxamideformyltransferase MKYTLKIMTNRNVIKNVLISVSDTSNIIEFSKSLISKNIKLFATKGTANF LKKNNIYATDITNYTNFPEIMNGRIKTLHHKIYASILAQPKHDKKTIEKY NIILMDIVVINFYPFEEASNNTNLHLNDIIEHIDIGGPAIVRAAAKNYKN VLVVTQPNLYQSIVNEMNLNNNIISETTKLKFATIAFKHTMNYDNNIYQY LSKKNKTVPKNTQLQTLLPSHLTINFKKKQDLCYGENKQQQASWYTNTSK NTSGRMKIKQLQGKILSYNNLSDIHLALSCIHEFNKTTCAIIKHGNPCGV ATAKNNDQAYKLAYETDPISAFGGIIVFNQKLNDVTARKIIKTQFSEIIL APDFTQEAKKIFDKKPNLRIIKYDPNYNYLNYNIDIKSIYGDILVQSNTN SIININQWDIVSKKRPNEQEINDAKFALRVVKHLKSNSIVLIKNQITISI GSGQTSRIDATKIAIYKANNNNISLNHTTLASDAFFPFSDSIDLISKSGI TCIVQPGGSIRDNEIIMSANKYNISMIFTKQRYFKH >bbp297 pykA, pyruvate kinase MIRRFRRTKIVATLGPSTDNHIILENMIKSGVNVFRLNFSHGTREEHIYR AKLVTSIAKRLNCHIALLGDLQGPKIRICKFQDKKVFLKVNNYFILDANL NENLGTSERVGIDYKNLPKDVKKCDILLLDDGKIQLKVINIVDQEIFTKI IIGGVLSNNKGINKLGGGLSARILTKKDKRDIITSIDIGVDYLAVSFPRY GSDLDHARKCAVKFGSKAKIIAKIERAEAVKDLKIIDEIILASDAIMVAR GDLGVEIGESELAGIQKTLIRRARQLNRVVITATQMMESMINNPMPTRAE VMDVANAVLDGSDAVMLSAETASGKYPIETIKVMSKVCMGAEKMPSINVS QHRIHDKFHDIEEAIAMSAMYAANHLSGITAIITMTESGKTSLMTSRITS GLPIFALSSHIQTLKLTALYRGVTPIFFNSSKEGVSAANEVINLLVKRGF LEPGNLVIITQGDIMGKVGKTNTSRILKV >bbp506 pyrE, orotate phosphoribosyltransferase MCKWKIQFLDFCLEKKVLKFGKFQLKSGKCSPYYFNSGLFNTGNDLQKLG YFYAKTIIESNLDYKAIFGVAYKGIPIVISTAIALRKYFNINIPYCFNRK ELKKHGEKGNFIGQKLTGKIILLDDVMTSGFSINDTINFIHSHANTKISG IIIALDRTRNINNKKNIQKNIEKKYNLKIFSIISILDIINYFKKKKHLHI YLKYII >bbp251 pyrF, orotidine 5'-phosphate decarboxylase MHLKSNFKNINIIIALDFFDENKAMKFIYNLNPTIYALKIGNIMFTLFGV RFIKILQKLGFKIFLDLKFYDIPNTIFGAIQAVANLNIWMVSIHISGGIQ MLKSARLALKPFKNKPLLMGVTILTSLDKTDMSKLGIQISLSKYILSLAK IAHKCNLDGIICSGTEISNIKKHINVKNFKILTPGIRLNGCSSNDQKNVT TPMLAKQYNVDYIIIGRIVTSSQNPLKTLELIRSQI >bbp376 pyrG, CTP synthase MKKRFIFITGGVVSSLGKGITTAALAAVLEARNLNVTIIKLDPYINIDPG TISPEQHGEVFVTEDGAETDLDLGHYERFIRTKMTRKNNFTTGSIYSEVL NKERKGEYLGATIQIIPHITNTIKKRIISCAHNVDIVFVEVGGTVGDIES LPFLEAIRQIAIDIGRENTIYIHLTLVPYISITKEIKTKPTQHSVKELLS IGIQPDILICRSQYTIPIQARSKIALFCNVLKESVISLINVDSIYKIPKL LNLQKVDQIICHHFKLKVPPADLSEWDEVIYNELNTNNVVTIGIIGKYIK SPDAYKSVIEALKHGGIKNKTVVKIKLINSEKIEKNGTNRLNCLHGILIP GGFGHRGITGKLITVEYARINNVPFFGICLGMQIALIEFFRNVIGLKDAN STEFSQNCQHPIISLIPKGNRNLPNINNNVKKKLGGTMRLGNQTCYLKQD SISHKLYGKNIISERHRHRYEVNNKFINKIEKYGLKITGKSKKNKLVEII ELSNHLWFIACQFHPEFTSTPRDGHPLFIDFIKAAIQYKKIKQK >bbp215 pyrH, uridylate kinase MIFSNNKKLKFKRVIIKLSGEALQGVHKFGIDIIELNRIAKEIKAIFDLG VQIGIVIGGGNIFRGKKLAKFGINKVISDYVGMLSTIMNGLLLCDSMDLV HLSSCLMSSICIDKICEQYSFKKALSLLRRNKVVVFSGGLGNPFFTTDSA ACLRAIEMRADIVLKGTKVNGVYSSDPKKSSNSILYKNISYNEVLQKELK VMDLAAFALARDHKLPICIFNINKPNALYYIVTGQKEGTLIR >bbp339 rbfA, ribosome-binding factor A MRFIDMQKLNRSFKISNEIKKKISWIICYQLCDPRLFNILISVSSVNLSR DFSYAKIYVSILNNKNISFKEILTILQNSSKHIRYLLAKGIFLRIIPTLH FCHDSSYVNGTKITNLINNVLYNK >bbp404 recB, exodeoxyribonuclease V beta chain MITTIPKSINVTTIPLSGKILIEASAGTGKTFSLTILYIRLLLGITNHVK YKKGLLIKEILVVTFTEHTRAELEIRIKTYIKIFKTACIKKYSNNYVLSK LLSKITDFPKTIDILSKAENSIHELSIYTIHGFCYKILKLNKFNSELMLQ NKILKHTYPLYLKISIKFWKYYFAFLSLDITSILLEYFNNPKTLLKEILP LLNKTQLISKLTKTKRKNIVQEYYILIKKIKLFKQKWANYSHLIHSEIIK TNVNKRIYTKSNLKRWINNITAWATQKQTKNFFIPSELKYFRYSFIIKKT TSEKILDDKFFKFIDTFLDSKFSLKEIFIIDASLEIKAMFMQEKIKNRYF EYDDLITFCWNMVNKNNFNISQTILKKYPVALIDEFQDTNNKQYNIFKKI YKKENLLILISDPKQAIYSFSGADITSYLQAKSNIKNQYFLDTNWRSSPK IINSINLLFSRLKNPFLTKNITFYPVKSSRINKTTKFEVNGKNQPALRFL LNKNKNISINEYKEWISITTAKYISYWISSGIKGNATITISNKVRTVNFS DIAIIVRNNLEAKTIQLELTKLNIQSLYLTSKNNIFQSKEILEILWILQA ILNPNIERLLKRAMSTNIMSKNTKEIISIPNNHSYWIKLSQEFNQYLIFW NNYGILYVIQQLIINYNISNNNNLLHNFSPNIKNILYIGELLEEKSITIK NKFLLINWLKKNITQDFYLTKPKYIKPNYEKNNYIKIVSIHKSKGLEYPI TIIPFATITFNKTVSTVEKICFNLNNTKIKKQKTLKIEKHKFSEDIRLLY VALTRSIIHCSIGISLAQTITQKKKIQKEKSKFKINVLRYIIQSGKNHIS TKKLYTELSILKKNKNIEIISEIPNIIKKNFQIPTLNTNSQSLMHYQVSR KFNYNYNFTSYSQLKKNIKPSTMYSTLNTKKLFELNVKKKHCFENKILTP HTFPSGKIYGTLLHKILKNISFHKSINSNWLLKKLSEYNLDKRWCLILKN WMYSILYKNLDKNYNLRLSKLDSKNYIKELKFLLPIKKKLTALKLNNIFQ THQCSSLENKLCFHPIQGILSGSIDLVFLWKTKYFLVDYKSNWIGNSNQS YSQQNIKKIIKKHHYNFQLQLYSLVLHRYLKQHIKNYSFYNHFGGTYILF IRSINEIPSQNGIFYSIPNIEIIKKLEQIF >bbp403 recC, exodeoxyribonuclease V gamma chain MFTLYKSLKFNLFVKSAFKVILNEPLLNPLTKEIFIVNNKETEQWIKIFI AKKYKVCTNIKFFKLKHFILNILKQNTPKLYSKSEFSKYSIMWKIINIPD IQHLLTKIVSKNNTYSTLFKIASSISNLFQLYLKYRPDYIKKWEQKSNIP KTRLKQKWQQIIWMRIIKYTKDANKPILHFSNLLYDSIKKMQRNNFINTK LPVRIFIFNITPITPQYAIFLKSISKYCSVHFFYATASYNDKQMFSTSFI KFKQTQEISNNQLLSLLHSKNKNIIYHEIENFQKNTKFQSYWITYEYEQM LFLSLIKDKTINLNFKIKQNSLLQYLQNKILNLHSIQKKNNEQENNKILI LKTDKSLSIHSCHTLIREIEVLHNNLLNILNDNNDILFQDVLVISKNLDT YIPYINQIFNSASSKNFIPFSINYKNIKNIEFYKTILELIDLPNIELNIN KITNLLNIPTLLKKVQINEQEIPILLQIINQTEIQWENDNILSNDWLSND ITKCWEHGLQRIFLGQIINNIDYKFWENIVPYNEFSTLYYNIFNKLISLI SLLNKWKKILSKPKFLSHWDITFKKLLNDFFTDHEQKQPEAKLIIKKWTE IIHSGMQEKYTKKISITLLKNELCNSVSYISQSNYLFSGKITFCNNFTLT NIPFKIIYLIGLNDNISSNTHESFDIYNLLKLHPRAYDPCDEINHKNLLL KTLLSAKKFFYISHQIVSNNYKKLNNIPIAIDKIIKYITQYFYIKNKNKD NFNDNLKDIKSHIYHNYTFYAHEKRNFLEKLNYPNFNTTIWKMATLINNS HKEFIKKLPSIKNQTINYNTLILFWKNPIQTFFHVRLNIQLNTTKNKHMH QNKHFINKLDQYKMNKTLLKFFLYKQNTNQLFQYYKNIGIIPNNNIGNII WEYTKKLITPLYDQIMKIKKILNNSKFCINVKNKCMLHGQLKNINSSGGL LRWKATKLSFQDIISCWLEHLLYCSLYKKHNSILIGTNHQIITFYKLENK TAKYYLKKYISGYFDGMEQPILLTKSGINWINAIYDKKNNKFYTNTNKNL NAYKIFLNTWNGNNWITGEKDDPYIQKMIVYLTKKNIQKIYKTTKKWLTP ILKNISYSKYH >bbp405 recD, exodeoxyribonuclease V alpha chain MTITSILQKMVKLKIITSSNFYLSTMLFNKNTLATFLSICVNHFTNHGHV CLPHVLIQHQKIFFTNHIALITKLWEIAKINTCGWIEQLLNSNTISNGSK NTPFIFYKNNFYINKFWLAEQKILKFISQKQNFKLINKNKIQKILKNIFN TNIDDTQKLAIILSIINNITFIIGGPGTGKTTIILKILLVLIRLHKKKIN IKLTALTGKAANRLSESIHENIKKLNLTEHEKNIFNQKTTTLHNLLDLKP NKSFNYSCCKNKLYNLNLLIIDEASMIDITIMDKLISSIPKTTKIIFLGD YNQLPSISGGNILKNICSYYQEGFSTTTNKFLKQLFPNRITIKTIKKHQF SNINDKIIMLKKSYRFKKKSDIFKISEMLTKNKINNIKTLYQNINNDVNF KQISSKTNYNNIIFEITNSYSKYWSALKQSLPFLKIINIFNNYKILCILK NGLFGITELNLAIEKEMKKIGWIKKVTIINGQTWYFGKPILILKNNEEMN LFNGECGLTLLDANKKLKVFFLPKNQEQIYSIPIHLVPEHQTNWTMTVHK SQGSEFSEVVLILPTIMTSILTKELIYTAVTRSKKKLTIYSDENIFIKSL KKNIIRYSGLSIHQKIKF >bbp540 rep, ATP-dependent DNA helicase Rep MLFNEHQKKAISYISGPCLILAGAGSGKTRVIINKIVHLIKICHFDPKCI TAITFTNKAACEMKSRILNVLSVNVSNLVKISTFHALGLEIIKSEIELLN IKSNFTIFDEQDQISILQEIVSKEDRSFVRQIRQSISNWKNKLLCPNQVN KISNSSIEFKFFRYYELYNAYLKSSNILDFDDLIFLPTILLRDNKLSRER WNDKIKYLLVDEYQDTNFIQYKLIKLLSSKRSNFTLVGDDDQSIYSWRGA NIHNFESLKHDYPNLRTIIMQHNYRSSGRILKVANALISNNLHFFNKKLF SNLDYGSIVEIISAKNEEDEARVILQTLMLHKSNYNAQYKDYAILYRSNY QVKIFEKFLIKFKIPYKILANISFFSRPEIKDLIAYLRLIINPDDNAAFL RVVNRPLRGIGAVTLQKLKEWSKKRNQSFFMASLDIGLESILPVHNLKSL QEFVYLIQTISYQIQLNPIEVLEKLVATIKYEKWLMRSLKFSKLYVASIK NISIVLNWIINELKYKIMNSKKFVMKYLIDIISEFILQNSLNEDIVINND YVQLMTLHASKGLEFLYVFIVGVEEGVLPYYRNTTMENNIDEERRLAYVG ITRAQKKLFLSYAIQRCQYGVVINTKPSRFLRELPQSDILWQKSKILNLN EKNNFLFKAYKKSLKKKLLR >bbp538 rho, rranscription termination factor rho MNLTALKNIPVSELIFLGDNAGLENLARMRKQDIIFSILKQHAKSGEDIF GDGVLEILQDGFGFLRSSDSSYLAGPDDIYVSPSQIRRFNLRTGDTISGK IRPPKEGERYFALLKVNKVNYDKPENARSKILFENLTPLHANSRLRMERG NGSTEDLTARVLDLASPIGRGQRGLIVAPPKAGKTMLLQNIAQSIAYNHP DCVLMVLLIDERPEEVTEMRRLVKGEVVASTFDEPSSRHVQVSEMVIEKA KRLVEHKKDVIILLDSITRLARAYNTVVPASGKVLTGGVDANALHRPKRF FGAARNVEEGGSLTIIATALIDTGSKMDEVIYEEFKGTGNMELPLSRKIA EKRVFPAIDYNRSGTRKEELLTKSDELQKMWILRKIIHPMSEIDAMEFLI NKLAMTKTNNEFFDMMKRS >bbp252 ribA, GTP cyclohydrolase II MKLTKISEAKLPTSFGEFLMIVFEESKTDKNHIALVYGDIKDTNNSVLSR IHSECLTGDALFSIRCDCGFQLKSALMEIVKEGSGILIYHRQEGRNIGLS NKIRAYALQDIGLDTVEANHHLGFSADERDFSVCIDIFNTLNIKKIKLLT NNPSKVTVLNNAGIQITERISLIVGRNAKNSKYLNTKAHKMGHFLPIEY >bbp056 ribB, 3,4-dihydroxy-2-butanone 4-phosphate synthase MTQNLLDQFGTPKTRVKNAISALRYGHGIIVLDNEDRENEGDLIFSGETM TTEQMALTIRYGSGIVCLCITESKRKQLKLPMMVQNNTSKFGTNFTVTIE AAEGISTGVSAKDRLTTIRAAINDNAKPSDLNRPGHIFPLQAHKNGILGR IGHTEAAIEFVTLAGFKPAGIICELTNRNGTMSKVPDIIKFSKLKKMTIV TIRDLIQYISR >bbp408 ribD, diaminohydroxyphosphoribosylaminopyrimidinedeaminase MKDIFYMKKAIKLAKKGSLTTSPNPNVGCIIVNNNIIVGSGWHKKTGMKH AEIYALKTSGEKAKGATAYITLEPCSHFGKTPPCCVALTKYGISRVVIAT LDPNPKVSGNGVKWLKKHGILVTIGTLSKESIKINKGFFQRMTTGIPWIK LKLASSIDGRTALNNGKSKWITSDKARHDVQHVREKSDAIISSSETILFD NPLLTVRNTNNNDNNQKLLKHSKTFLKQPIRVIIDSKNRITPSHKCIKQP GLLFLIRIHSDNNIWPSHIKQIILNNKSKKIDLIDLVKMLAKYQINNILI EAGPSLSSSFLKLNIINELIIYIAPKILGNYAKPLFFLENYSNLSDVPQF KFEKITQIGKDLKLILTKHNSS >bbp107 ribE, riboflavin synthase alpha chain MFTGIVRGLGKVVKILKEKKISQWEVETSNELVKNLMLGASISCNGCCLT VRNIFRTIFCVDIVEETLRSTSLNTIIVGQYINLERSIKFGEEVGGHLVS GHIITTGVVSDKKELFSNQELWISLSASFFIKYFFYKGFVCVDGISLTIG SIKNNAFCVFLIPETILRTTIGQKIIGDVVNIEIDFYTQITVDSVERLLK VHPSKFINCIDI >bbp407 ribH, 6,7-dimethyl-8-ribityllumazine synthase MKIVQETISTKTKKNIAIIISRYNNFINQHLLDGALDILKRIGQINQKNI PIIHVPGAYEIPIIASIISKQKKYNAIIALGTIIKGHTLHYSHISHAVNS GLTNISITNNIPISIGIITANNIEQAIERAGTKLGNKGSEAALTALEMIN IINILAQNK >bbp358 rimM, 16S rRNA processing protein rimM MTKKFLNIHLTIAKFGAAHGILGWIRVFSYTEKKENIFDYVPWFIKKEQK IIKILPKYWKILKKTFLVKINDVNNRSMAQKLTNYDILINQKTLPKLNNN EYYWKDIVDCTVFDTNFIKLGRVSELIRTPSNDILVVKASNIKNISQNDM LIPFLHPQIISEVNINNKKIVIKNWKQTFE >bbp318 rluC, ribosomal large subunit pseudouridine synthase D MTNQFSSTHFLNITENSEKQRIDNFLRKTFKRLPFNLICKIIRTGQIRIN KKRINQNYKLKLGDSVRIPPITIQSDSNKKIKLNTRLSIIFNNMILYEDN YFLILNKPSGMSVHSGSGINYGMIENLRILRPYNRYLDLVHRLDRDTSGV LIIAKKRSILRNLHEQLREKKIKKKYVALVHGVWPDILKSISKPLLKTSS RKNKNIVKIDPKGKESITHFNIKKKYTKNTLISITPITGRTHQIRVHLLH LNYPIVLDAKYGIKKLDYFIKNKFNINRLLLHAESINFFHPKRKKNILIT APLDYVFKTVLKNLI >bbp363 rluD, ribosomal large subunit pseudouridine synthase D MQNKLKLIAIVPKISLLKNRLDQVLASLFKKHSRTILKRHILSKDVCVNG RILDQPDAKVLYKDIISINLKFKAKNDYQAENIFLNVIYEDDDILVINKQ DNFVVHPGAGNTSGTLLNALLHRDSTFFNIPRAGIVHRLDKDTTGLMVIA KNNLSYMALIDQIKCKKVIREYQAIVYGKVISGGTIVKSIIRNPIKRTTM IVNKCGKRAITHYRILKRFTHHTHLKIILETGRTHQIRTHMLYINFPLVG DKTYGNKFKFYKNISLTLLEQVKKFPRQALHASRLCLYHPVTKHLMEWNS TLPRDMLNLIALLNKNI >bbp247 rnb, exoribonuclease II MLRNHPLLSKLKRKLNSNIPRVEGIVKSTEKGFGFLEIDSKTSYFIPFKN MKKVMHGDRITALLKIDNSREIAEPEKLIEPFLTRFIGTIQVNKSIISII PDHPFFKEKIVCSVSCILPKCVKTGDWAVAVLMQHKLIQGHYKFLAKLVK YIIKKDDVLVPWLVTLSRYQLESDCFKLNSSSIIFDNSLKREDLTHLDFI TIDNSSTKDIDDALYVEKQSLGAFNLIVAISDPTSYIPFGSSLDNFALKR SFTNYLPGFTIPMLPSELSENKCSLKVNKSRPVIACKIRIDSDGCILHNY SYFFLAWIKSKATLVYECVSDWLEHKGKWVPECSNIANQLFMLNSIYNIR RNWRKNYAVLFKEHPEYNFKLSSNFQVLNVFMEMRRTAHKIVEEAMIAAN ICAAKVLSEKLGFGIYNVHIGFDASNSENVVRLLSKYGFNFCKDEIRTLK GFCKLRRILNKHSYKYLDNRIKKYQSFGELQFFPGPHFALGLDAYATWTS PIRKYSDMVNHRLLKSIITHTHVIKPSCDILLKINDRRKRLKMAERDLED WLYSKFFSSIEYTKNSFNAEIIDVFRSGIRVRSLKNGANIFIPSSFLHNI RNELLCHQDQGIVYINDKKMYSVSDIIQVKLINIRTQTRNLIGKPV >bbp239 rnc, ribonuclease III MNHTVIQKLQKILGYTFIKKDLLIQALTHRSANSKHNERLEFLGDSILSF VIANALYHCFPHVNEGDMSRMRATLVRGHTLAKIAYEFDLGDYLQLGQGE LKSGGFRRESILANTVEALIGSIFLDSNLKTIEKLILKWYKNRLKAINPS DTQKDPKTRLQEYLQSKHLPLPSYLVEQVYGEAHNQLFTIYCEISGINEK TIGIGSSRRKAEQEAAQNALIKLGIE >bbp317 rne, ribonuclease G MRRMLINAIEIKKLRIALIDGQQLYDLNVENIDKKQRKSNIYKGKIVRIE PSLEAAFVDYGEKKNGFLPLKEISRNYFPNNCSNYRHLHIKNILKEGQEC IVQIDKEERGTKGALLTTFISLAGNYLVLMPNCPHLEGISRKIEGIDRFH LKKIISMLMVPENMGIIIRTSGVGRSIETLQLDLNFRVKNWYTIKKSAEI NTAPCLIHKESNIVIRTLRDYLKKDIQEIIVDNPEILELARDYMFNMNCS YFEKKIKLYTGSDPLFSYYKIESQINALLRRIVKLPSGGSIIIDYTEALT AIDINSSQSTKGVNIEETAFNTNYEAVREIARQLRLRDLGGLIVIDFIDM SVLKHQKMIELHLHQVLQKDRARVQVGSISQFGLLEMSRQCLGSPLKKIN HNYLFEMQKC >bbp108 rnfA, electron transport complex protein RnfA MVMHFFLLFVSNILINNFILVRFLGLCPFMGISRTIDSAIGMGLATTCVI VFVSIISWLINFYILIPFHLIHLCTMTYMLIIAVSVQIFEIIVKKVSSTL YRLLGIYLPLITTNCSVLAIPLMNTKLNSNFIESVLYGFSSSLGFFLVLV IFSSIRERISESDVPMYFRGYPIALITASLLAIAFMGFDGLIKF >bbp109 rnfB, electron transport complex protein RnfB MIISIIIFSILSFILGVIVSLVSCFCKVKSNLSLINDIDELLPQMQCAQC GYPGCYAYSQAIVDGNENIYKCIPGGKEVVLKLENLLNKSDHRGNFLESL EDSVTYSIVEIDENNCVGCSKCRLVCPVDAVVGTYNFRHTVLIDSCTGCN LCIPLCPTNCIKKKIMFYE >bbp110 rnfC, electron transport complex protein RnfC MYKFIKYISIYIKKLFFLNISFFKKVISIFQVDNILFLKKSSQELLKLSR VTLPKKFFVLINSEVLNRGKLCVRKGDLVLRGQTLTLGCGNIVSIHSPTS GRIIDVINNYIFFLDQFFAVVIVESDGRDLWISRTPICNYTQFSSKKLIN LIYHSGILGLSGSGFSTSKKLQCAVGKVHTLVVNAVESEPCVTSDDCLIQ NFSKEIIDGCKILIWILKIKKILIVVSEEKIIAFNVLKKSVINLKDFELL KVKNKYPSGSSKKLIQILFNKEIPQGKHAIDLGIIMYNVATVFAIKKAIL DGEPLTERVITLYGDKFLPSKNVLVRIGTPISHLMKIYKLNEKTLKVNIG GPITGLLIRNFNFSVLKTNNCIMFVSIQNNELNNFEEKNCIRCAACSYSC PMNLLPEQLYWYSKHSNHEKTQIYNIQDCIECGICEQVCPSDIPLMSYYR REKKQISIAKFKNYQIKKFKNLFLLRKQRLNNLNSRKKNTIVSQYIALNK FNFKV >bbp111 rnfD, electron transport complex protein RnfD MKYMRHFLDFYHHKNTSEIMLLVFCAAVPGICTEIYYFGFGVLFQILLSV FFSVSFEFLVKRLRKQTVKSLFSDNSAAVTGVLIGISLPSLSPWWLSFFG AFFSIVIAKQIYGGLGNNIFNPAMTGYSILLVSFPILMTNWSFQNSSYFN LFDLNNTFSVIFCTDINHYYSLIDEFQMMYKFITQATPLEQIRTHVLDFN NKIDNIFEFVNYNYYFKNWKWISINISFLIGGIVLLGFNVICWRIPVSIL FSLYVFFALDYYFFKKSMYYPIMQLFFGSTMFSVFFIATDPVTTSITKIG RIVFGCIVGFLIWLIRSFGNYPDAIAFSILLSNSIVPLIDHYTQPRVYGY VKKK >bbp112 rnfG, electron transport complex protein RnfG MLKKNNKRKIFCSALVLGSFGFLAASFVSIIYVITKNKIQYQEQRYKNII FNHIVPSNLHDNDIQRSCLILNNKLLGDKKNHYLWLAKKKQDITAVIFET IAPDGYSGIIKMVISLDIKNGKILGVRVLSHNETPGLGDKIDVNISNWIT KFSGVKIFSLDERDLSLKKYGGNIDQFTGATITPLAVVNSIKRTIVLVKM LLSSKFSELTSCDNYE >bbp229 rnhA, ribonuclease HI MLKTIKIFSDGSCLGNPGPGGYSFIIQHLEYENISSSGFYLTTNNRMELM GIIVATESLKQPCCITISTDSQYVQKGILYWIKNWKTKGWKTSRKTYVKN VDLWLRLEKSLNLHQVTWKWIKSHSGNKKNEQCDHLARESAKFPTLKDFG YIL >bbp014 rnpA, ribonuclease P protein component MIEFYFNKKRRLITPNDFNYVFKSPNVIRCKEITILGRLNLLSFSRLGIS VSRKNVKYAYQRNKIKRLIRENFRIIQHRLVSSDFVVIVNSSSMQISFKL LAKKLENLWSYYYQ >bbp177 rnt, ribonuclease T MCYSKINNSLRKRFRTFYPVVIDIETAGFNPETDAILEIAIITLKMNEFG LLEKEHLLHFHIQPFKGSRIDKKAIEFHGIDPFSPLRRAISEYEALYSIF NLIHKGIKSNNCTKSIIVAHNAIFDYNFLTAAITRTKIKNNPFHSFVIFD TATLSGLAVGQTVLARACKAIGLTFDNNQAHSALYDTQQTANLFCKIVNR WKTLGGWPPNDTRTIKL >bbp479 rpe, ribulose-phosphate 3-epimerase MKKFLLSSSVLSANFSRLGEDIFDVLKSGSDMIHYDVMDNHYVKNLTFGP IVLESLRSVEKIKSMVIDVHLMTCPVDDLIIKFAKLDVNIISFHPESTNN VEKTIKLIKSYGCKVGLALNPLTPLCVLDNVLDKIDLILLMSVNPGFPGQ KFIPSILNKIRIVRELIDKSKKNILLEVDGGINLSNIFKIASFGTDIFVI GSAIFNSINYDLTIRSFRDVLKNINCKK >bbp371 rpiA, ribose 5-phosphate isomerase A MKTNELKRLVARKVVDYINPGSVIGIGTGSTVSYFIEVLSTIKNLISGAV SSSNFSTACLKRIGIPIYDLSKINSLVLYIDSADEINPQLQMIKGGGAAL TREKIIAATAEKFICIADESKQVEILGKVPLPIEIIPMARSYISNEIIKI GGMPKYRKNVITDNGNVIIDVFNLVITDPVCLENKINSFPGVVSVGLFAT RKADIALIGTSSGVQVIY >bbp038 rplA, 50S ribosomal protein L1 MKKLTKKQNLFKTFLNHTKKYDIDEGITLLKKMATSKFIESLDVAINLGI NPKNTNQNIRNTTILPHGIGRLIKVAVFTQGENEKIAKKFGAEFVGLHNL IETVKTKTILFDVAIATPDVMPYVSQLGPILGPRGLMPNPKLGTITEKLE YAIKNAKSGQIHYKNDKNGIIHISIGKINFENTKIKENLNALISSLKQSK PSQSKGTYIKQVVISTTMSSGIKIDLNTLNNAS >bbp464 rplB, 50S ribosomal protein L2 MAIIKCKPTSPGRRHAIKVVNPSLYKGKPISSLIRKNSKSGGRNNCGRIT TRHIGGRHKRFYRIIDFKRNKDNIPAIVERLEYDPNRSSNIALILYSDGD RRYILASKGLMVGSKIVSGFNAEIKIGNALPMKNIPIGTVIHNVEIKPGK GGQIARSAGTYVQLISRENSYVTIRLRSGETRKLESKCRATIGEVGNSES MLRVLGKAGASRWRGIRPTVRGTAMNPVDHPHGGGEGRNFGKHPVSPWGL QTKGKKTRKNKRTEKFIIRHRHK >bbp467 rplC, 50S ribosomal protein L3 MMGLIGQKLGMTRIFTEEGTVYPVTIIKVKENRITQIKTISRDLYHAVQV TTGIKKSNKLLKPEIGHFLKSGVKIGKGLWEFKLTNSSINDFKIGQSLNL ELFSNIKKVDIIGTSKGKGFCGTVKRWNFHTQDATHGNSLSHRAPGSIGQ NQTPGRVFKGKKMAGHLGNHRVTVQNLDIVKIDLNQEIILVKGAVPGYSG GNIIIKPAIKTRGV >bbp466 rplD, 50S ribosomal protein L4 MELVLRDDEHSVLNVSDITFGRDFNEALVHQVIISYSSSIRQGTHAQKNR SEVSGSGKKPWRQKGTGRARVGSLRSPLWRSGGVTFAAKPKSFYQKINKK MYRGALKSIFSELIRQKRLVVFREFTIEFPKTRLLIDKLRDIKLHDVLII TKTKDNNLKLASRNLYKVDVQTVNHMNPRSLISFNHVLITSKAIQKVEEL LT >bbp455 rplE, 50S ribosomal protein L5 MVALYDYYKNSISKKLMLNFNYSSVMQVPKIDKITLNIGVGIATIDKKNL DFAISDLTKISGQKPLITKARKSIASFKIRKGYPIGCKVTLRGNRKWDFF ERLIFIVIPRIRDFRGFSNKSFDGKGNYSIGIKEQIIFPEIDFDKIDRIR GINITITTTALSDREGYALLSAFNFPFRT >bbp452 rplF, 50S ribosomal protein L6 MSRIAKQPIVIPSDVSITLIGQMVIVKGSKGELKRLIHDSVLVKSVKSCL VFSSRINSSVKGWAQAGTARSLVNSMIHGVTVGFFKKLKLFGVGYRISIN SSKNLNMSLGYSHIIEYVLPFGIFVESISQAEIIVKGINKQLVGQVAANL RAYRKSEPYKGKGIRYSNEIVRVKEAKKK >bbp508 rplI, 50S ribosomal protein L9 MQIILLEKLDNLGNKGDILFVKSGYARNFLIPYGKAIFATKDNIKFEINK KEELERELIKKISIAKTKCEKIKNIKSIVIPAQVGIEGKLFGSVGSRDIA KKLSELSNIKIKKHEIYFLNGALKHVGQHKVIFKPHHSVSITVEINIVSQ DKDK >bbp037 rplJ, 50S ribosomal protein L10 MMLDFKKKKELVTQINLIAKTALSIVVANPQGIKSNDITQLRKLARKSNV KLGVYRNTLLNLGIKNTPFECLKNILIGPTLIAYSSEHPGSAAKLLKNFS MSQSSNPNFKILGAVFEGKAISGSNINSLADIPTFNEALRRFIIIAKEIS AGKLLRILVSIKNIKENS >bbp039 rplK, 50S ribosomal protein L11 MAKTIQAYIKLQVSAGTANPSPPIGPALGQKGINIMEFCKAFNTRTNNLE KGLPIPTIITVYSDKSFSFITKTPPASVLLKKAAGITKGSSKPNQNKVGT ITMQQILDIAQIKKIDMTGSNIDNISKSIIGTANSIGLIIAEGTNK >bbp036 rplL, 50S ribosomal protein L7/L12 MSITKEQILDAISEMSVMNIVELISDMEKKFGVSSIIPSSSTSTQNIETA EAKTEFDVLLKSIGGNKVSVIKAVRSATGLGLKEAKDLVESAPTIIKERI TQDAAESLKKILNETGAEVEIK >bbp354 rplM, 50S ribosomal protein L13 MYIKSFSAKSNDFKKMWYCIDATGKILGRLATNIASRLRGKHKVEYTPHV DIGDYLIVINAKNIKVTGKKCTDKFYYHHTGYVGGLKKIAFKDMLHRYPE RIIEIAVRGMLPKGPLGRSMFKKLKVYANDNHNHSAQNPKILNI >bbp457 rplN, 50S ribosomal protein L14 MIQEQSILNVADNSGARLAMCIKVLGGSRRRYAGIGDIIKISIKEAIPRG KVKKGEVFKAVIIRTKKGVKRSDGSIIRFDTNACVVLNNNDQPIGTRIFG PVTRELRNDKFMKIISLAPEVL >bbp448 rplO, 50S ribosomal protein L15 MYLNTLSPNSKSHKKSKRVGRGIGSGFGKTSGRGHKGQKSRSGCKIRRGF EGGQMPLYRRIPKFGFVSLKKEKVAEVRLEDLKNFSNCIINLQFLKKTGL IKKNIKYVKIISSGSIITNILIIRNLFVSKSVRNIIESSGGKIEENN >bbp460 rplP, 50S ribosomal protein L16 MLQPKNTKFRKMHKGKNRGLAIGTNVHFGLYGLKAITRGRLKSSQIESAR RAITRAIKRQGKIWIRIFPDKPITKKPLEVRMGKGKGNVEYWVALVQPGK ILYEISGVSEELSRIAFKLAAAKLPVKTMFVTKLVM >bbp441 rplQ, 50S ribosomal protein L17 MRHRKIGRRFNKSATHVKAMLKNMVCSLFRYEMIKTTVSKAKELRRVAEP LITCAKIDSVANRRLVFSRIRDNKIVFKLFRDLGPHFLGQFGGYTRILRC GFRSGDQAPMAYIQLINRVKNKKELVYKK >bbp451 rplR, 50S ribosomal protein L18 MIISINKKKARLRRAARTRFQIKKLHLIRLVVHRTSKHIYAQIIDSKNAL VLTSASTVEKEILNLVKYTGNIHASICIGKKIAERALMKGIINVSFDRSG FQYHGRVKALADAARESGLKF >bbp360 rplS, 50S ribosomal protein L19 MNYIQKYEKKQIKKTIPIFKSGDTIIIKVWIVEGTKKRIQLFEGIVIAIR NRGFNSSFCVRKVSNGEGIERVFPKYSPIIEEIIVKRHGDVKKSKLYYLR NRIGKSAKIRELISKKTS >bbp122 rplT, 50S ribosomal protein L20 MAHVKRGVIARARHKKVLKQAKGYYGARSRTYRTARQAIIKAGQYSYRDR RQRKRYFRKLWITRINAAVRENQISYSKFMYGLKKASIAVDRKMLSELAI FDNVSFCSLIKSSKDALTSIELNKNL >bbp350 rplU, 50S ribosomal protein L21 MYAIFKSGGKQHKVIKGQTIRLEKINQSIGTQIKFKKILMCCNGTHITIG KPHIHNNFILANIINHGRHKKIKIIKFNRRKHYKKQQGHRQNFTDVLITN IHNNYREQNNGS >bbp462 rplV, 50S ribosomal protein L22 METIARHSQARSSAQKLRLVADLIRGKNIEHALNILTFCNKKASILVKKV LKSAISNAEHNHGSDINNLQVKKILIDEGPTMKRMMPRAKGRSDRILKRT SHITIVVSDSKVKDKKGRG >bbp465 rplW, 50S ribosomal protein L23 MIYEKILLKVLLGPHISEKSSTLSGNFSTVIIKVSICATKLEIKRAVQNM FNVAVKNVNTLVVQGKCKRKKSRITCSSNWKKAYVTLKRGQNINFIGSSE >bbp456 rplX, ribosomal protein L24 MAAKIKKNDQVIVLIGKDKGKIGIVRKVIAKSKVIVEGVNIVKKHTKPSP SQNKKGGIVEQESSINISNIAILNPTTKKSDRIGFRVKNGKKVRFFKSNN TICN >bbp129 rplY, 50S ribosomal protein L25 MLTIYGISRTKCGKKASRRLRLQNKFPAIIHVSLISNISIELSQNDFINI EMKNSDFYKSEVILIVDKVKYIVKIQEIQRHAFKSKILHIDFLKVSV >bbp351 rpmA, 50S ribosomal protein L27 MAHKKAGGSSRNGRDSHSKRLGVKHFGGETIRSGSIIVRQRGTKFHAGNN VDCAKDHTLFATSQGKVKFEKKGKCNRTYVSIIPE >bbp080 rpmB, 50S ribosomal protein L28 MSKICQITGKKPITGNNRSHAMNATKRRFFPNLHFHKFWNPKTKRFIILR VSAKGMRNIDKLGLNSLKIKKLHK >bbp459 rpmC, 50S ribosomal protein L29 MKKVEIKKKTIKELNIELMNLLREQFNLTLQHSAKKLQQSHLLQHVRRNI AQVNTILAEKEKECD >bbp449 rpmD, 50S ribosomal protein L30 MIKLISITQIKSSIGRLPKHKATLSGLGLRYIGHTVLRKNTPSVRGMIKL LSFMLRIN >bbp522 rpmE, 50S ribosomal protein L31 MKKKIHPDYFKINVTCSCGNNINIFSTLSKNINVDVCSKCHPFYTGQQRT SDTGGRIEKFHKRFNISSH >bbp319 rpmF, 50S ribosomal protein L32 MAVQKNKPTRSKRGMRRSHDYLKIPLLSKDKLSGEIHIRHHITKNGYYKG KKVI >bbp079 rpmG, 50S ribosomal protein L33 MAKSSREKIKLISSSGSKHYYTTTKNKKAPSKKIELKKYDPKIRKHVLYK EAKIK >bbp013 rpmH, 50S ribosomal protein L34 MKRTFQPSTLKRNRSHGFRARMSTKNGRHILSRRRSKFRTRLTVSSN >bbp121 rpmI, 50S ribosomal protein L35 MPKIKTLRSAAKRFKKTESGKFKRKQAHLRHILTKKNTHYKRHLRSKVMI SKKDIQKVRLFLPYL >bbp446 rpmJ, 50S ribosomal protein L36 MKVRTSVKKLCRNCKIVRRYNVVRVICKSEPKHKQRQG >bbp442 rpoA, DNA-directed RNA polymerase alpha chain MQSSVTEFLIPRLVNIEQISMTHVKITLEPLERGFGHTLGNALRRILLSS MPGFAVTEVEIDGILHEYSTKEGVQEDIIEILLNLKGLAIRVYGKDQVYL TLVKTGIGVVTAADINHGNDVEIINLDHIICTLTCKNASISMRIKVQCGR GYVPVISRTNVISDNKENYVGKLLVDACYSPVERMIYKVEAARVEKRTDL DKLVIEMETNGTLDPEEAIRRAATILSNQLESFVYLRDIREPEIKEEKPE FDPILLRPVDDLELTVRSANCLKAEMIHYIGDLVQKTEVELLRTPNLGKK SLTEIKDVLAAKNLSLGMNLENWPPDNILDN >bbp035 rpoB, DNA-directed RNA polymerase beta chain MVVYSSTEKKRIRKDFGKRPKVLDIPYLLSIQLNSFQKFIKHDPNGIHGL ESAFRSIFPIRSYNGNSELQYINYKLGQPIFNVKECQTRGMTYSSPLRVK LRLVIYEKETLDITVKDIKEQEVYMGEIPLMTTNGTFIINGTERVVVSQL HRSPGVFFDSDKGKTHSSGKVLYNARIIPYRGSWLDFEFDPKDNLFFRID RRRKLPISIILKALNYNTEQILDTFFKKNIFKFTENSILMKLVPHRLRGE TASFDICIDNKTYIKKGQRITARHINILKEKKIHTIKVPTEYLIGKISAK NYFNKKTNEIIVSANTELNINIIKELKNNEYTNIETIFTNDLDHGPYISE TLNIDPTHDKLSALVEIYRMMRPGEPPTREAAENLFENLFFSEERYDLSS VGRMKFNRSLQKQNITERGVLNQSDIISVIKKLIDIRNGHGEIDDIDHLG NRRVRSVGEMAENQFRIGLIRVERAVKDRLSLGDLDMLMPQDMINAKPIS AAIKEFFGSSQLSQFMDQNNPLSEITHKRRISALGLGGLTRERAGFEVRD VHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNSYGFLETPYRKIHNGKV TNEIKYLSAIEEGNFIIAQANTNLDETGAFVEDLITCRYKGESSLFNKNQ INYMDVSTQQIVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRSEKPL VGTGMERAVAVDSGVTIIAKRGGIVQYVDASRIIIKVKKNEINSEEAGID IYNLKKYTRSNQNTCINQIPCISLGENVEKGNVLADGPSTDLGELALGQN MRVAFMPWNGYNFEDSILISEKVVQEDRFTTIHIQELACISRDTKLGSEE ITSDIPNVGEAALSKLDESGIVYIGAEVNGGDILVGKVTPKGETQLTPEE KLLRAIFGEKASDVKDSSLRVPNGVLGTVIDVQIFTRDGVKKDKRALEIE EMQLKQAKKDLTEEQKVFELGLFTQIKSTLINSGMNIDQLNKIPKSELFK VKVTNNLYQKKIHKLFLKYEELKKCFNKKLETTRNKITQGDDLAPGVLKI VKVYLAVKRHIQPGDKMAGRHGNKGVISKINPIEDMPYDQNGLPVDVVLN PLGVPSRMNIGQILETHLGLASKGLGNIIDTMLKQQKSILNIRKFIQKAF NLGNNTRQKTNLNNFSDDEILSLAKNFKNGIPISTPVFDGAQESEIKALL KLADLPSSGQITLFDGRTGEKFERPVTVGYMYMLKLNHLVDDKMHARSTG SYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVN GRTKMYKNIVDGNYKMEPGMPESFNVLLKEIRSLAINIELENE >bbp034 rpoC, DNA-directed RNA polymerase beta' chain MKDLLKIFKSQIKTDEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFK PERDGLFCARIFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQSKVRRE RMGHIELATPIAHIWFLKSLPSRIGLLLDMPLRDIERVLYFESYVIVNEG LTNLEKNQILSEEQYLNALEKFGDEFDAKMGAEAIKLLLNSINLKQECNK LRDELNNSNSETKRKKLTKRIKLLESFIHSNNKPEWMILTVLPILPPDLR PLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLELSAPDIIVRNEKRMLQ EAIDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYS GRSVITVGPYLRLHQCGLPKKMALELFKPFIYGKLEKKGLATTIKAAKKM VEREESIVWDILDEVIHEHPVLLNRAPTLHRLGIQAFEPILIEGKAIQLH PLVCAAYNADFDGDQMAVHVPLTKEAQYEARSLMMSTNNILSPANGEPII VPSQDVVLGLYYMTRKKINAKGEGMIFKNSKEAEKSYQMGFSELHAEVQV RITEYKKIDKQNFLKNTKIENTTIGRAILWMIVPKGLPFFMVNKILGKKS ISKLLNTCYRILGLKSTVNFADQIMYTGFNYAARSGSSVGIDDMEIPKKK SDIISEAEIEVSEIQEQFQSGLVTAGERYNKVIDIWAAANERVSKAMMKN LSTESTTNKQGNEEKQISFNSIFMMADSGARGSAAQIRQLAGMRGLMAKP DGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRL VDVAQDLVVTEDDCNTHKGIIMTSVIEGGDVKESLREKALGRVTAENIIK PYSSDILITRNTLLNEKWCNVLEKYSIDSIKVRSVVHCDTNFGVCANCYG RDLARGNLVNKGEAIGVIAAQSIGEPGTQLTMRTFHIGGAASRAASESSI QVKNSGIIKLHNAKSVINSEGKIVITSRNVELKILDKFRRTKESYKVPYG AIIAKMDEELVNSGEIVAKWDPHTIPVISEVNGYIEFVDMIDGQSITRQT DELTGLTSIVILDTSERTSLGKDLRPALKIVDSNGENVLISGTDMPAQYF LPGKSIVQVDNSIKISSGDTLARIPQESGGTKDITGGLPRVADLFEARRP KELAILAEISGFISFGKDTKGKRRLIITPYNNNTPYEEMIPKWRQLNVFE GERVEKGDVISDGPESPHDILRLRGVQAVTKYIINEVQEVYRLQGVKIND KHIEVIIRQMLRKATIIKSEHSEFLDGEQVEYSRIKVSNRNLSKIGKKTA IFSRDLLGITKASLATESFISAASFQETTRVLTESSVAGKKDELRGLKEN VIVGRLIPAGTGYAYHKKRLKNCQKDKTKEKNKPSSISVEEASANLSELL NSTL >bbp052 rpoD, RNA polymerase sigma factor RpoD MEQNPQSQLKLLVTYGKEQGYLTYSEINDHLSDNIINSDQIEDIIQMIND MGIQVVEKAPDSDDLILHEIKRNNETDEDIVEATAQVLSTVESELGRTTD PVRMYMREMGTVELLTREGEIDIAKRIEDGINQVQCSVAEYPEAITHLLE QYNRVELGELRLSELIHGFVDPNAEAVHTSITNHINTNSEEHHHNDNTEE NNDDDHLVDPELAREKFIALKNQYHITNYAIKTKNRNHQDTLIEINNLSE IFKQFRLVPKQFDHLVINMRKMMQKIRIQERNIAKLCIEYGNIPKKALLN FFSLQKTNQIWSKIVQNIKKPWIDKFNTIKPDIQMILKKLQKVEEETGLT IHQVKNINKRISLGEAKAKRAKKEMVEANLRLVISIAKKYTNRGLQFLDL IQEGNIGLMKAVDKFEYRRGYKFSTYATWWIRQAITRSIADQARTIRIPV HMIETINKLNRISRQILQEIGREPTPEELSERMLIPEDKIRKVLKIAKEP ISMETPIGEDDDSHLGDFLEDTNIELPLDSATSASLRSATKNVLSGLTTR EAKVLRMRFGIDMNTDHTLEEVGKQFDVTRERIRQIEAKALRKLRHPSRS EILRSFLDD >bbp027 rpoH, RNA polymerase sigma-32 factor MIKVETKTLPAISLGNLDSYIREANSWPMLSSQEEKYLSEKLFYHGDLNA AKTLILSHLRFVIHVSRNYSGYGLLQADLIQEGNIGLMKAVRRFNPKIGV RLVSFAVHWIKSEIHEYVLRNWRIVKVATTKSQRKLFFNLRKTKQRLGWF NDHELELVAQELGVKREDVREMESRMSAQDIALHHVPDNFREEQNFSYTI PYLKDSLSDFANHVEEDNWEAHKTNKLSNALSSLDERSRNIIHARWLDDS DHKMTLREIAHNYGISAERVRQLEKNAMKKLKVAIET >bbp286 rpsA, 30S ribosomal protein S1 MLKLYFTIINMTESFAQLFEESLKNIKTRPGSIIQGTVVAITKDTILVDA KLKSESKIPIDQFKNSQGELEVKVGDQIDVALDAIEDGFGETLLSREKAK RHEAWLTLEQAYKDSKTVVGLINGKVKGGFTVELEDIRAFLPGSLVDIRP VRETMHLEGKELEFKVIKLDQKRNNVVVSRRAVIESEYNAERNLLLETLQ EGLIVSGIVKNLTDYGAFVDLGGVDGLLHITDMAWKRVKHPSEIVNIGDE VKIKILKFDREKIRVSLGLKQLSDDPWTKISERYPEKTKITGRVTNLTDY GCFVEIEEGVEGLVHVSEMDWTNKNIHPSKMVQVNSVVKVMILDIDEERR RISLGLKQCKNNPWMEFSKKYNKGSHVVGKIKSITDFGIFIGLEGSIDGL VHLSDISWNISGEESVKKYKKGEEVLAVVLQVDPDRERISLGIKQLQEDP FAKYVSSHKKGSLVSGTIKKIDNNVIVVSLSEHIDGLIKFLNISDEIMNV HDNKPWNKAKIGEIVEVKLNSIDKKERIIYLSILEKQELKISNDIKKNNS HKQEIDKDKNFSNAMTEAFKAAKNVD >bbp213 rpsB, ribosomal protein S2 MMVSMRDMLNAGVHFGHQTRYWNPKMKPFIFGSKNKVHIINLEKTMTMFN FALFELKKISLRKGKILFVGTKQSASKIIKESAILCKQFYVNHRWLGGML TNWKTVRQSIKRLKDLESQSQDGTFNKLTKKEVLLRMRELSKLENSLGGI KEMGSLPDALFVVDADHEHIAIREANNLGISVFSIVDTNSDPDGVDFIIP GNDDAIRAVNLYLNAVSKVIKKNVKNEK >bbp461 rpsC, 30S ribosomal protein S3 MGQKVHPNGMRLGIIKHWNSVWFSNSKDFAKILDSDYQVRLFLRKELFKA SVSRIVIERPSKSIRVTIYSARPGIVIGKKGEDVEKLRLSITNITGVPTQ INIAEIRKPELDAKLVADNIVSQLERRIMFRRAMKRAVQNAMRQGAKGIK VEISGRLGGTEIARREWYREGRVPLHTLRADIEYNVSEAHTTYGVIGVKV WIFKGEILGGIGSIPKIEKQKPMSQLKKHQRRYRK >bbp443 rpsD, ribosomal protein S4 MAKYLGPKLKLCRRENTDLFFKSGIRAIDSKCKFDQFPGQHGSKRQRLSD YGVQLREKQKVRRLYGILEAQFRNYYKHASRLKGNTGENLLFLLENRLDN VTYRIGFGSTRAEARQLVSHKSILVNNCTVNIPSYQVSPGDVISIHKNSK LQSRIKAALELSEQRETPIWIEVDFNKMQGIYKRVPERSDLSAEINEYLI IELYSK >bbp450 rpsE, 30S ribosomal protein S5 MLQENLGLSFEVEILSNIGRNVSGDLKEKLISVNRVSKTVKGGRIFSFSA LTVVGDGHGKVGFGYGKAREVPSAIQKAMEKARRNMIQVPLNNGTLQYSV TGSYTGSYIFMKPASNGTGIIAGGAMRSVLEVAGVHNVLAKTYGSTNPIN VVRATMLVLESMKSPEMIALKRNKLVKEILENSYL >bbp510 rpsF, 30S ribosomal protein S6 MRHYEIILLIHPDCSEKLPIMIEKFKKLVIGYKGRIHRLEDWGRRQLAYS INKLHKAHYFLMNIEVPSNCIQDLSNTFRYDDLVIRNIIMHVKKSVTEIS PMLKSKEDKLDKKDRVVVS >bbp471 rpsG, 30S ribosomal protein S7 MPRRRGIGHRKILSDPKFSSEMVAKLINIIMVDGKKSIAEEIVYQALTML AKKIGKPELEVLELALENVRPTVEVKSRRVGGSTYQVPIEVRPVRRHALA MRWIVHSARKRIDKSMIIRLSNELSDAIENKGSAVKKREDVHRMAEANKA FAHYRW >bbp453 rpsH, 30S ribosomal protein S8 MSMQDPIADMLTRIRNGQFASKISVIMPSSKLKVKISILLKEEGYIKDFS VNSTNKPILEIFLKYFRSKPVIENITRVSSPSLRIYARNNKLPQVMSGLG IVIISTSQGVLTDQVARKKGLGGEIICNVS >bbp353 rpsI, ribosomal protein S9 MENMYQYGTGRRKSSSARVFLKTGTGNITINNRKLNNYFSRRTARLIILQ PIEFVNMSKKCDLYITVKGGGISGQVGAIRHGISRALIKYDSSFRNELRK LGFITRDSRQVERKKVGFRKARKRPQFSKR >bbp468 rpsJ, 30S ribosomal protein S10 MQQNQRIRIRLKAFDHRLIDQSTSEIVETAKRTGAQVRGPIPLPTHKEKF TVLISPHVNKDARDQYEIRTHKRLIDIVEPTEKTVDALMRLDLAAGVDVQ ISLG >bbp444 rpsK, 30S ribosomal protein S11 MVKELIRVKKRVKKQILDGIAHIHASFNNTIISISDKKGNVLGWATSGGS GFRGSRKSTPFAAQVAVERCADIVKSYGIKNLEVMVKGPGPGRESSIRTL NTIGFRIINITDVTPIPHNGCRSPKKRRV >bbp472 rpsL, 30S ribosomal protein S12 MATVNQLVRKSRSRKLIKNNVPALNKCPQKRGVCIRVYTTTPKKPNSALR KVCRVRLTNGYEVTAYIGGEGHNLQEHSVILIRGGRVKDLPGVRYHVIRG ALDCSGVKSRSQGRSKYGVKKKK >bbp445 rpsM, 30S ribosomal protein S13 MARIAGINIANHKHVVVALMDVYGIGKTRSKLICLRTNISESIKILDLTK DQLELLRCEVLKFVVEGDLRREVTLSIKRLQDLNCYRGSRHRKKLPVRGQ RTKTNARTRKGPRKLMKK >bbp454 rpsN, 30S ribosomal protein S14 MAKQSMKAREVKRIKLAKKFYSRREHLKSIISDLSVLEQDRWKAVLKLQT FPRDSSPIRQRNRCSQTGRPHAFLRKFGLSRIKVREAAMRGEIPGLKKSS W >bbp337 rpsO, 30S ribosomal protein S15 MSENMNIKSKIITQFGVNSKDSGKSEVQIALLTNRINYLQNHFSLHKKDH CSRRGLLNMVSKRRKLLNYLKDENISRYINIINQLKLRR >bbp357 rpsP, 30S ribosomal protein S16 MVKIRLVRLGAKKRPFYKIVIADSRYPRNGKFIEKIGFFKPLLSIKHPPQ ICINTLRITHWIKNGAIMSKRVKKLVKIHSYINKKIK >bbp458 rpsQ, 30S ribosomal protein S17 MIDKFRTLSGQVISNKMQKSAIVSIKRLIKHPLYKKFVKKTTKLCIHDEN NQCSFGDIVEIRECRPISKTKSWMLVRISKKSLRS >bbp509 rpsR, 30S ribosomal protein S18 MVRYFRRRKFCRFTVEKIKEIDYKDLSMLKNYITESGKIVPSRITGTSAR YQRQLARAIKRARYLSLLPYTDQHQ >bbp463 rpsS, S19 ribosomal protein MPRSLKKGPFIDIALLRKVEQAVEIRDKKPIRTWSRRSTIFPKMVGLTML IHNGRQHIPVFITEDMVGHKLGEFVLTRTYRGHTADKKVKKR >bbp140 rpsT, 30S ribosomal protein S20 MANIKSSKKDSIKSRKKKKLNASKKSMIKTLIKKVKIAILSGDKLKSELA FSKIQPILDRYSAKGLIHKNKAARHKSNLKCKINAL >bbp054 rpsU, 30S ribosomal protein S21 MPIIKVRDNEPFDVALRRFKRSCEKAGILSEIRRREFYEKPTTERKRAKA SAIKRLTKKLSRENLKRIRLY >bbp305 rsmC, ribosomal RNA small subunit methyltransferase C MSSTKNVLITGNTINFYMPNRPKLKVKMHTQCFNNFKNNQKNSMFAIIFD VLVNKKIIQNSDVIIYIWPNSKLEALFQINYIISLLSKTQKIFFLGSNRS GIKCIQNLLKKWIIITKIDSSNHCILYSGIIVLKPIFLYENFIKFNKWNN IVVKTIPGVFSYNNIDHGTKLLMSTCTKNLRWKTVLDIGCGSGVLSTYLA TIFPEIKLTLIDSNIAALESSKLTLTSNNVCGEIFPSNIYSNVHYQNFDL IISNPPLHVENKLNFSIIDNIIKNSVKYLSNKGEIRIVTLKNVPCHKSFT LYFKKYTILKTSSHYKVYQANYKDRV >bbp503 sbcB, exodeoxyribonuclease I MDIQKNTSLTFLFYDYETFGKNPALDKPSQFSCIQTDIDFNIIGSIQEIF CYPSVDYLPDPESVLITGISPKYTSLFGVNEFEFAKKIYSLFMKSDTCII GYNNIYFDDEFTRNIFYRNFLNSYEWSWKNGNSRWDMLDLLRACYVLRPE GINWPRNEDNSVSLRLSDISLANNIVHNVAHNASSDVYATMNIAKLIKQK KPKLFNFFFKYRTKKAILTLIDVNSLNPIVYISRFFGVVNRYISYIVPIL WHPINSNILVSIDLSQDVQKILNFFKRNSILNVNYKEIFLMGIRFIYVNR CPILIPTNVIRMKDRIRLRINYKLFQNNLVLLRKNIFLKKKLKKFLCSIA EAPKYNGSNVDLKMYNSFFSYIDNNVIKNIHSTLPKRIKINFMKYDNRIN QLFILFLARYRPDMLDYSEKYFWIQRYLNIFSYANIQKYENKILKLIVKY KNHVRNVQLLEELFEYVKYTRKNFLKSIFTN >bbp187 secA, preprotein translocase MIQKFLKKLFSDRNDRILQNIQTVISKINSMEKFFEKLSDLELKRNTTRF CYRLNNGETLDQLLPESFATVREASKRVFGMRHFDVQLIGGIILHQRCIA EMRTGEGKTLTATLPAYLNALQRKGVHIVTMNDYLAKRDAEKNRLLFNFL GLTVGINISGLSSKLKKQAYNADITYGTNNEYGFDYLRDNMVFCREDKVQ RELNYALLDEVDSILIDESRTPLVISGSIEDVSDVYIKINEIIQVLFSQK QEDSDVFVGNGHFYIDEKQRQVFLTERGLVRTEEWLVSQNLIDKKESLYS SKNIVLMHNVVAALRAHYLFFKNVDYIVKNKKVIIVDEHTGRTMEGRRWS DGLHQAIEAKEGLKIRSENQTLASITFQNYFRLYKKLSGMTGTAITEAFE FRAIYNLDTVVIPTNTPMIRDDKPDLVYMTELEKFDAIIEDIKQCVSRNQ PVLVGTISIQKSELISQKLLKLNIKHNVLNAKFHAQEAKIIAQAGKLRAV TIATNMAGRGTDIVLGGNLEFLLAHNNEKHTDEKMEDVIKKWNIEHNLVL KSGGLHIIGTERHESRRIDNQLRGRSGRQGDCGSSRFYLSMEDSLLRIFS SERMISIMRVIGVKKNEAISHPFVTKAILNAQQKVEYRNFEFRKQLLEYD NVSNEQRRVFYYQRNQIINSKDSNIGDIIKNIFCDVFLKIVNKFIKQKLL KQSQKILELESCLRDNFNIVCSISKKIRDNIVVYKSDLSKIVLKKVYQSY QCKINKYILKDVRKYERLVILDTLDYFWREHLASMEYLRQGIHLRGYGQK DPKQEFKRESFFMFLNMLSSSRYEIVSILLKKSISNNDFLKIYNHAKLVF >bbp041 secE, preprotein translocase SecE subunit MIKATKLKKKYDKLKIAKWSFLGILIILFILSNHYYIKHSNIFQNILLTS LTILSTGLIFLTKSGKKFLIFTKSAIHETKLITWPNFKDTLHVTFTVIIV TILLALILWGLDNILIWFISLITSLRL >bbp447 secY, preprotein translocase SecY subunit MIKKKLETKLKNFGNQFSELKQRMYFVIFSLIVFRMGSYIPIPGIDTVAL ASLLEHHRGTIIEMFNMFSGGALSRASIFALGIMPFISSSIIVQILTLIH PKFIEMKKDGEQGRHRINKYIRYITLILAALQSFGMSISLPNIPGLKDVI IDPSISFYGIAIISLITGTIFLMWLGELITEKGIGNGISIIIFSGIVSGL PSSFLNTVEKVRQGSLHVLLFCFIGIVIFLVTLLVVYIERSQRKITISYA KRNLGHRTYSMNSTHLPLKLNMSGVIPAIFASSIVLFPATIASWFGNRDH FKWLVDIVFYLQPTKPLYILTYITAIIFFCFFYTGLAFNPRETADNLKKS GAFILGIRPGEKTAQYINKIMLRLTFLGSMYMAFICLVPELMRFFMDVPF YFGGTSLLIIVVVIIDFISQVQTYIMSTQYESVLKKNKFRF >bbp289 serC, phosphoserine aminotransferase MIMNDTTKVYNFSAGPAMIPREVLCQVKRELYNWKNLKKSIMEISHRSQE FISVVQEIKHNLRKLLHIPNSYKIVFCHGGARGQFSAIPMNFSKNANHSS HNNVVDYINSGYWSYSAALEAKKYCYTNILNVCKTNNKKQYILPMNTWEI NDNSLYLHYCPNETIDGIAIHEEPKFNDKKIVIGDFSSTILSKRINLERY SFIYASSQKNIGPSGITLIIMHESLLQNINSYVPSILNYKILVNSNSMFN TPNTFSLYLSGLILKWIKKIGGIKEIEKRNIIKSNMLYNMIDSTDFYIND VVSNNRSRMNVPFTIINTKLHEIFVKEAYKYGLHALKGHNLKGGIRASIY NAMPIKGVLKLINFMKIFEKKYG >bbp290 serS, seryl-tRNA synthetase MLNPNLLRNHIEFVFKNLARRGFSLDVKQFTEMEKKRKILQTKVEELQSR HNTLSKHIGRIKLIHPNIQCMKERIITLKKKIDVMKKELKILLEQIHIFL MNIPNLPDINIPDGMGSDDNQEVSRWGIIKNYNFKIKNHVELGNHLNGFD WKSAANISGSRFFIMKGKIALLYRVLGQFMLDLHTNEHGYLETYVPCLVK TNNLYGTGQLPRFKTDLFYAKSLLDESQNNNNFALIPTAEVPLTNLFRDC ILDEQQLPIMLVAKTPCFRSEALSYGRDTQGLIRTHQFDKVEIVQIVHPS DSMQKLEELTIHAERVLKLLKLPYRKTLLCTRDIGFSSSKTYDLEVWFPS QNVYREVSSCSNMLDFQARRIKARFHCNAQNKKIFIHTINGSGLAVGRTL AAILENYQQKDGRIKIPKILRNNYMNGLEFLE >bbp397 sirA, SirA protein MTVDNNVLDLRKLRCPEPIMLLRKKIREIKNGTTLLILSDDPSTIREIPQ YCKFMHHKLLKINTKDTIYKFWIQKTHKM >bbp235 smpB, SsrA-binding protein MKRNSNRKPNEICINRKAKYSFSIKETFEAGIVLLGWEVKSVRCGKINIS NSYISLKNGEMYLVNSQFDPISKSNLYITYECNRIKKILLRKREITYLYS KLYKSHLTIIVLSIFFKKQWCKVKIGIAKGKTIKDKREHKKLSEWKKTQN RFVKRIRH >bbp178 sodA, superoxide dismutase MTYVLPSLPYSYNSLEPFFDEKTMIIHHTRHHQAYINNTNSILNGTHYEN LLIEELISKLNILSIENKLALQNNAGGHINHSLFWKWLKLNTILKDDFKI ILEKNFKSVDFFKKQFEKIALSHFGSGWIWLIKKYDNTLRIVTTVNQNTP LMGKEISGISGIPILGLDLWEHAYYLKYKNNRSDYVNAFWNVVNWDEVSY RFFNISNM >bbp263 sohB, putative protease SohB MHFIYDCSLFLFKIVIVIFFIIFVSSIILKISRKKNKNFGILSVSSLNDH YELVKNSIIVQLMDKKTKKLWNKKNKMLKRSTLLTNNNKLIDKDHNIIVV RAQPTLYVIDFKGGIAAHEVKSLREEISSIISVAQKHDEVLLRLESSGGT IHGYGLAAVQLQRLRSRKIFLTISIDKIATSGGYMMACVANYIIATPFSI IGSIGVVAQFPNIHKFLKKNNIDVELHTAGVHKRTLTIFGENTPEDRKKF VEELNVAHDLFKKFVKTMRPSLNIEKLSNGECWFGSIALKKKLVDDINTS DDFIISRIRKFNILHVKFKYNESIIKALFYKKLKTINNLIYKYLNNKLF >bbp488 ssb, single-strand binding protein MASRGINKVILIGYLGQDPDVRYMQNGSAVTNITLATSETWKDKNNGEIK EKTEWHRIVFFNKLAEIAGEYLKKGSQVYIEGSLQTRKWKDQNGIERYIT EIIVSVGGTMQMLGSRNSSSLTASSGLSKNNDNLSKQLLSEKKQESFNDS KLQNNNLDFDDEDIPF >bbp280 sucA, oxoglutarate dehydrogenase MYKNEFNSSWMSSFNSSYIDNLYNKFLLDPTSIDNSWYIVFTELSKENYI NSTNKYLNNKFQDSKDTIKLTIELLINIFRTLGYKFAHLNPLDTFKNDNS LSLKKFLKSSEAFRIQDSYLVKLSQYVLDDITTKNVYDDYKNIYCKRIGY QFMHIHNSNEMNWIKNYIETKHSNILKKKKKIQILKHLIISEMLEKYFSS KFPSIKRFSIEGAESLIPMLKEVIKYTKKFNLHKIIFGMSHRGRLNVLAN ILDKPIKTIFNEFCENNSNNFNSGDVKYHMGFCCTKTIGLRKIILDLKSN PSHLEVINPVVVGSSRAYIDSNDNLNDENILPIIIHGDAAISGQGVVQEL LNMSQARGYKVGGTIHIVVNNQIGFTTSKVKDLRTSQYCTDIAKMIDSPI FHVNADDPESVIFVTHLALNYRFCFKKDVFINLVCYRRHGHNEIDDPSIT QPVLYSKIKNHPTTATSYYNKLLLKNIINKSFLITYQKKIKKKLDVEYNL HNKKMSEKRLKCCSIVKADYINVSNTPINNISQSDLTILAKKIFSIPNNI EVHNRVFKIYKDRLKMANNEKLFDWGASELLAYASLLNEGISCRLSGEDV CRGTFFHRHAVIHDQKNDSKYIPLKNIKLKQGNFYIWDSVLSEEATLAFE YGYSIDQKNTLNVWEAQFGDFANGAQIIIDQFICSGEQKWNVTCNLVMLL PHGYEGQGPEHSSARIERYLQLSANNNIKIIIPTISSQIYHIIRKQAFSL IKKPLIIMSPKSLLRFPLAASSLSELSNGKFRTVIDEIDNLDTKKVQRII LCSGKIYYDLLTQRRINQQKNIVILRIEQIYPRPTKKLSAILYNYKDVHD YIWCQEEPCNQGAWLYHKSYLKKLLPKHSKLNYVGRSSSASPATGYMKIH KEQQKKIIYDALNISD >bbp281 sucB, dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex MNIINIFIPDLPESVTDATIIKWHKKKGDKVQEDTILVDIETDKVILEIP SPSDGILNSIIADKGKIVLPGQVIGTLLKIGIKNEEKIIKTTNNVVNTDN NQNINLKLLEKTYSPTVRRLISMHDLRDVDIIQGTGTKNRLTRKDILNYL KNIRSNTNKKINNYDLNAYNFNTTHKNHRSIKRVKMTRLRKKISERLLST KNNTASLTTFNEVNMQSILNLRRKYGELFKQKHGIKLGLMSFYVKAVIEA LKIFPEINASIDNDEIIYYNYFDISIAISTPRGLVTPVLKNADLMSMAEI EIKIKDFSEKGKNSKLTIDDLIGGNFTITNGGVFGSLFSTPLINPPQSAI LGMHAIHKRPVIVDENIEVHPMMYLALSYDHRLIDGKESVGFLLKIKEFL EDFSRIVLNI >bbp264 suhB, myo-inositol-1(or 4)-monophosphatase MHPILNIAIRVARKCGNILIQYYDRNKTNNEKQILKKDFITKIIFVLEKT MIDMIHKSYPEHSIITYHKNNKIFKNTEIIWLINALDGIKNFENNLPHFC ISIAIIVRKTTQISVIYDPIRNELFTSVKGQGSQLNGYRMRCKSTNTLKR SLVGLVYPCNNSKFQNYFFTIINLLFSHEVKLRCTGCISLDCAYVAMGRL DYLFNGNLIPLLFSSGSLQIKESGGLISDLNGGHDYVSSGIILIGNPKLM RVILVKIRELFQNNLK >bbp087 talA, transaldolase MNQLECLKKYTDIVVDSGDLVSINKFKLGDVTTNPSLIRQVMSLQKYQYI IYDSIRYAKKKGGSHKFKLENAIDKVSVILGSEILKNISGKISTEIDSRL SFNTNLCIERAKKLISMYEEHDIHRDRVLIKLAATWESVSAAKELKKENI QSNLTLLFSFAQAKICAEAGVFLISPFVGRIYDWYKSKSLIKSAMIDDDP GVNAVRKIYQYYKEYGYHTIIMGASFRNVDQVLALSGCDRLTISPNLLHK LQLSDDLVIRKLIPPKHKKLQPVCMSKSEFCWFHNEDAMAVEKLSEGIRQ FGKDQQELENIINNNF >bbp017 thdF, putative tRNA modification GTPase trmE MNVFNDTIVSRVTSEGKSSVGIIRISGKLAFEVSIKVLNRDYLPIRTACY LSFLDLSGKIIDQGIVLWFPGPSSFTGEDVLELQGHGNPIIIDLLITTIL SIPGIRLANPGEFSERAFLNGKIDLAQAESISDLINATSEQAARSAMQSL QGLFSIYINNLIKDFTKFRAKIEAQINFSDHEINADNLDVFIEHEINRII SRIKKIRNTAIQGSVLREGIKVVISGAPNSGKSSLLNALSLTNRAIVTNF PGTTRDVIYENIIINGVLFILIDTAGLRITNNPIENIGIERAWNEIKLAE HILFVIDGSRSVQNQLKNYNNFIKSLSKTSCITIVFNKSDLSKFKINSDL RNLNNGVLVSSKTGVGIEALRQHLYFSFKSSFEVNNSEGVVSARRRHINI LSMVLEKFLSSKKDWKKINNIELLADDLRTCQDLLGGITGKITSDELLSE IFSEFCIGK >bbp183 thrA, aspartokinase MKILKFGGTSLSNSELFFHVATIIENNLNNEQIAIVLSAPGNTTNLLEIA INQTINNKNIIPIVQKIEKNFLKLINDIYQVEQKLLYEKIKNNIENKLLE LKNLLQGINLLRQCPDKIRAKIISSGEYLSISIMNSILISRGYNTTIIDP VKKLLTKEDTYLNATVNIKISKFRILSMKIPKHHIILMPGFTAGNKQGEL VTLGRNGSDYSATILSVCLNSTMCEIWTDVNGVYTCDPKLVSDAKLLTSL SYREAIELSYLGAKILHPNTIYPIQKFKIPCTIKNTHNPSSIGTKISCNH VKNKNLITGVTYLENVHMFSISCLYSKNIETIIPKIFSCMSLSKIWIILT IQTSSQNTISFCILKTMTNTALHVLHKALYLELKHKLLKPIKVEKKLTLI SVISSDILNNTKITEKVFSILKHVNINTLAISKGASKNSISIVVKHDDGI LGVRALHKGIFNKNCTAEIFLIGIGRVGQTFLKQIIEQKNWLKSKNIDLK ICGIANSKNFILNLDGINPKNWKRDLNLSKKSFNFKHLLNSIQNYYLINP IIVDCTSDKNIANQYISFINCGFHIVTPNKKANTTNWKYYEDIRLAAQKE KKKFFYETNVGAGLPVIENLKNLLRTGDTLIHFKGILSGSLSFIFGKLED NISLSEATKQAQSLGFTEPNPKDDLSGIDVARKLLILAREVGYKLELKDI KIEPLLPKEFNNISNTTDFITKLKELDQIFCNRVKKARKLGKRLRFVGII NQKGNCQVKIDEVDHNDPLYNIKNGENALAFYSKYYQPIPLVLRGYGAGN NVTASGIFSDVLRILL >bbp182 thrB, homoserine kinase MIKIYAPASIGNVGVGFDVLGAAISPIDNSLLGDVITITSSKQFSLTSTG TFSNQLPKDINKNIVKKCWTYFCKILKKNLPVSITLEKNMPIGSGLGSSA CSIVATVVAINTFFNKPINNFELLKLMGKLEGKISGSVHYDNVAPSYLGG MQLIINKNDIVCQKISIFKNWLWVIAWPGISISTEQARTLLPLQYSKKVC IQHSQNLAGFIHATYTHQSKLASMFMHDIIAEPYRIKLLPYFLKTKQIII DMGAIACGISGSGPAIFAVSDNLLTAKKIATWLTNYYLTNDRGFVHICKI DTIGARKIGL >bbp181 thrC, threonine synthase MKLYNLKKKQDQVNFSKAVKLGLGKNQGLFFPKELPILTKEQLYKLLKMD FLTRSSKILSMFIGDEIHYSELTKRIKNAFSFTTPKIVSISKNIACFELF HGPTLAFKDFGARFMAQILSFLNHDKNDTITILTATSGDTGAAVAHAFFK MKNVRVIILYPKGKISELQEKLFCTLGENIITIAVNGSFDECQKLVKQAF NDDQLRIETGLNSANSINISRLLAQICYYFEAFALLTKKQQKNLVISVPC GNFGNLTAGLLAKALGLPIKSFIASTNSNDTVPRFLKTGFWKPNNTVSTI SNAMDISQPNNWPRVEELFKRKFWSLKTLKYGSVSDILTKKSLKKLAFLG YVSEPHAAVAYYTLKNKLKQNEFGLFLGTAHPAKFKKTIEKILQITLFLP SKLRNQIKLPLLSHNIRPDFSKLKKFLLEK >bbp119 thrS, threonyl-tRNA synthetase MPTIKFIDGTCRVYPGSISVLDILKDVSPNSVQDFMFGCVNGISVDRNAI VTNDSIVKFVYKTDQSTLDIIRYSCICLLGKAVKKLWPSSKIGESDVLEN GFFCDIEVDFSFNETSLHLLEACMRQMINKKYKIYTKTFSLKKASTIFKN RNETYKLFLLDRLVNFSNQVVSLCFHEEYIDIQKKISVPNIFLCRNFRLQ KFSGVYWKGKRENKVLQRIYGTSWITRIQLEKHLDNVKKLDSRDHRKISK ILDLYHIQEDLPGMIFWHRNGWIVFQELKKLIRVKLRKYNYQEVKTPVMM NKKIWKDSGHLDNYKESMFMVCSSNFEYGIKPMNCPGHVQIFNHVVRSYR DLPIRISEFGSCHRNEPSGALHGLMRIRNFTQDDAHIFCREDQICSEVSN CIRMVYEIYKIFGFKKILVRLSTRPKNRIGNDNIWDKAENDLATSLRESK IEFEYQHGEGAFYGPKIELSLFDSLGRVWQCATIQLDFCLPINLKAFYID HNNERKVPIIVHRAVLGSIERFIGILIEEYIGNFPTWLAPIQVVLANVNS NHLQYIKLLYKEFYALGIRSEIDSRNETISYKIREHIARKIPYIIICGDK EVKNNTITLRTRSGKNFYCIDVQFFISKLCKEINSYSCSLMEE >bbp386 thyA, thymidylate synthase MKSYLVLLKKILKEGSNRKDRTGIGTLSVFGYHMEFNLKLGFPLITTKKC HFPAIVHELLWFLKGDTNIKYLNDHNISIWNPWADERGYLGPIYGEQWRS WKTKDGRVIDQIDNVIHLIKNNPNSRRIVVSSWNVGDLHKMALLPCHVLF QFHVVDHVLHCQLYQRSCDVFLGLPFNIASYSLLTHMIAQQCNLKVGNFI WTGGDVHLYKNHIKQAKKQILRRPYLLPKLVINRKPTQIFNYLLQDFNLL NYKYHPSIHAKIAI >bbp088 tktB, transketolase MCLRRKLANAIRALSIDAVQEAQSGHPGMPMGMADIAEVLWREFFKHNPK NPLWNNRDRFILSNGHGSMLLYSILHLTGYKLSIDDLKKFRQLGSNTPGH PEIGSTPGVEMTTGPLGQGLGAAVGMAIAERTLASTFNKPNYDIVDHYTW VFVGDGCLMEGISHEVCSLAGTFGLGKLIVFYDSNGISIDGKVEEWFTDD TENRFKAYNWHVVSNVDGHDYRSISSAIKDAILVKNKPSLIICKTIIGYG SPNKSGLETSHGAPLGENEVLLTKQKLGWTYPPFVIPQDVYDHWNFNLQG VILENEWNKKFQGYYNKYPDLANEYLRRISKNVPDKFVDNFNKFIKELYL CPKNIATRVASQNVLEFLGKSLPELIGGSADLAPSNLTMWSKSKSIKQDI SGNYVHYGVREFGMTAISNGIAHYGGFIPYVATFLAFMDYARSAVRMSAL MKTQNIFIYSHDSIGLGEDGPTHQPIEQLSALRFIPNVNVWRPCDQLETA IAWKNAIERKDGPTALILSRQILCQIDRSQEQINDIYRGGYIVNTTVRSP KVIIVATGSEVKIALDVSNILFKKGILVRVVSMPSTNVFDQQDNDYKEFI FPRCLVHRVAIEAGISDFWYKYVGLTGCIIGIDTFGESGSSDQLFSKFGF NSDIISEKIISYLKSS >bbp361 tldD, TldD protein MILESVAEHLLFKNDINYQNVFSILSDILEKKIDYSDIYFQSIIHESWIL ENSIIKEGTYNINQGVGVRIVLGDKTSFSYSNDITFNSLISSSKLAMSIL DVKAITKNVCPLTTTRTKPIYTSCNPLTSIDTQKKLEILNRINCVAKNYD HRVVSVNAELSSSYDEVLIATSDGNLAADIRPLIRLSINVLVNDKGKFER GVSGGGSRSGYSFFLNKHKSGKILAEYYACEAARIALINLSAQEAPSGTF PVVLGSGWPGVLLHEAVGHGLEGDFNRQGTSVFANKIGRQVASELCTIVD DGTLKDRRGSLTIDDEGTPGQYNILIKNGILKKYLQDKTNARLMEMDLTG NGRRESYAHLPLPRMTNTYMLSGPFNPKEIICSIDYGIYALNFSGGQVDI TSGKFVFSTSEAYLIKQGKIGKSIKNVTLIGSGIDVMKEISMVGNDLKID EGVGICVKNGQSIPVGVGQPTIKLNNLTVGGTI >bbp323 tmk, thymidylate kinase MDINNMLKGKFIVIEGIEGSGKTTICKTLKNILYEHGIKNVICVRDPGST PLAEKIRSLLITKDKNEYMVNETELLLFYAARIQLIKNIIQPALNKGVWV ISDRYFLSSLAYQCAGRKIKEEIVLLLQSLFLKNFNPNITFYLDVTPEIG LNRIKNRNEIDRIEQNTKFFFNNVRNKYLNLIKTKPGIIKINANRKIDKV KHSCKQQMLSWLNTENL >bbp285 tpiA, triosephosphate isomerase MKKKIIIANWKLNGNIQLLQTLLKPLVNFYIRHKNKSSIKLVIMPPYVYL YPMKSIISHSSILLGSQNVDINLIGAFTGEVSINMLKDVGVSYVLVGHSE RRQYHRENDVIIAKKFKIVKDSHLIPVLCIGETEHEYLSCKTEKICKFQI DAIFDLLGPSGFNNSVIAYEPKWAIGTNTIPSINFIQKILMFIQNYIFNK QNSTIKLFSLQYGGSVNEHNIIELYDVKNIDGFLVGSASLSLDFFKKLLN NC >bbp359 trmD, tRNA (Guanine-N1)-methyltransferase MLINVISIFPKMFDIIKDYGITKRAIQKHLVKINVLNPRKFTKNKYKNID DRPYGGGPGMIMTAEPLFLAINQAKSLSSNPVKVFYLSPQGKKLDQSKIM ELSHQKHIILLCGRYEGIDERLLISKIIDEEISIGDYVLSGGELPAMVLI DSICRVTPGVLKNSKAIQEDSFYNGLLDYPHYTRPKCFNCIKIPNILLSG NHSEIKRWRLKQSLTKTWLKRPDLLNKLILTKEQESILHECQSKMDKPKI >bbp242 trmU, putative tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase MYKLNKKVIVAMSGGVDSSVTAWILKKKGYHVEGLFMKNWEEHNSDSDMH CSSKKDLSDAQGVCNQLNIFLHKVNFSFEYWENVFQKFLFEYKMGRTPNP DVLCNKEIKFKIFFEYSIQDLQAHYIATGHYVQKRIFKNKYFLLRGLDAT KDQSYFLYTINQKVLKQCLFPIGHLTKCEVRKIARRINLIVAKKKDSTGI CFISPQNIKKFLNHYLPHKSGNIITTLGQKIGQHYGLIHYTIGQRRGLGI GGIKGFNNIPWYVVSKDITNNSLIVSQGMNNFYLMSIGLIANELHWINDI NIQNSFFCTAKIRYRHIDIPCKIVMHKKKQIKVLFERPESSVAPGQSVVF YLSDLCLGGGIIKKRLPVLK >bbp257 trpA, tryptophan synthase alpha chain MNNRYYQLNKNLIPYKLGCYIPFVVLGDPSIEISLEIIYSLIKNGADGLE LGIPFSDPLADGPIIQQANLRAFSANITLTKCFEMLFKIRTHNPKIPIGI LIYANLIFKLGIQKFYSICSKIDIDSVLIADVPIEESFEFEQHSIKNNID SIFVCPPDASKNFLKKLSKHSTGYIYLLSRSGVTGIDMKITPPLKNFVKE LKKLTSIPIIQGFGISNENQIKNIILSGVSGVICGSVIIQIIANNLNNKK IMLKKIKKLSNRFKKATII >bbp258 trpB, putative tryptophan synthase beta chain MTLLKSYFGEFGGMYVPQILMPALYKLEIEFLKALNDLQFTNELSNLLKN YAGRPTPLTLCKNITKNTNTKLYLKREDLLHGGAHKTNQVLGQALLAKKM SKKEIIAETGAGQHGVATALSCALLGLKCRIYMGFKDVIRQQQNVFRMQL MGAKVISVKNGSGTLKDACNEALRDWSENYCTSHYMIGTAAGPHPYPTMV KKFQSIIGIETRCQILKQESCLPNIIIACIGGGSNAIGIFSEFIKDKSVC LIGVEPAGKGIKTGKHGAPMQHGSTGIYFGMKAPVMQTSEGQIKESWSIS AGLDFPAVGPEHAWLKHIGRATYVSITDCEAINAFKILCKLEGIIPALES SHALAYALKLISKDTNKKQIIIVNISGRGDKDIDTIRKIDVYKE >bbp259 trpC, indole-3-glycerol phosphate synthase MNSILKEIINDKLMWVKYHKKKQPLFTFQNKIVRSNYNFKNSLKSIHPSY ILEIKKASPSLGIINNKLDLKKISLIYKKYASSISILTDEKYFHGNFEFI PIVRKIAHRQPILCKDFFIDPYQIYLARYYQADAILLMLSILNDNQYVFL RNIAEMLNMDVLTEIENKKELTRAINLKSKIIGINNRNLNNLSIDIQKTK VLAPLIPKKIIIISESGIQNYNQIRQLKPFVQGFLIGSNLMRKKNLEEAV CKMILGNNKICGLTQSSDVKIIKEYGIVYGGLIFCKFSPRYINCNNAYSI INNVSLKYIGVFCNENLKRVAYIGTKLSLHAVQLHGNEDQIYINNLKLIL PKHIKIWKSIIYLDFLKNQKHLFYNVNKYIIDNKDGGSGKTFNWKYLKNC KLDNVILAGGLDINNCILATDLGCYGYDFNSKLESSPGIKDLKKIVALTY SLRRHTVFNYRNLICLGKK >bbp260 trpD, anthranilate phosphoribosyltransferase MKIILNKIYQGDTLNISETYTLFKSIMLKKINNIELSAILIALKIRGESQ NEILGAVKACLEHMITFPKPTYMFSDIVGTGGDNSNSINISTTSALVGSA CGFKIAKHCNGNISSKTGSADILKKFGINIQISPEKSKKMLDELNICFLF APQYHINFKVVTQVRKILRIKTIFNIIAPLLNPAMPKLTVMGVCNFKLML PIAQVLKTLNYHHAIIVCSDNIDEVTLHSFTKIIELKNNNITSYILHPDD FGVKYCHKNDILGGNTEENYNIIKKILQGKGPSAVTETIAVNVAILFKIF GYSNLKKNTEYALKVIRSGKVYEKIIQLSKF >bbp526 trpE, anthranilate synthase component I MKKNLISIDVFLTETRYQPNPTAIFNQICKKKSETLLLESAEINKKHHLE SMMIIDAALKISFLNQIVIVEALTKNGVNLLSVFKSLLPKNVIILSDNNP LEIKFPILSMYLDEDQRLRSLSVFDAIRFLIKSVKNLSEFAPKSMFFGGL FSYDLITSFENLPILNTHQHCPDFCFYLSETLLILDHKNKTSIVQVTSFT NDNFEKKRLKDRLEILKNKLSKNLCPIKFDTLKNMKLWCNKTDEEYNKII VNVKKFILQGEIFQVVPSRKFYLSCVNPLSSYEVLKKNNPSPYMFFMQDR KFTLFGASPESALKYDINSRQIEIYPIAGTRPRGRRSDGSLDLDLDNRIE LEMRTNNKELAEHLMLVDLARNDLAKICEPGTRHVADLIRVDRYSHVMHL VSRVIGKLRFDLDFLHAYQACMNMGTLTGAPKVRAMELISEIEGEKRGSY GGAIGYFTGLGMLDTCIVIRSAYVENKIATIQAGAGIVLDSVPQLESDES KNKAKAVIQAIANSHSCQIEYL >bbp525 trpG, anthranilate synthase component II MGNILLLDNIDSFTYNLVDQLRSNFHQVFVYRNTVRKNIILKKLSKMINP ILILSPGPGNPDNAGCMPQLLMELKGKLPIIGICLGHQAIVKMYGGHVGY SGEILHGQASLINHDNKAMFLGMSNPLPVARYHSLICSNIPNMLVVNAHF NNMVMAVRNDYEKICGFQFHPESILTTRGTEFLQRVIQWTKI >bbp478 trpS, tryptophanyl-tRNA synthetase MEKLNKNVFSAVQPSGQLTIGNYIGVLREWILMQHDFTCFFCIADLHSLT VRRSSAILKNSVLDVVATYLACGLDPCKSVIFLQSCVHEHSELHWLLTCC TYYGELIRMTQFKDKARKNSKNINVGLLSYPILMASDVLLYDTDVVPIGL DQKQHMELICNIARRFNLLYGNTFKIPKNKMSYYGSNILSLSDPTKKMSK SDVNENGVIFLLDNLSSVKKKIKLAVTDSDNPPRIRYDKDTKIGISNLIN ILSCFQNRDISDIEKEFYYYSYQDFKSVVIKEIVNFMTNFQNLYFSFRKN EDYLEKILSEGSKRASWYAKKLLKKVKTSMGLF >bbp185 truA, tRNA pseudouridine synthase A (Pseudouridylate synthase I) (Pseudouridine synthase I) (Uracil hydrolyase) (PSU-I) MYKECFKIALGIEYNGSNYHGWQYQKFASSVQEKVELALSIIANHPVRVT CAGRTDAGVHSTGQVVHFCTSSIRNDQAWILGTNRYLPKDISVIWKRDVP MHFHARYSALSRRYRYILYNNSCRSSIFYQGLKFYHRILNVEKMNQAAQY LLGEHDFTTFRSSHCQSKTPFRKILYVNVFCINCLIIIDIVANSFLYHMV RNIVGCLIEIGISKKKVTWIRDILKFKNRTSSTKIVESNGLYLVQVQYSS LFKLPICPVGPFFV >bbp338 truB, tRNA pseudouridine synthase B MYSEFRSIDGIILIDKPYGLSSHETLQKVKGILKIKKMGHTGTLDPLATG MLPMCCGRATKFSQFLMNFKKRYRVIAKLGQKTSTSDSEGQIIHVRPITF TNLQLQKVLKSFHGKIKQIPSMYSAIKYHGHALYKYARQGIVISRKVRDA IIYELKVLGYSYKHKYLELDIICSKGTYIRTLIEDVGEKLNCGAHVISLR RLQVGNYTSFQMIDIKTLNKLVKYNINVLEHILLSVDNAISCFPEVNIVP NVIKNLQNGQKVKTHSGFINQFVRITEGINRRFIGIGKINNINELYSYRL II >bbp539 trxA, thioredoxin MTNCIVELTDGIFKQYILESKKAVLVDFWAEWCNPCKILAPILEDIAKEY EHKLIVTKINIDKNPNTAPKYSIRGIPALLLFKNSELVGTKVGALSKVQL KDFLNLYLK >bbp291 trxB, thioredoxin reductase MIENTLKIEHHKLIILGSGPAGYTAAIYSARANLEPLLFTGNNKGGQLIN TNEIENWPGDSKSLTGLELMERMHNHAKSLNTKIIPNEIIRVNFFKIPFL LVSDTNQYYTSDSVIIATGASPKYLGLTSESKFIGKGVSVCAVCDGFFYK NEDVAVVGGGNTALEEALYLSNIARKVYLIHRRKTFSAEKILISRMLNKT KKNIILRTGCIVNKIIGGVNGVRGVQITCNDSKENKCLINLSGVFIAIGH APNTKLFKNQLFMKNDYILVKSGIHGNVTQTNIPGIFAAGDVIDHVYKQA ITSSASGCMAALDAEKYIDQKYGFKI >bbp214 tsf, elongation factor Ts MTNISAFLVKKLRARTGVGIMDCKRALMCMKGDIDKSVDFLRKMGQIKAE KKQFLLTQNGSIFISFDHNLGVMLELSSETDFVSKHKDFLCLGEKILDYV LTHPMESIEFIRKHFEDLRTSLVMQVNENIVIRRIQTLNKKYITGYLHGR RIGVLVQTSSINNHLAKEIAMHIAASNPKYLRSDLVPKSIMEREYEIQLE LAMQSKKSKPILEKIIKGRMIKFANEISLLGQNFIFDPHRKVSEVILKNN IDVISFVRYEVGEKYI >bbp469 tuf, elongation factor Tu MSKEKFKRSKPHINVGTIGHVDHGKTTLTSAITTVLSKKYGGAACAFDQI DNAPEEKARGITINTSHVEYDTSIRHYAHVDCPGHADYIKNMITGAAQMD GAILVVAATDGPMPQTREHILLGRQVGVPYIVVFLNKCDMVDDEELLELV EMEVRDLLTQYDFPGDSTPIVRGSALKALEGDPQWEQKILDLSNYLDTYI PEPKRSIDQPFLLPIEDVFSISGRGTVVTGRIERGIIKVGEEVEIVGIKS TVKTICTGVEMFRKLLDEGRAGENVGVLLRGTKRDDIERGQVLAKPGTIT PHIKFESEVYVLSKEEGGRHTPFFKGYRPQFYFRTTDVTGSVELPEDMEM VMPGDNVKMVITLIHPIAMSDGLRFAIREGGKTVGAGIVVKVLQ >bbp384 typA, GTP-binding protein TYPA/BIPA MSLNIMQKKTNKNLRNIAIIAHVDHGKTTLVDKLLQQSGTFKKHEEFSER IMDSNDLEKERGITILAKNTAIQWKKYRINIIDTPGHADFGGEVERILSM VDSVLLVVDALEGPMPQTRFVTQKAFSYGIKPIVVINKIDRKHARPNWVI DQIFDLFVNLNATDEQLDFPTIYTSALLGTSGVSYNHMNPDMIPLYNAIV KYTPPPTVYPNCPFQMQISQLDYDNYLGIIGIGRINKGSVTSNQSISIIN NTEVKRTGKIGKILQYLGLNKIEINEAQSGDIIAITGIDKLNISDTICDP QYISALPMLKIDEPTVEMLFSVNKSPFSGTEGKYITSRQIFNRLKKEENY NVALKIKETNDTNTFSVSGRGELHLSILIENMRREGFELEVSRPQVILKT INELIQEPMETVVLDIENKYQGTIMKTIGQRKGTISNITPDQNNERTRLD CIISSRSLIGFRTEFSTLTSGSGLFYSTFSHYQKIESNKIKRHRNGVLIA NKTGQAIGFSLFNLQNRGKLFITHGTKVYEGQIVGIHNRVNDLTVNCLSG KKLTNMRASGSDEAITLTTPIKMTLEYAISFINDDELVEITPKSIRLRKR YLKENERKILLRNIKE >bbp115 tyrS, tyrosyl-tRNA synthetase MLTDTLIQEFQDRNLISQITNEIDLKNILLHNKISLYCGFDITADSLHVG HILPLLCLRRFQNLGHRPVILMGGGTSLIGDPSFKLLERQLNSIELVHTW KQKITKQLSLFLKFNVGKNNALIVDNYEWFKNINVLTFLRDIGKHFSINQ MIVRDAIQRRIKRLDQGISFTEFSYNLLQAYDFYFLNKQLDVILQIGGSD QWGNIISGIDLIRRLHKKRAYGITVPLLTKKDGRKFGKTELDTIWLDKMK TSPYKFYQYWMNISDSDIYSFLKMFTFLSLSEIKALKDTTKPTELNSVKK ILAEYLTNLVHGSNEVRAIQRITSSLFSGKFSEMKETDFFQLEQDGMPSV QLYNSGNLQQLLVYSRLALSRSHAKSMIVSNSVRINNIIQNNPFYILCNR DKMYHKYTLLSRGKKNFCLLCWTK >bbp172 ung, uracil-DNA glycosylase MDNRTLLNWSSILKNEKKKYYFINIINHLFFERQKKMIFPPKGKVFNAFV HTQLYDIKVVILGQDPYYKINQAHGLAFSVENIVKFIPSSLKNIQKEIIS DLGQNRSFSHGCLTKWALQGVFLLNSVLTVEAGKPGSHYKLGWERFTNKV ISIINEYCKGVVFLLWGSYAQKKICLIDRTRHYILLAPHPSPLSAYRGFF GCRHFSKTNKILKQQNKSPINWFF >bbp218 uppS, undecaprenyl pyrophosphate synthetase MSYSKNNMLFKNVLNFKKNIPSHVAIIMDGNGKWARKRGKSRFFGHFSGF YAARRAISFALFHKLKILTLYAFSSDNWNRSPREIKVLMELFFYALSNET NNLNKYNIRLKVIGNKEKFNTVLKNKIRVVEKETLKNTGLLLNIAANYSG RWEILEAIKKIVVAIKCKNLSLNAITESTVSDFLLINEKIPVDLVIRTGG ECRLSNFLVWQISYSELYFTNTLWPDFDRKEFKKAIDEFSNRERRFGRVS H >bbp530 uspA, universal stress protein MMNYRHILVMIDLSPDSYSLIHKASFISNLHNDAKISLIYVNTDYSDAYT GLIDVDIRNIQSYRLQDINNMLKNLKNYIYFPVHKVFIGNGDMTSCLLDV TQKYNIDLIIFGHYQDFWSKIVFSLRQIINSLHIDMLIVPFY >bbp331 valS, valyl-tRNA synthetase MIKKYFDPLRMEKSLYEFWEKNGYFKPQNNKGKPNFCIVMPPPNITGNLH IGHAFQQTIMDILIRYNRMIGKNTFWQVGTDHAGIATQIVVEKKILKEEN KTVQQLGKKEFLERIWKWKNTSKNVITSQMRRLGISVDWTHEKFTLDPQI SFAVRKVFMTLYDECLIYKRKKLVNWDPVLKTVISDLEVKNRNVIGNMWY IKYYLVKNHSIKISQEYYLVIATTRPETLFGDTAIAVHPNDSRYKKYIGC YALVPIINRIIPIISDEFVDVNKGTGCVKITPAHDFNDYEIAMRHNLSII NVFTRNGKITDVIEEYDISGEKSCIYKQNVPLRFHHLDRFIARKIIVKEL IALKLLIKIQKHNLAIPYGERSGSVIEPLLTDQWYLRVEPLAKIAVEAVK SGKIIFIPKKYEKIYYSWMNNIKDWCISRQLLWGHRMPIWYDKKNNIYVG LDEKHIREKYHISDDIFLIQETDVLDTWFSSSLWMFSSLGWPNNKDLFKN FYSTDVVVSGFDIIFFWIARMIMLSMHLIKDHNGNGRVPFKKVYITGLIC DEHGKKMSKSKGNVVDPLDMIDGISLDALIQKRIKSTVFSTHSKKIITQI QSLYPNGINSSGVDALRFTCAALSTPTRYIKWNINRLYGYRNFCNKLWNA SRFILMNLTHEVEPVKLILIKPMSLSDRWIVAEFHNLVKRYRTALDNYRF DIAANVLYEFVWNKFCDFYIELVKSFINSCSMLELKSTRCTLVYILDSVL RLAHPIIPFITEEIWQKLQVFVKKNDKNTIMLQSFPKYDVKLVNKTILED MDWIKNIFIIIRSFRMDLKISHTTLISISFKNVSSKIHKLIEEHKDYIKK IAYLDNVSIILSNVDSMLFFKSYIVLGAELLIPYSKIFPKEKELKNLNKE ISKIQLAINKLQQRLSNEEFIGKAPIHVVKKYKNQLQIYIEHKTQLCHKK LTMLRD >bbp206 yabC, hypothetical protein MKNNFSHTPVLLNETIQNLDIKNDGIYIDATFGYGGHSKEILKHLGKNGK LYSIDQDPYAIKIANKLKNDTRFNIIHGKFSNILKYSNKNKIRGKVNGIL LDLGMSSMQINNPNRGFSFISDGPLDMRMNPNTGIPAYMWLKKTNLTTLY HVLKKYGEEPFSKKIAYNIIAYNKKKTITRTLELSKIITNSIPIKKYRKH PARRVFQAIRIYINHEIYELQQALEHVLNILIPGGKLLILSFHSLEDRTV KKFMIKYSKPPFVPPGLAITETQLKSLANKQLKIITKIFPSTIEIRKNPR AHSAILRVAQKNNNE >bbp130 yabI, putative DedA-family membrane protein METWFLYFITKSISYALFMVLIVTFLESLALVGLFLPGIVLMSILGTLIG NGTLSFYPAWIVGIIGCMCGDWISYYCGFKFKKCITNLHLLKNNNVVLDK ITNTLTNYPITTILLGRFIGPTRPLVPMVCGMLNISLKTFIIPNILGCIL WPPIYFLPGIFTGIAISNTTNYSENTYFKIQFLAAILLIWLGIFLLWKLW KRYTDTGKKKIYISNVNLCLLLTISLSAGITIMIYIQSNSTLIFFRKILW KILISSQ >bbp193 yadR, HesB/YadR/YfhF family protein MKNNISKFPLSFSKSAIKKIKTIISEKNIPNLKFRVYIAGGGCSGFQYKF KFDKNKNKNDTIVNIFNNIIIIDPISLQYLRGGQIDYIENLEGSKFIILN PKAKHTCGCGSSFSI >bbp125 yajC, putative membrane protein YajC MDNFISHIYAVENSTTIPSSNSYSLIFMLLVFLSIFYFMIFRPQRKKIQE HDRLIKSLSYGDEVFTSSGFVGKIVKITKTGYIVLELNNNVEVFVKSDFI VSIFPKGTLKNMKSM >bbp411 yajR, putative transport protein MSFDEIKTHNKKAIIGIFMIFSLRVFGMFMIVPVLSTYGMCLKNSNIFLV GVAIGIYGIFQIIFQIPYGWLSDKYGQKLIINIGLLCFLLGNIIAWSSNS IWGIILGRGLQGSGAISSVCMTLLSELVLPHNRIKIMGLLGVSFGISFFL AVILSPIIVNMFGFYCLFLINSLLSIFCLFFGMFYIPASLLNKNVVCNFR SEISNFFKILSNRVLCQINLSVFLIHFFLMCNFIIIPVELKKIFEFFEYV PEIIYIVILLVSFLIVLFCICFIQSKVLYSNITITTSAFLFVLCYGIFLL FGHNNISLILGLQIFFIAFIFLETILPALVNKFSSKNYKSTTMAIYSTSQ FLGSSMGGIIGGILFSYLNYFEVLFFEFVVSILWFITSILYLIK >bbp117 yb1688, putative membrane protein MQNPREGMDLPQVIFSLVFIFIMIISSLWIMRPFFLGFAWASMVVVATWP IFLKLQILLWGNRACAVVMMTFSLLLVFIIPIVCLVNSLIDNSTSVISWL SSDKFRFPSLEWLQDIPIIGIKLFSSYQKLLNEGGAELITKVQPYMGKTT EFFVIQAGHFGRFILHLIFMLIFSALLYWNGEKVQSVIRHFAIRLGSKSG DSVVLLAGQAIRAVALGVVVTALVQGILSGIGLAISGIPYSSLLMMLIII FCLVQLGPLPVLIPAIIWLYWNGKTTWGTVLLIWSCVVCILDHILRPILI RIGVDLPTVLILSGVIGGLIAFGMIGLFIGPVVLIISYRLISSWMDEIPA PNSLSKKSVQQLLFKKKN >bbp092 yb2331, hypothetical protein MNKSDSLLSKDLFLLYQEFSEIRKIKQDTVFQSRRFKLVQDIKIKKNMYE QDIHYHYLSCQKFQISFNHDSIFYLRNKNYFDVLKKLKIGKYVPEIILDV HGLNQDQAKRKLGELLNICHKENLFCASVIHGHGRNILKNKIPIWLSRHP SVIAFYKIPKKFGRSTAILFLIHSSD >bbp170 yba2, hypothetical protein MNNEEQKLIENLFSRLYKAESDFPNRDKNAEQLINDLLRKQPSSSYYMTQ TILVQEMIIEKLNAKILELEKNLSMNEKQTKHGSFGFLSGLFKSKKKEID ACNQGNKAGNHKDDISKRPIMDCLNNNVGKTTSVLGRETIYNTSNNSMSG FLSGSLQTAAGVAGGMVMANLLMNLFQHKRPEEEMIDQISHNPTPVSADS DDLVNNNMNNDKHDVASSDYINDEHEYGEHVKNDHQLHDSPLCSDVSDST SNNNYDESLNFSNDNNNSSFNDFDDDNFI >bbp529 yba3, hypothetical protein MSSMSVVDNVQLVDVNKKTHPQAILIQNDKFNNENLNDSVLSDIDSNEIV KLQYKTRSNDGNAVYAELPPNQLIDFEVGPVMQNSSNFSFSEEAVNQPSI FQRVSEFFAPIYAFLKDLLPSFDSITNAAKSVEDFGVSAYQTGKDIVCDS VDAIGDMGKSAFDYTVDFGKSIFSAVVNFFSGDSSTLDLGEENTEKKFEG SIPSNLHRVSREIHQSLMSNEISKPYWKSLNKIIGDNQQVSTGKKFFNRF MSLRNTSRLDDSFIFEGEHSILQINGQQVSKYSPKTMLDDFKTAIPDLAS RQLISSFSHQGIFSQPYIELFSEHPDLVKFKPKDSQFSYVVHEVEDGVFQ FTATSQADLESSYETSDHKKYNAFGVQVSMTLSKDKSPEDVEYSYYLR >bbp426 ybaB, hypothetical protein YbaB MFSKDGLNNLMQHAQKIQEQMKKIQQEVSEIEVTGESGAGAVKVTLIGSH YCKKIELDKNTILEHDKEILEDLITAAFNDAVRKISDLQKQKMSSISSEM KFSNNLNLPF >bbp432 ybeD, hypothetical protein YbeD MRKNKLEKMLKFPCLFTYKVIGLAQPELVDKIVKIIQCKLPGDYVPQIKS SNKGNYLSISITICANTFEEIESLYYELSNINIVRMVL >bbp393 ybeY, hypothetical protein YbeY MNKKITLNIQIASKKIIFLPKKCQYLIWIRSSLMHVYQSNIKVLIRIVEK SEIKSLNYKFRQKNKATNILSFSYINDKMIDKNYIGDLIICSEIVTEEAK KKNVTLESHWAHITIHGILHLLGYNHDNLNNRIKMEYLETKIMASLNYKN PYIY >bbp279 ybgI, conserved hypothetical protein MNNFELEKIVNKKLNSNQYNDVIPNGLQIEGRPKIKKIVTGVTACQLLID LAISNNAHGIIVHHGLFWDNHPKIIKGIYRHRIKSILANNINLYSWHFPL DVHPILGNNAQIGHILNINVRGYIKSCVPWGMLKEPIKSKDMSQLITQKF HRVPFYYGNNITQNIHKIAWCSGKGQKFINFIPEYGVDTFLTGEVSEETI HFAHENKLHFFSIGHHASEINGIKALTNWLKIKFSLDINFINIDNPI >bbp274 ybhE, conserved hypothetical protein MKQIIYITLAKNQEIEVWKLHDDFSLNLLQRISTQGEPQPIIISKDKKYL YIGVRPKFKVYSYKIKADGTLTKHACSTLPGSPNHFEIDHTGKYLFSSSY HFNCLSITPLDTLGIPRPVTQTIKNIFGCHASKMNCYNTCLFISALKKDC IYAYNFKKNGKLLKNTRKNFMTNVNFGPRHLDLQKCNNRLYSVNELNGSV DIWSINSFSNELILLKNINIMSKNYCNAAWSSDLHISPCEKFLYVSDRIE NTISIIKLEKDVQNIEKIGHIKTELQPRTFSINSTGENLIVVGEKSNSFS VYKISKITGLLELKNTYSTGNRPVWISSLML >bbp412 yccK, putative sulfite reductase subunit protein MNYIPDWNEELAKKIAKSEFINMTPDHWEIIYIIRNFYLNFNLAPSIRIL IKTLEKMKYNKKKCSSRYLLKLFPKNPIKQASKIAGVPKTNDCI >bbp330 yceA, conserved hypothetical protein MLYLYNKHPRIKLRNAAIFDNINRVTVSFYKYIFIHEPIKFRNSLYRMFF KFNIFGRVYIANEGINAQISIPKKIYHKAINIITTSFAVLKDINVNLALD NRESFWVLRMKVRKKILFDNLPIDFFDPNNVGTYLSAKDVNNMLENKNSV LVDMRNHYEYKIGHFDSAINVPVNTFREQLFHIVDFLKHYKNRDIIMYCT GGIRCEKATAWIKYNGFKNVYQIKGGIIKYVRDARIENLLVKFRGKNFVF DERMSEVVSKDVLSKCDQCENLCDTYVNCFNSRCHNLFIQCNFCRKKFHN CCSEHCFKTLLK >bbp243 ycfC, hypothetical protein YcfC MLSLAGICQSIVLVNQLSETGECHSKSFEICIDSMLNLYPTTVLSIYGNK EKNLKLGITTLMSLLNVNAILKCKNSIKMIRYIFNLITLENRLENNIKYK NILFKELSILIQQHKNRVYTYDLLADRLAQIYLDTVSKLGFRIQVSGSKK VLHNIVIQNKIRCILLSGIRATMLWKQIGGRRYQFVFYRNSIFHYADMIL KKINDTKYS >bbp327 ycfF, Hypothetical HIT-like protein MCQNIFQKIIKGIIPSKIIYQDKEITAFHDINPIAPIHILVVPNLLIKSL NEINENNKHILGNMLYISIKIAKKFKIDKNGYRLIINCNQHGRQEIQHLH LHLLGGKKLNKI >bbp325 ycfH, putative deoxyribonuclease MFLIDSHCHLDLLNYNKIHTGIQDVLNKSKKKHVNVILTVSTSIENFCYL LKFIKGNRNVLLSCGIHPHYIPENKNEILKLKKYSNNEKVVAIGETGLDY YRNNDNKKLQQILFREHIKTSITLKKPLLIHTRNSINDTINILKEENSKQ CIGVLHSFTEDMHSARILLNMGFYISFSGIVTFKNSKIVHETAKFVPIDR ILIETDSPYLSPVPYRGIENQPAYLYDTMLYIAQLKNMSPECFAIQTTKN FLKLFNLPSYFTNMS >bbp163 ychA, hypothetical protein ychA MTYFLNSDFSKLPLCESIIEVSRAIRQDFPSKRVIEDLKHKVEVARNYVV SENLPFLKLRKLIKLFYKNWKFECASGIYKLSDVLWLDHVLKTHKGTAVS LGIIILHIAQQLNLPLMPVIFPTQLILRADNGNGNMWLINPFNGDTLNKH VLKVWLKGNISPTAELYNNYLNKVQYFEVVRKMLDILKSALMEERNLELA LNVSNVLLKIDPKNPYEIRDRGLIYSQLECDHVALTDLIYFVEHCPDDPI SEILKIQIHSMEKKVITLH >bbp248 ychE, putative membrane protein MNVEMFDFSIYISFFFSLFALVNPIGMIPIFTSMTNHQSIVERNKTNLIA NFSVAIILSISLIFGSFILNLFGISINSFRISGGILVMIIAISMINGNFI NNINNQKNGKLDKDIARNISIVPLAMPLIAGPGAISSTIVWSTHYSSVEN IFGCMVTIMLFSCFCWTLFKVSPIIVDILGRTGINIMTRIMGLLLMSLGI EFILAGLKASCSNYF >bbp180 ychF, hypothetical protein MGFKCGFVGLPNVGKSTLFNYLTKLNIPADNYPFCTIKSNVGIVPVLDNR LNKIAQVVCSNKIIPATIELVDIAGLVKGAYKGEGLGNQFLDHIRDTNVI MHIVRCFENRYVTHIYGSVDPVRDVQIINLELILSDIEVCKNRMCKLEIN KLSHNKQVNKELLILKKCVYHLEKSKSLRSLNLTEEEIFVINYLRLITLK PVVYIFNISIDQSRNLYKREIFDIIKNEHNAKTVNVCLDLMQSSKNDVSA YDHLSLKYKQLFNKMLKNVIWAGFNALNLITFFTAGKKEVHAWTTTNNLF IFQSVKCIHTDLSKGFIRAQVISYDDFIKYKGEKRSKELGKIRIEGKRYV ICDGDIIHVLYNV >bbp254 yciA, putative acyl-CoA thioester hydrolase YciA MNIKNQKPKGKMVLRTLAMPADTNANGDIFGGWIMSQMDIGGAILAKEIA RGRVVTVSVNGMTFLKSVSVGDVVSCYAHCIRTGNTSITIKIEVWIKKVS SEPLGKFYCTTEAIFVYVAVDEFGQPKTLLPFSII >bbp256 yciC, hypothetical protein MHITANSLFRDTIHFLRSKWPIIVTFVLLSSTITVVIDSIITPNARSLLA FYQLDIKKYHSLLDFVRTLTIDQQKLLLYASIAKSFSLLIGSTFLLGNLI TFIQMTSYKKNITLSIFNNIPYKTFFKLLQLIFTTTIITQLGFLLYFIPG FTTIILFSLSPIILLIEEKTILNSIYASINITLSNFKIIVPAIIFWLCFK IFIILIISYFKFFSDFLAYFILNLCINFISSILIIYLFRCYMILPKFLKN >bbp262 yciL, ribosomal large subunit pseudouridine synthase B MCEKIQKILARHGYGSRRYIESLIKSHSVKINDEVVKVGQRISINVIQKV IINNNNYKPKLNINKSLKVLLYNKPEGEICTRKDQRNRRTIFEKLPKLSN ARWINIGRLDLNSSGLLLFTTDGELAYRLTHPSFNIERIYKVRVFGQFTE NILKQLNVRVKLLDGYANFKSIQFKYGEGKNKWFNVSLCEGRHRIVRRIW EKLGFQVNKLVRISYAHLTLPKTLFPGTWITLNKHDIDVLCKKVNLR >bbp113 ydgQ, electron transport complex protein rnfE MSNILKIFVDGLWKKNSSLVQLLGLCPVLAITVNAINAIGLGLATTLVLI CSNATISLIKNNIQKDFRIPIYIIIISSVVSSIDLVIKAYAFNLYQSLGI FIPLIITNCIVCNRADLIAVHNSVLVSILDGLSIGLGSTLTMFLLGSIRE IIGHGTLFFGIEHVLGESFRFLYIEVLDKNSVFLLFAFPSGAFMILGIVL AGKNFLDEVLGIIEHKNVCVCSNKVLVYKDGNKKIESQKSL >bbp176 ydhD, thioredoxin-like protein 2 MNDIIKKIQNQIQNNPIIIYMKGSPDAPSCGFSAQAVHAISSCGKKFAYI DVLKNPDIRLELPKYANWPTFPQLWVNGELIGGCNIILELFQKGELKKTI SICDKLNS >bbp116 ydiC, conserved hypothetical protein MTHKNSCITLISPQNNKIKNTQGIKITSSAKKQILFLTKKNKKKIKLRLK KTGCAGFKYCMEEVVDTSTNLSEIIFYANDVSIIVNTNELHMLDGVKIDF VKEGLNYSFKFSHTKIKNFCGCGNSFEF >bbp301 yeaZ, putative protease precursor MLKTILAFDTSMSVCSISLLHKNRKYNIQKECRNNHTLYLLPMIHEILKK NHVSLNEINIIATSKGPGSFSGVRIALAVAQGISLGLNLPHVISLSTILI MAEQVWNNHKISKVLAIITVNKTSVYWIQYSRNFHGLWIKKSKAIILNLS KALEKILSLKKQWALVGNGWDKFPKNILKKIFITNITFPNSKYIISLISA NSIYQKKEVLHKIIPIYLNER >bbp296 yebA, metalloendopeptidases-like membrane protein MTKCNIFNMIFLKFSNAFIKKIKYLSIISIISVFLLNSSIVYSCSKIILI FDNNFKENNKNILNKLVLPIKNIILKGTSNLEFNDYLLKLSNFYGSPIHK CIYNFPYKKLQNNNLNNLKYIIFKSKIDNNFIKNMQYLNVSNDNIDNVVR CIKLELKIHQLKQDHKCNILIQNNSFLKHNIVQKNIILSFEIPYNTKNIY GFFTKKNKFFDVHGISSAPIFLKFPFLKKYRISSKFNPNRFNPITKKNSP HQGIDFAMPIGTPILSIGDGVILNAKFSIQAGNYITIQHNCSYITKYMHL KKILVKIGDKVKMRDKIGLSGNTGYSTGPHLHYEVWLHKKVINPKNLKTR ECLIKKNLKEHINFSNIIITQFEIFK >bbp166 yfaE, putative iron-sulphur binding protein MINSKIIILNNNKVIYYKPQNITLISILEKNDIILDSQCKQGYCGSCRIK LLKGHVYYKNIFPLASCKPKDIFPCCCTISGSILIKI >bbp265 yfgB, conserved hypothetical protein MNMINYECKMQKIKLKTNLLNFDLQSMKKFFCSIGELEFRAQQVMKWIYQ HYCDDFNKMTNISLQLRKKLSTLCCITPPKFLNHKVSVDGTMKWSVVIGN QCIETVCIPKNQRTTLCISSQLGCSLACSFCLTGQQGFNKNLNVSEIIGQ VWYIQKLIYFSKINITNKITNVVLMGMGEPLLNLSNVVHALRIMLDEFGL NMSKNHITLSTAGIVPALKKLHTMIDVSLAVSLHASNNTIRNQLMPINKK YNIESVLCAIKKYLYYSNANKKRVTIEYVMLSGINDAAYHAEELFNLLKS IPHKINLIPWNHFSGSNYICSNDITINNFANILIKKGCIVTIRKIRGYDI NAACGQLSGIVFDRKFNKINCIS >bbp550 yfgM, hypothetical protein MIKNSYINEKLNFYQKSFLTCMLLIVIVIVYFFSKNYLDKPKNSYVHTKM MTFLTNSNELNISKNLIWTKKTISGNLMSLKLAKVYVINNQLEKALKILE KSKNNSVDLNFFNLISFKIAQIYFQKNNIKKAITTIKDILGDSWDSIRNN FIGDVYFKLDNQKRAVTLWKRSIIQNKKIEFEKIIQMKINNYN >bbp236 yfhC, putative deaminase MHDSDKYFMKCAIFLAKISEMIGEVPVGAVLVFNNTIIGKGLNSSILNHD PTAHAEIKALRNGAKFLKNYRLLHTTLYVTLEPCIMCYGAIIHSRISRLV FGAKYKNLQKYICCKNHFFINKNFRKISITQEVLESECSNLLSSFFKRKR KIATKYFNNNII >bbp234 yfjF, hypothetical protein MITITIVYFTNKIQHVKKIKLNIGTPVHEALKILQINIKKNNKIGIYGEL VSLNHILNNKDRLEIYRPLKINPRELRKQKINRKLK >bbp370 ygfA, 5-formyltetrahydrofolate cyclo-ligase MLLKCRDFQRKYFRKLRKKINNKIREQLAISISKKIFYCNILDSVKNIAI FCSFDGEIDTYPLILKLWRQNYNVYLPIINYNYKKILGFMKYLPNTSLIK NRFNILEPVFDRKNFIQSDDLDIMFVPLVAFDEFGYRLGMGGGFYDRILI NYDIKKSFFPIGLAFDCQFSKNINIKYWDVALPVIITPKKFWIWI >bbp391 ygfZ, conserved hypothetical protein MNNELIEYNLHFSKTIKLTFLKDWSFITVTGKDCFNYLQGQITYNLKLLK SNKHIICSHCTIDGKVLSILRLFMHNDGYAYILRKSTSKFQINELKKYSI FSHVNICQKKDIILLGIMGREARTKLLQIFKNIPHERDSVYQENDVIILK YDQPHERYLIIIKKHNLILNKILSLVDKIYHHKIWLALEIASNFPIIDYN INKKFFPQSLNLEKLNGLDLKKGCYYGQEMIAKIHFKKLNKHYLHWLSGY SYPIPKIGDNIEQKKNKNFSSCGWILSVVKLSTTKIWIQAVLKHYNHYKT NVFRIKNKINSFFYITDE >bbp402 yggB, putative membrane protein MTQLNVVNDINHAGNWLIRNQELLLSYIINLISSIIILIIGFFAAKIISN LINKVLITQKIDTTIANFLAALVRYIIITFALIASLGCIGVQTTSVIAIL GAAGMAIGLALQGSLSNFAAGVLLVILRPFRTGEYVNLEKISGTVLNIHV FYTTFRTLDGKIVVIPNGKIISGNIINYSREKARRNEFIIGVSYDSDIDK VIKILKNVVKNEKRVLKDRDIIVGLSELAPSSLNFIVRCWSHTDDINIVY WDLMVKFKKALDSNNINIPYPQFDINLKKKY >bbp499 yggH, hypothetical methyltransferase MYFYLKYNINNMIMRRVRSFVSRNRKLTQNKRQFLKNYLLKYGIDFSCSY VNFNFIFNNEYPVILEIGFGTGEFLINMARKNLFSNFLGIEVYIPSILSC LRYIHKYNLPNVKVIFYDAVEVISYMISNNSLSEVYILFPDPWPKRRHHK RRIITKELLEVILKKLVFGGYLNIATDCQIYAKSILNIIENIKGYINLSN TGDYVIRSDYRLVTKFEKKGLVLGNKIFNLKFKSIFNNSNFL >bbp497 yggS, hypothetical protein MKNIQKNIKKLKQKITNISKKFKINTQKIKLLAVSKNRSVNDIKKAILCG QNSFGENYVQESQPKIKLFNNIEWHYIGQIQSNKAHIIAKNFSWCHTITN KKTAVLLNKYRPYSLPKLNTLIQINIRDNTINIDDDIETIKQLAKTINSL DNLNLRGIMAMPYFKNTYLEQIQSYKYIHLYFDILKKKYTYIDTVSLGTS HDIQAALYSGSTLLRIGSSIFDV >bbp498 yggW, putative oxidase MKLLGLYINIPWPTKRYKYHDFKFPEYKKKINEKKYIHHLLQDLKKDSLL VPNRTINTIFIGGIAPNFFKLTSIKYLLKKIKNIIPISKNAENTIEFHIS KLSEKKIFYYKKFGINRFSIRIQTFDQKKFNSLSKVHISKNILHKIKKIN IEKFKNINLDLIYGLPKQSLQEALLDLKTAISLKPNHISWCEFYIEKNNN NYKNLSKSCNLNIIWKIFLQGEKLLKKSGYKKYEISSYSKTNYQCLHNLN YWKFGDYLGIGCNAHGKITQKNGKIIKTIKNKNLKKFMNGKYTYKNHIIS KKNLSLEFFMNRLRLNTPIYRKDFKKYTYISEFYIKNEIKQAIEQNYLIE TKKYWKMTSKGIQFLDSLLEIFIT >bbp501 yggX, conserved hypothetical protein MNKKNDINRKIFCNFFKKYEEGLTYIPYPGLLGHKIYNEISKLAWNKWIL QQTIIINEKKMNMLNKNDQKKIENYMIKFLFKNKQQL >bbp156 ygjT, putative transport protein MENTIGTPTLWCSFGVFLIIIIIIEMSIQKIFVYKESAFKIALYSSCISM LTAILFDVLIWIYIKFTVNSYLANINFLTFISGYLLEQSLSMDNVAMWFF LFQLFSISMVHQRVILFYGTFLALVFRSSIIFFGVWLLSKWSFLFYVLSI ILLFTGIITILSNGVNKKTDVQNTFIMSWIYKKFRITKNFSKNNFFTKEN GVIVATPLFLVLILIELNDIIFSIDSIPAIFLITKDPFIIITSSFFSIIG LRSIYVILANSIQKFYIIKYGITLILIFISIKILLKEFVDIPIMLSSFFI VCILVACFIIEKFFFQVKSKN >bbp334 yhaR, translational inhibitor protein MIKEIHTHKSPKPIGPYSQAIQIKNFTFLSGQISQTDNINTNISFQTQSI LQNINYILESKEMNVGNIVKTTIFITNLNDLTIVNDVYQKFFLKYTKTFP ARSCVEVSKLPKNAKIEIDAIAYKNK >bbp352 yhbZ, GTP-binding protein MKFLDKAIIHVIAGNGGHGRTSFRREKYIPKGGPDGGDGGNGGNVWLQTV TNLNTLIDFKFTKIFKAQDGQQGFNKKKTGKKGSDIVIQIPIGTKIIDHN TNEIIEDMIQDKQLVLVAKGGWHGLGNTRFKSSTNRIPIKHTKGTQGEFR ILRLELILIAHVGTLGLPNSGKSTLVRNISNAKTKIANYPFTTLKPVLGT VKINHKEFFVIADIPGLIQGASHGIGLGYQFLKHLERCHLLLHIIDISQI NFKNTITNIHVILDELKTYNKILHNKPIWFVFNKIDLIDDIDINTKLKSI LEKLGSIQQYFLISAIKKTGLKKIVKKIYDFLKNKNLL >bbp473 yheL, hypothetical protein MLHILMRSPFETNMVLLMNMLESVDDILMLQNSVVLALKNNVFLNKILSY SVSMYALKQDLCARGILDNISPNVNVIGYNRFVDLTVKHKQQMSW >bbp474 yheM, conserved hypothetical protein MKKIAFVFSYVPHGVSLGREGLDLLLSVSIMNSKISVFFIGDGIFQLLKN QKPDEILSKNYVLSFKILPFFGIYDFFLCNESLKERGLFKKTDFLLDVSI LSAIEIRNKLKNSDLIINF >bbp475 yheN, conserved hypothetical protein MNYTVLVIGPPYSTQNSTSAFLFSRAVILNHHKLLSIFFYCDGALNANKF ISPNFNECNLVEEWTWLHNKYLVKLCVCVSAALRRGVIDVVSNTKQNKNI KVGNLKSSFFLTGLGEFSNYLKISDRVIQF >bbp477 yhfC, putative transport MINKSNLIGLTCISFLSYALTGALITITGIFLENISKYFNIPITDMGNTF TFLNAGILSSIFISSWITNIINLKTQLIFGFILTIIATLILIFSHNLTYF SISMFMLGIISGITMSIGTYIITNLYTDQTRASMLLLTDSFFSMSGIIFP IITALIISNNMKWYWVYFIIGIIYLIIFLITINTKFPIIYTEISKKRIKT WNFSILCLSISALLYILGQLSFISWMPEYTMKYIHISINQSSKLVSAFWM AYMVGMWIFSFILKFFDLKKTIITLSGISLFLMSLFNIFYDYALLYIIIL SLGFFSSAIYTIIITLASQQTPLSSPKTINYILTSGTVGTLLTFIITGPI VQKYGIFSALLVSNILYGIVFFLVIIFATLTKTKPIHD >bbp486 yhgI, YhgI MVSVSQSAQNYFLNLLKKQKYGTNIRVYVKYPGTPVAKCGVSYCYKDDVT RLDVAFTMNKFIVYVYKPHIPYLRESKIDINVEECNSQLTLIAPYANKCY FIKNNDLKRRVENFLNLNINPQLSAHGGKVDLMNITESGYLSLKFSGGCN GCSMVQKTLKEGIEKQILAKFSEFKGVYDITQHNRGNHSYY >bbp399 yhgN, putative membrane protein MKEIISVTILLILIMDPLGNLPIFMSILKHLEPQRRKKILIREMMIALLI MLLFLFAGEKILIFLNLRAETVSVSGGIILFLIAIKMIFPTYESKKKSGN IIKREEPFLVPLAIPLVAGPSLLATLMLLSHQYPKKILYLIGSLLIAWMI TVVILLLSDIFLRLFGSKGVNALERLMGLILIMLSTQMFLDGIKSWFYI >bbp025 yhhF, putative methylase MKILKKKSKITSIQIISGKYKNSRIPIINTKNLRPTTNYIRETLFNWISN EKIKKSHCLDCFSGSGALGIEAVSRYALSSTCIEIQKKAIFFLKKILIKL SITNVHVIRANTIQWLKKPNKSYDIIFLDPPFKTTLLKQTIALLIKNNWL KNNALIYIEQENTLNKLITPPNNWILKKEKKTKKIHYSLYMNVNNF >bbp050 yibN, hypothetical protein MFKIIVSFFCDHVFLSVIWLISCVLMIFFTLKDILFCTQFISIMKLIRCI NYDRCLLIIDARTEKCFLKGHIINSVNIPYIDVKSVCNISVFKKYKNFSI VIVFKNDNQIDRNYVNFFKSIGCNKIYILRGGMNGWLSNNYPTVCLK >bbp016 yidC, putative membrane protein MHLQRNFFILIFFFISFLLWKTWQQKEFSSDVHKIINKYENVNLVNNNIN KLASNIIIKTDVLKIQVNLYGGDIEKAELLHFKSKLNSSQSLVLLDTNEN FVYQAQCGITGKDGADNLQKHIRPLYIAKRKYYELSRHNKKIEVPLQWIS KDGIIYKKIFVLKSGEYDVSVKYKINNITNKHLKVSMFGQLKQTINLPED KNTYTNNFALQTFRGAAYSSDNDKYVKYSFDSIVNKEKKNIVVTHSGWVA MLQKYFATSWIPDNSYLNTMYIGSSGDNLAEIGYYSRPIDIFPHSTISLS SKLWIGPEIQNKMAVIASNLDLTVDYGWLWFLSQPLFKLLNFLYNICGNW GVSIILITFIIKGITFPLTKSQFKTMAKIRKLQPKINYIKKKFKNNNQKI SEEIMSLYKTEKVNPLGGCFPLFIQMPIFLALYYMLISSVELRHAPFFLW IHDLSDQDPFYVLPILMGVTMFFIQRVTPSNVTDPVQKKIMNYIPILFTV FFLWFPSGLVLYYLISNLVTIIQQKIIIKALNKTLK >bbp015 yidD, hypothetical protein MVLLLSMISRCLILIILCYQRYISVFLSPRCRFYPTCSHYAVDALYTFGL LKGLLLIAKRILKCHPFHSGGLNSISIKTKSKREY >bbp030 yigL, putative haloacid dehalogenase-like hydrolase MYYIVASDLDGTLLSPQFYLTEYTKKIIKRLVNKGIYFVIATGRHYNEAK EIQKMLNVPVFLITSNGARIYDLNKKLIYSCDIEQKVVKELLQKCLLNHD ILIQLYSHNNWYVSNNNYSASSLYVSFSFRSKIFEFKTIIKKKISKIFFT CKNVKKLLCLEKYIISHWGKYVNVSFSFLNCLEIMSKTVSKGNSLQLIAN MLGLSIKNCISFGDGMNDKEMLDMSGKGCMMDNSHYLLKKSLPNLEIIGS NKFDSVAMYLNKIYFKK >bbp528 yjeA, putative lysyl-tRNA synthetase MNCNYLWKSSALLKNLHRRAKIIFEIRNYFFNLGILEVETPILSNYSVTD VNFIPFKTKLQITKKRMWLVPSPEYHMKRLLVQNIGAIYQISRSFRNNEF GGPYHNPEFTMLEWYSPYCNMFDFMKKVEKFLVFCLKVVQVKYISYQRAF IKYLNIDPLLAKKRELLDLINKFKFNHLISDCDSISTLLEILFTLKIEPN LNNKKLIFVYHYPADQAILAAINDNDSRVSDRFEVFFKGVELGNGFYELT DQAEHIRRFKLNNIQRRHKGICSVEVDQFFLKSLSRGLPPCSGIAIGLDR LIMLSLNLKTINEVIAFPIERC >bbp022 yjeK, putative aminomutase MLNKKIKKNHKEDWITELTNAITNPDELLRTLNLKSNTKYFKNIQVQKLF SLRVPKTFVSRMKKNDPFDPLLLQILPHTKELKNNHNFVQDPLEETKNVI IPGLIRKYNNRILLLLKTNCAINCRYCFRRYFPYSQHPGNKENLNLAIQY IKNQTDLNEVILSGGDPLMAKDHEIQWIVNTLSNIYHIKRLRIHTRLPIV IPSRITNNLCKILSTTRLKILIVTHINHAQEINHELQYNINKLHKLGITL LNQSVLLRGINDNAKILSQLSNKLFDINILPYYLHILDKVKSTTHFYVSE KQASIIVVELLSMISGFLVPKLVCEHPGKNSKIYINLNMK >bbp392 yleA, hypothetical protein MKNNKIYIKTWGCQMNEYDSALITQILKQKHGYENTKDPKLANVLILNTC SIREKAQEKVFHQLGRWKKLKQKNPNLIIAVGGCVATQEGKNIYKRANYV DIIFGTQTLHYLPNMIQEVKKNKKSVTNIDFPLTEKFNFIEYPRKPKVTA FVSIMEGCNKFCSFCIVPYTRGHEISRPVDDILLEISTLSSRGVKEIHLL GQNVNSYKGKTFNGDICKFSNLLRLVASIDGIDRIRFTTSNPFEFTDDII EIYAEIPKIVSFLHLPVQSGSNRILQLMKRMHTIDEYKTIINKILKLRPN IQISSDFIIGFPGETLIDFEQTLQLIKDLNIDMSYSFIYSPRPGTPASEL QDNVTLCEKQKRLHILQTLIRNNTTMWNQKMLGSIQSVLVEGRSQKNPKE LFGRTENNRIVNFKGNQNMIGEFINLKITKINPNSLRGSYEKRNN >bbp532 ynfM, putative transport protein MQLKIYSSNKNYIQRGTKAFTEVTIAFFLAGFSTFSTLYCVQPILFLFSK EFSLNPAQSSLSLSASTAMMAFGMLFTGPLSDSIGRKVVMSSSLFLASFC TFCCSNMNSWESIIFMRALTGLALSGVAAVAMTYLSEEMHPSVLSFSIGL YISGNTIGGFLGRFLSSLFSEYFSWNIALEFISFLAFTSAVLFVYLLPKS KNFCSSPLDLRKILLYFIFQWRDPVLSKLFFMGCILMGSFITLFNYVGYR LISQPFFLGQTTIGLLSIIYLIGVYSSPQAGVLIERYRKGVILTLALTMM IFGVLITQCNIVLLIIVGLTLFAAGFFAAHSVTSTWISQCSKINKGSTSS IYLFSYYLGSSIFGTFSGIFWITEKWLGISIFIITFLCIGILLSIRLLQY KNI >bbp300 yoaE, putative membrane protein MELFLDPSTWAGLLTLIILEIVLGIDNLVFVAILSEKLPPCKQDKARLIG LSFALFMRLGLLALMSWMVTLTSEIISNKYFSFSGRDLILLFGGLFLLFK ATIELHERLDNDIQKNENNKHYAGFWTIVIQIVILDSIFSLDAIITAVGT INNLPIMMIAVVIAMVLMLIASKPLTKFINLHQTVVVLCLSFLLMIGCNL VSEALGFYVPKGYLYAAIGFSIIIEIFNQIARRNFMLHQSRRPMRQRAAE AILRLMIGDQFRNTTTNISTKNKDKEKIRNRTTDTESFKEEERYMINGVL TLAARSIRSIMTPRNEISWVNIYQPKNKIRSQLLDTPHSLFPVCKGQLDE VIGIVRAKELLVALERTINIIDFSSTTLPIIIPDTLDPINLLGVLRRAKG SLVIVTNEFGAVQGLITPLDVLEAIAGEFPDADETPDIIFEKDSWLVKGG TDLHSLQQCLNITNLIKQENSYASLAGLLIAQKGQLPLPGETIVIPPLRF YILEATQYRINLVRITKQH >bbp491 yqgE, conserved hypothetical protein MIINFKNHFLIAMPGLKDPLFKNSVIYMCKHDNNGAMGIIINKKIKNLTI QKILHQLKINIKSSNTLDFKNPVIIGGPILEDRGFILHTFKKKFTTSTHI SNDLSITTSRDILEYIANLNNPKNILMALGHCIWKQHQLEQEIAKNIWLT TPADIDIIFNTPISEKWKKSMYSIGIMNILQLTSEIGHA >bbp492 yqgF, hypothetical 16.0 kDa protein MIIIALDFGTKNIGVAVGQNYTNTARSLPSIKVKNKKLNIEKLNKLIDEW KPNAIVVGHPLNIDGTKQKITQCSENFSKKLKNIFKIPILLHDERLSTVE AKAILFEKYGYKSLKKERIDSMSAVIILESWFLYSKN >bbp085 yraL, putative tetrapyrrole methylase MNAKNIKQTGILYIVPTPIGNLNDISYRAINILQHVDLIAAENIFHSQIL LKHYNILTRTTSLNKDNEKIKSKTLIIQLKNKKNIALISNSGTPLINDPG FYLINECYNHIIKIVPIPGPCAAITALIASGLPANRFCYEGFLPSKQNSR CKILNQIKEEQRTIIFFEVTHRIIESITDIINILGPKRIITFAKELTKKW EIIQKNTSYNILIWLKQNYTYKKGEIVIIISGYNNKNTNLISDAVLKTLK ILKTHLSFNKAIKITAGIYKLPKNYLYNYAINNTISKNNDIH >bbp348 yrbA, YrbA MTITNTIKSLLKKKIPLTVIHVTGDNKHINITAVSDIFNNINTLRRQQII YKPLMPYIINKTLHAISIKTYSLQEWKNK >bbp438 yrdC, conserved hypothetical protein MNILSLSECVDRLRKNLVIAYPTESVLGLGCNPESIDAVKVLLKLKKRKL NKGFILVASHFNQIRSYISESKLSIYHKKILYSSWPDTITYLLPAKSFVP DWLTGRSNFLGIRISAHNGINKLCSAFGKAIISTSANISGRNPCRTYEEF LKQFGTTVPILCGPLGTRKNPSKILNIINGSLIRHG >bbp081 ytfN, RpoD protein MDKLYVLVGFILMNILKKVFLSTIFVSIIFCLGILFLVKSNLGLRTIFFL SHYLVPELEVDQLIGTLNNFKLINVKYKSKNILLTIKVLQLNFIVHIFKK FYIDVNLVTCKNVNFFIKNINDVNFKTNGVFPLNLKSKFFSYFFIFFKDI RFYNFTANVDGVELFTNFFSSKGYWNKQFLELEFFKTDVVSINNFYCFDS TNNYCRFNSRNFLVCCRQYLKMLFNYFKKGNFDTFVNIDIANFSCNKIYL EDNKNISISKFFINFRIFKNSVNIKRLFFVFRRMFKVRINGFININQNYI NLTINCVNKNEIYGSSSNIKIIIHGLWLSILKINFYIDKININFLIKRIL MPEKLIFKCKLRLSNLNSYIHRKNFSYLNNFKLEIFTNSSEYFFQSYSVL NIKDVFPIKFCLLGIGNYKNIFLKLIKFRIFQKKILCNYEWKYCSNRDLV QKFLLNKFFDNLKKTKLLINIKKIILNNDFNEKILLLSSNFLNIRDKYIF TDVHIISGKNSFSMRSDFNSFLNLNVFFSIKDLKFFFPNFDGKFDIDVKI FRSINYYHAICKFIGNKLDFNIFKIVNIKFLIDINSKDFLNTIFLSVTKL FFGNLYVNHVFFKIKNEHDKRYLATICLSSYNNFMRLILDKYFNINVFIQ TNVLRKINYFKFYLDSNVNKTVFALISYLFSNYYKKININYVSFFKHSIK SKFVKFLNKFIYVKQIF >bbp294 znuB, high-affinity zinc uptake system membrane protein ZnuB MYKTFFFGWLAGVLLTTITGPLGLFIIWRRMSSFGDTLSHSSLLGISFAV LLNIHPFFMVIITILLFGMLIIWLNYTTVLSLDTILGIIGYSFLSLGMII INSISNFQKNKLTNYLFGNLLEVTYIDIVILIISCVSILFVLVWYWDLML LTTINSDLAKIDGVNVLKINSILIFLITLTIGIAIKFIGSLIAISLLIIP AATAQRFSTSPEKMAFFSVIIGIISITWGILMSVYYNLAISPTIVFCSSI VFVISNLKKIL >bbp295 znuC, high-affinity zinc uptake system ATP-binding protein ZnuC MSIFIQLNNISVNFNNRSILSNISLALTPNCILTLIGPNGAGKSTLVRVI LGLLKPNQGKIFFKNNLRIGYIPQKLNLHSTLPITVNRFMNLSYFNDKNY IQGMLSRINIIHLKHHPLQKLSGGEMQKVLLARALLKKPELLVLDEPTQG IDIIGKIAFYKLVNQIKNELKCSILMVSHDLSIVMANTDKVICLNNHICC SGPPETISKNSEFIAIFGNIGKNYLALYRHRHNHHHDF >bbp298 zwf, glucose-6-phosphate 1-dehydrogenase MKNKNSGYDLVIFGAKGDLSCRKLLPSLYQLEKKNKLCTHTRIIGVGRAN WDKIIYTNVVYKSLIKFLNETIIESIWKKFSSRLEFCNLDINCLHNFKKL KQIIQQNNNIIINYLAMPPHTFGNICLGLESINLNLEPTRIIIEKPLGSS LKTSININNKIGKFFKEKQIFRIDHYLGKETIQNLLAFRFSNSLFYYNWN NKFIDHVQITVSETIGVEGRFNYFDTVGQIKDMVQNHLLQILTITTMSTP IDCHENSIRDEKVKILKSLRPFNINNIHKNVILGQYTSGIINQKKVKSYL DETNNQEYQMNKYTETFVSMKIYIDNDQWSGVPFYLRTGKRLPKKCSEIV IFFKTPPLNIFSKNYNTLSKNKLILSLQPNEAIKIYILNKKPKLTSQYKL DLITLDFNYSKFYKKIQLSDAYEKLLLESMKGIQSLFVRRDEVELAWKWI DSTLQCLHLKPRLPDLYPAGTWGPARSKTMINNDGYEWNE
|
Beutenbergstraße 11 D-07745 Jena • Germany |
Phone: +49 3641 65-6000 Fax: +49 3641 65-6351 |
E-mail: info@leibniz-fli.de www.leibniz-fli.de |
Data Privacy Imprint |
|